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ABSTRACT
Epilepsy is one of the most common neurological disorders and, in addition to the personal
burden,  it  has  significant  economic  implications.  Anti-epileptic  drugs  can  achieve  a
successful outcome in about 70% of epilepsy patients, but, unfortunately, there is no
treatment to prevent or modify disease development before seizure onset in patients at
known risk.  The published data from studies investigating animal models of the acquired
epilepsy suggests that in adult brain, the changes in the GABAergic network in post-injury
brain play a major role in epileptogenesis. However, it is still uncertain whether data
obtained from one of the animal models can be extrapolated to others.
The aim of this thesis study was to profile and compare alterations in the GABAergic
network after traumatic brain injury (TBI) and status epilepticus (SE). A special emphasis
was placed on assessing a reduction in the number of the inhibitory interneurons in the
hippocampus and in the reticular nucleus of the thalamus (RT) in rats whose epilepsy
phenotype was studied. Moreover, TBI induced plasticity was studied in ventral posterior
medial (VPM) and lateral (VPM) nuclei of the thalamus. Finally, the quantitative RT-PCR
array was used to investigate if the loss of presynaptic inputs changed the gene expression
of the GABAA receptor subunits.
The results indicated that the loss of GABAergic interneurons in the dentate gyrus and
hippocampus proper was clearly greater and more widespread in rats with TBI with no
spontaneous seizures during two weeks of video-EEG monitoring at 6 months post-injury
than in rats that developed epilepsy after SE. Moreover, there was a clear decrease in the
number  of  parvalbumin  positive  neurons  bilaterally  in  the  RT  at  6  months  after  TBI.
Furthermore, a robust increase was found in the intensity of PARV-ir axonal labeling in the
lateral aspects of the ipsilateral VPM-VPL. Unlike the situation in controls, there were no
correlations between the seizure susceptibility and density of parvalbumin
immunoreactivity in the RT or VPM-VPL after TBI.  Relatively few changes in the expression
GABAA receptor subunits were found at 6 months post-TBI.
In conclusion, the present unbiased quantification of different interneuron classes in well-
phenotyped animals challenges the previous concept that the more severe the loss of
hippocampal interneurons, the more severe will be the epilepsy. Furthermore, it provided
new information on the role of post-traumatic molecular and cellular alterations in the
GABAergic network in the hippocampus and thalamus.
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Medical Subject Headings: Epilepsy; Status Epilepticus; Seizures; Brain Injuries; GABAergic Neurons;
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TIIVISTELMÄ
Epilepsia on yksi yleisimmistä neurologisista sairauksista. Sairastuneelle koituvan haitan
lisäksi se aiheuttaa merkittävän taloudellisen rasitteen yhteiskunnalle. Nykyisillä
epilepsialääkkeillä kohtaukset saadaan hallintaan noin 70 prosentilla sairastuneista. Vielä ei
kuitenkaan ole tarjolla sairauden kehittymistä estävää lääkitystä potilaille, joilla on suuri
riski sairastua hankittuun epilepsiaan. Aikaisemmat koe-eläinmalleilla tehdyt tutkimukset
ovat osoittaneet, että aivovaurion jälkeen tapahtuvilla GABAergisen järjestelmän
muutoksilla on keskeinen merkitys epilepsian kehittymisessä aikuisilla. Eri eläinmalleilla
voidaan kuitenkin saada toisistaan poikkeavia tuloksia, joten lisää tutkimusta tarvitaan.
Väitöskirjatutkimuksen tarkoituksena oli määrittää ja verrata aivojen GABAergisessä
järjestelmässä tapahtuvia muutoksia traumaattisen aivovaurion ja status epilepticus (SE) -
kohtauksen jälkeen. Tutkimuksessa mitattiin erityisesti inhiboivien GABAergisten
hermosolujen vähenemistä hippokampuksessa ja talamuksen verkkotumakkeessa
aivovaurioiden jälkeen. Tutkimus tehtiin rotilla, joiden epilepsiaoireet määritettiin kahden
viikon jatkuvalla video-EEG-mittauksella ja kohtauskynnystestillä. Lisäksi mitattiin
traumaattisen aivovaurion aiheuttamaa aksonien plastisuutta talamuksen ventraalisesta
posteromediaalisesta (VPM) ja -lateraalisesta (VPL) tumakkeesta. Lopuksi mitattiin
käänteiskopiointi-PCR-menetelmällä, oliko inhiboivien hermosolujen väheneminen
traumaattisen aivovaurion jälkeen vaikuttanut niiden kohdesoluissa olevien GABAA-
reseptorien alayksiköiden geenien ilmentymiseen.
Tulokset osoittivat, että rotilla, joilla ei havaittu traumaattisen aivovamman jälkeen
epilepsiakohtauksia, inhiboivia hermosoluja tuhoutui enemmän ja laajemmalta alueelta kuin
niillä, jotka sairastuivat SE-kohtauksen jälkeen epilepsiaan. Aivovaurion jälkeen
parvalbumiinia sisältävien hermosolujen määrä verkkotumakkeessa väheni. Lisäksi VPM- ja
VPL-tumakkeiden lateraalisissa osissa havaittiin lisääntynyttä parvalbumiinin
immunoreaktivisuutta. Mitatut talamuksen GABAergisen järjestelmän muuttujat korreloivat
vain kontrollieläimillä kohtauskynnystestin muuttujien kanssa. GABAergisiä aivosoluja
tuhoutui runsaasti traumaattisen aivovaurion jälkeen, mutta tästä aiheutui vain vähän
muutoksia kohdesolujen GABAA-reseptorien alayksiköiden geenien ilmentymiseen.
Tulosten perusteella voi kyseenalaistaa aikaisemman käsityksen, jonka mukaan epilepsia
ilmenee sitä vakavampana, mitä enemmän hippokampuksen GABAergisiä hermosoluja
tuhoutuu. Lisäksi tutkimus tuotti uutta tietoa hippokampuksen ja talamuksen GABAergisen
järjestelmän solu- ja molekyylitason muutoksista traumaattisen aivovaurion jälkeen.
Luokitus: QU 60, WL 312, WL 314, WL 340, WL 385
Yleinen suomalainen asiasanasto: epilepsia; epileptinen sarjakohtaus; aivovammat; GABAergiset
hermosolut; GABA-A-reseptorit; välineuronit; pykäläpoimu; hippokampus; talamus; parvalbumiini;
koe-eläinmallit; rotat
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1 Introduction
Epilepsy is one of the most prevalent neurological disorders. Symptomatic epilepsy is the
most common form of the epilepsy syndromes encountered in adults. Brain insults [e.g.
traumatic brain injury (TBI), stroke or status epilepticus (SE)] can trigger epileptogenic
cascade which predisposes the brain to be capable of generating spontaneous seizures and
eventually epilepsy (Scharfman, 2007; Pitkänen and Lukasiuk, 2009).  These insults can be
both structural and functional changes predisposing the brain towards ictogenesis. In
addition, according the present knowledge, epilepsy is a progressive disease as structural
and  functional  changes  can  continue  after  the  onset  of  seizures.  Current  treatments  of
epilepsy focus on preventing or suppressing seizures and there are no therapies available to
prevent epileptogenesis in patients at risk which is one of the major challenges in epilepsy
research.
As present, the data suggests that in adult brain, the changes in the GABAergic network
in post-injury brain play a major role in epileptogenesis – either because of reduced inhibition
of excitatory neurons or via a synchronizing effect on neuronal activity (Miettinen at al., 1997;
Sloviter et al., 2001). However, data supporting these concepts have originated from
hippocampal tissue taken from a very select population of surgically operated patients with
drug-refractory seizures (Ojemann, 1987) or animal models in which epileptogenesis has
been triggered by SE (Gorter et al., 2001). According to published results, it is uncertain,
whether data from one of the animal models can be extrapolated to others. This is a major
issue regarding the strategy of development of novel treatments (etiology specific vs. non-
specific antiepileptogenic treatment), and this problem is tackled in present study.
The aim of this thesis was to assess of the alterations taking place in the GABAergic
neurons after two different epileptogenic brain insults. To achieve the goal, the quantitative
measurement of the interneurons in the post-SE and post-TBI hippocampus was performed
in rats. In addition, alterations in the GABAergic cortico-thalamic-cortical network were
studied in more detail in post-TBI brain as this network is known to be compromised after
TBI. Finally, because the loss of presynaptic GABAergic terminals has been shown to result
in reduced transmitter release and abnormal expression patterns of GABAA-receptor
subunits  in  post-synaptic  neurons,  a  quantitative  RT-PCR  array  analysis  of  subunit  gene-
expression was conducted at a chronic time point after TBI.
2
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2.1 EPILEPSY
Epilepsy is a chronic brain disease that affects people of all ages. According to the World
Health Organization (WHO) over 50 million people worldwide have epilepsy
(http://www.who.int/mental_health/neurology/epilepsy/en/). Epilepsy has significant
economic implications e.g. in terms of the health-care need, premature death and lost work
productivity. With anti-epileptic drugs (AEDs) seizures can be successfully treated in about
70% of newly diagnosed epilepsy patients, but, unfortunately, there is no treatment to
prevent or modify disease development before seizure onset in patients at known risk.
2.1.1 Definition and classification of the epilepsy
According to the International League Against Epilepsy (ILAE) and the International Bureau
for Epilepsy (IBE), an epileptic seizure is a transient occurrence of signs and/or symptoms
due to abnormal excessive or synchronous neuronal activity in the brain (ILAE, Fisher et al.,
2005). Epilepsy comprises a set of neurological conditions, which are all characterized by the
recurrence  of  paroxysmal  events  (seizures)  associated  with  excessive  and  synchronous
discharges of neuronal populations. The elements of a definition of epilepsy include: 1)
history of at least one seizure; 2) enduring alteration in the brain that increases the likelihood
of future seizures; 3) associated neurobiological, cognitive, psychological, and social
consequences of the condition (ILAE, Fisher et al., 2005).
Epileptic seizures are classified as being either partial (focal) or generalized according to
their onset location (ILAE, 1989). In a partial (focal) seizure, the activation of the system of
neurons is limited to a part of one cerebral hemisphere. In comparison, a generalized seizure
involves both hemispheres. A disease with focal seizures is called localization-related
epilepsies and with generalized seizure it is referred as a generalized epilepsy.
As the origin of the disease can be different, epilepsies are divided to three classes
according to their etiology (ILAE, 1989). Epilepsies where there is no underlying cause other
than a possible hereditary predisposition are called idiopathic. When the epilepsy is the
consequence  of  a  known  or  suspected  disorder  of  the  central  nervous  system  (CNS),  it  is
called symptomatic. A disorder with hidden or occult cause is named as cryptogenic.
However, cryptogenic epilepsies are presumed to be symptomatic. The new knowledge in
the fields of molecular biology and genetics, neuroimaging and neurophysiology has led to
proposals  to  revise  the  terminology  and  concepts  for  the  organization  of  seizures  and
epilepsies (Berg et al., 2010).
2.1.2 Definition of epileptogenesis
When one or more pathological disturbances in brain structure or metabolism can be found,
the epilepsy syndrome can be called symptomatic (ILAE, 1989; Engel, 2006). Various types
of the brain injuries [e.g. traumatic brain injury (TBI), a stroke, infection, status epilepticus
(SE)] can trigger an event which eventually leads after a latency period to the development
of epilepsy (Pitkänen and Sutula, 2002; Scharfman, 2007; Pitkänen and Lukasiuk, 2009;
Goldberg and Coulter, 2013). The time between the initial insult and spontaneous seizures
4can be as long as decades (Annegers et al., 1998). The definition of epileptogenesis usually
refers to this latency phase before seizure onset (Scharfman, 2007; Pitkänen and Lukasiuk,
2009). A large number of cellular and molecular alterations occur during the latency period
including cell death, gliosis, neurogenesis, axonal and dendritic plasticity, the rearrangement
of the extracellular matrix, angiogenesis and alterations in gene-expression (Jutila et al., 2002;
Lukasiuk and Pitkänen, 2004; Lukasiuk et al., 2006). The term epileptogenesis also refers to
the progression of the epileptic condition as the development of the epilepsy does not stop
at the time of the diagnosis (Pitkänen and Sutula, 2002; Scharfman, 2007; Pitkänen and
Lukasiuk, 2009). Recurring epileptic seizures can contribute to continuing molecular, cellular
and network changes and create long-term alteration in the brain circuits.
2.1.3 Status epilepticus
The generalized tonic-clonic SE is a major medical and neurological emergency with
significant morbidity and mortality (Leppik, 1985; ILAE 1989). Most often SE is described as
being continuous seizure if it lasts more than 30 minutes or there are intermittent seizures
without full recovery of consciousness between seizures (Waterhouse and DeLorenzo, 2001).
However, shorter durations of SE have been proposed based on the fact that most generalized
tonic-clonic seizures last less than 2 minutes (Lowenstein et al., 1999). The mechanisms
involved in initiation and spread of the SE are generally similar to those of self-limited
seizures (Engel, 2006). However, some additional factors have been highlighted including
mechanisms that can prevent seizure termination, progressive features contributing to
subsequent functional and structural brain disturbances and maturational factors (Engel,
2006). In adults, the most common causes of SE are cerebrovascular accidents, hypoxia,
metabolic disturbances or low antiepileptic drug level in a patient suffering from epilepsy in
comparison to children in whom SE is usually caused by febrile seizures or infections
(DeLorenzo et al., 1996; Knake et al., 2001). Moreover, adults are more susceptible to develop
epilepsy after SE than children (Hesdorffer et al., 1998; Raspall-Chaure et al., 2006).
2.1.4 Post-traumatic epilepsy
TBI is recognized as a critical global public health problem (Hyder et al., 2007; Maas et al.,
2008). According to the WHO, TBI will surpass many other diseases as the major cause of
death and disability by the year 2020. Though the problems experienced by those suffering
TBI  are  often  not  visible  (e.g.  impairments  in  memory  or  cognition),  the  disease  has  been
many times called the “silent epidemic” (Langlois et al., 2006). After the initial damage
caused by the direct mechanical force to the head, secondary damage develops over time.
During this development stage major molecular changes occur which underlie the
reorganization of the cellular networks (Pitkänen and McIntosh, 2006; Loane and Faden,
2010; McAllister, 2011; Pitkänen and Lukasiuk, 2011). Approximally 25% of all patients
suffering TBI will develop posttraumatic epilepsy (PTE) (Asikainen et al., 1999; Garga and
Lowenstein, 2006) and TBI is estimated to be responsible for 10-20% of all symptomatic
epilepsies (Annegers et al., 1998). The risk of developing seizures after TBI is clearly related
to injury severity (Annegers et al., 1998). Even moderately injured individuals continue to
have increased risk of developing epilepsy for up to 10 years and after severe TBI for as long
as 20 years (Annegers et al., 1998). Posttraumatic seizures (PTSs) are usually divided into
three categories (Frey, 2003). In general, seizures that happen during the impact or
immediately after that are classified as “immediate” seizures and seizures appearing during
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impact are called “late” seizures. The definition of PTE includes the same characteristics as
other epilepsies, i.e., one or more unprovoked seizures after brain trauma associated with
long-lasting alterations in the brain that increase the likelihood for future seizures.
2.1.5 Neuropathology of acquired epilepsy
Temporal  lobe  epilepsy  (TLE)  is  the  most  common  and  the  most  widely  studied  form  of
symptomatic epilepsy. Seizures in that condition arise from temporal structures that include
the hippocampus, amygdala, subicular complex and entorhinal and perirhinal cortices
(Engel, 1996). The most common histopathological hallmarks associated with TLE are
hippocampal neurodegeneration (Ojemann, 1987; Mathern et al., 1995b; Wasterlain et al.,
1996; Magloczky et al., 2000; Andrioli et al., 2007; Toth et al., 2010), granule cell dispersion
(Houser, 1990), gliosis (Yang et al., 2010), mossy fiber sprouting (Houser et al., 1990; Mathern
et al., 1995b; Sutula and Dudek, 2007), neurogenesis (Blümcke et al., 2001; Hermann et al.,
2006) and angiogenesis (Rigau et al., 2007).
2.2 EXPERIMENTAL MODELS OF ACQUIRED EPILEPSY
2.2.1 Animal models of status epilepticus
The molecular and cellular alterations which occur during the development of the acquired
epilepsies have been most extensively studied in rodent models of epilepsy induced by SE
(Pitkänen et al., 2007; Goldberg and Coulter 2013). Typically, SE is triggered either by using
chemicals (kainic acid, pilocarpine)(Nadler et al., 1978; Turski et al., 1984; Cavalheiro et al.,
1991) or electric stimulation (perforant path, hippocampus, amygdala)(Vicedomi and Nadler,
1987; Bertram and Cornett, 1994; Mazarati et al., 1998; Nissinen et al., 2000; Gorter et al., 2001;
Gorter et al., 2003; Tilelli et al., 2005). Seizures induced by the kainic acid arise from the
activation of the non-NMDA glutamate AMPA and kainate receptors (Miller et al., 1990). In
comparison, pilocarpine activates the muscarinic acetylcholine receptors (Kuhar and
Yamamura, 1976).
All these models produce spontaneous seizures after a latency time (Cavalheiro et al., 1991;
Mazarati et al., 1998; Nissinen et al., 2000) and have some similar neuropathological
alterations to those observed in human TLE as the loss of neurons (Nissinen et al., 2000;
Gorter et al., 2003) and mossy fiber sprouting (Nissinen et al., 2000). However, in all SE
models of the acquired epilepsy, spontaneous seizures develop in almost all treated animals
(Cavalheiro et al., 1991; Mazarati et al., 1998; Nissinen et al., 2000; Gorter et al., 2003). To limit
the later development of epilepsy to about 50% of all animals, rats can be treated with
diazepam after the onset of SE (Pitkänen et al., 2005). This creates an opportunity to study
post-SE animals with and without epilepsy at chronic time points after the insult.
2.2.2 Animal models of traumatic brain injury
There are five different rodent models used for modelling molecular and cellular alterations,
including also epileptogenesis, after TBI. The weight-drop model creates increased seizure
susceptibility to pentylenetetrazol (PTZ) induced seizures (Golarai et al., 2001). In this model
neuropathological findings include the loss of hippocampal neurons and progressive mossy
fiber synaptic reorganization (Golarai et al., 2001). Parasagittal fluid-percussion injury (FPI)
has been shown to produce epilepsy in more than 90% of animals (D’Ambrosio et al., 2005).
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neocortex and thalamus in the early time point post-TBI (D’Ambrosio et al., 2004). However,
hippocampal cell loss was also reported on a late time point after TBI (D’Ambrosio et al.,
2005). After lateral FPI, 50% of the rats develop spontaneous seizures (Kharatishvili et al.,
2006; Kharatishvili et al., 2007). In comparison, however, only 3% of the animals develop
epilepsy in a mouse model of lateral FPI (Bolkvadze and Pitkänen, 2012). Santhakumar et al.
(2001) also reported long-term hyperexcitability in the hippocampus after lateral FPI.
Histological studies of the FPI have revealed increased mossy fiber sprouting and
neurodegeneration (Kharatishvili et al., 2006; Bolkvadze and Pitkänen, 2012). Controlled
cortical impact (CCI) is a widely used experimental model of closed head injury and it has
been shown to reproduce the key behavioural, anatomical and functional features common
to human PTE and TLE in mice (Statler et al., 2008; Statler et al., 2009; Hunt et al., 2009; Hunt
et al., 2010; Hunt et al., 2011; Bolkvadze and Pitkänen, 2012; Hunt et al., 2012). Mice have
been reported to display lowered seizure susceptibility (Statler et al., 2008; Bolkvadze and
Pitkänen, 2012) and have EEG spiking (Statler et al., 2009) and spontaneous seizures (Hunt
et al., 2009; Hunt et al., 2010). As with other experimental TBI models, post-CCI mice have
been reported to suffer hippocampal neuronal death (Statler et al., 2008), and mossy fiber
sprouting (Hunt et al., 2009; Hunt et al., 2010; Hunt et al., 2012). The closed skull midline
impact model has been shown to lower the threshold for seizures in a mouse model
(Chrzaszcz et al., 2010). The investigators found an enhanced astrocyte and microglial
activation associated with the second hit with electroconvulsive shock emphasizing the
importance to understand post-TBI glial activation.
2.3 HIPPOCAMPAL GABAERGIC INTERNEURONS
The hippocampus is placed deep within the medial temporal lobe of the human brain
(Andersen et al., 2007). The hippocampus formation is a structure which consists of a group
of brain areas called the dentate gyrus, hippocampal proper, subiculum, presubiculum,
parasubiculum and entorhinal cortex. Despite the fact that there are some obvious differences
in certain regions of the hippocampal formation, the basic layout of cells and projection
pathways is similar rather than different across all mammalian species.
The  main  inhibitory  neurotransmitter  in  the  adult  brain,  originally  called  Factor  1  by
Florey and McLennan (1955), is the ?-aminobutyric acid (GABA)(Andersen et al., 2007). As
early as 1970, Curtis et al., linked GABA to be the neurotransmitter released by hippocampal
interneurons. After release from the interneuron terminals, the neurotransmitter activates
both pre- and postsynaptic GABA receptors (Andersen et al., 2007; Avoli and Curtis, 2011).
In contrast with the almost uniform morphology and connectivity of the principal cells in
any of the hippocampal subfields, the afferent and efferent connections of interneurons
display extensive variation (for review, see Freund and Buzsáki, 1996). The functional
significance  of  the  morphological  differences  of  various  interneuronal  cell  types  in  the
hippocampus was first reported by Ramón y Cajal and Lorente de Nó in the late 1800s and
early 1900s and investigated in detail later by Amaral (1978). More advanced techniques with
the intracellular labelling of neurons have further confirmed those findings and provided
almost the complete picture of at least 21 different classes of interneuronal processes in the
hippocampus (Han et al., 1993; Buckmaster and Schwartzkroin, 1995; Sik et al., 1997;
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interneurons can be divided into interneurons innervating pyramidal cell somas, axon initial
segments (AIS) or dendrites, interneuron-specific interneurons and interneurons which
project to extra-hippocampal structures. The first two systems control the local generation of
NA+-dependent action potential (for review, see Parra et al., 1998). In contrast, the dendritic
inhibitory cells regulate the integration of the afferent EPSPs, the dendritic generation of
calcium dependent action potential, reinactivate dendritic K+ currents and control the
somatodendritic propagation of Na+-dependent spikes (Parra et al., 1998).
 In this particular chapter some of the interneuronal subclasses will be described in more
detail.
Figure 1. A computer generated plot demonstrating the orientation of the different subfields and
layers in the dentate gyrus and hippocampus proper in the rat septal hippocampus. Abbreviations:
CA1,  Cornu  Ammonis  1  region  of  the  hippocampus;  CA3,  Cornu  Ammonis  3  region  of  the
hippocampus; DG, dentate gyrus; gcl, granule cell layer; h, hilus, mol, molecular layer; s.l-m.,
stratum laconosum-moleculare; s.o., stratum oriens; s.p. pyramidal cell layer; s.r. stratum
radiatum.
2.3.1 Chandelier (axo-axonic) cells
The somas of chandelier cells are located near the granule cell layer of the dentate gyrus and
in the pyramidal layers of the hippocampus proper (Gulyás et al., 1993b; Freund and Buzsáki,
1996; Klausberger et al., 2003; Baude et al., 2007). The dendritic trees of these cells are bitufted
and the dendrites have rarely short thick spines (Han et al., 1993; Freund and Buzsáki, 1996).
In most of the cases, the dendritic tree spans thorough all layers of the hippocampal subfield
(Gulyás et al., 1993b; Han et al., 1993; Freund and Buzsáki, 1996; Klausberger et al., 2003;
Baude et al., 2007). The arrangement of dendritic trees suggests that the excitatory input of
these neurons come from efferents from the perforant path and the associational commissural
pathway (Ribak et al., 1986; Soriano and Frotcher, 1993; Freund and Buzsáki, 1996). The
typical morphological characteristics of chandelier cells include a well described array of
8short, vertically oriented rows of terminal boutons, called cartridges (Gulyás et al., 1993b;
Han et al., 1993). These cartridges target pyramidal neurons throughout the AIS (Fairén and
Valverde, 1980; Soriano et al., 1990). In the hippocampus proper, the axon terminals are
particularly located to the part of the pyramidal cell layer close to stratum oriens
(Klausberger et al., 2003; Baude et al., 2007).  Many studies have reported the importance of
chandelier cells for controlling the threshold and synchronization of principal cells (Soriano
and Frotscher, 1989; Li et al., 1992; Woodruff et al., 2010; Inan et al., 2013).
2.3.2 Basket cells
The first description of basket cells originated from the studies of Ramón y Cajal reporting
axons and terminals around cortical Purkinje cells. In the hippocampus, the term “basket
cells” refers to a group of interneurons with heterogenous afferent connections to perisomatic
regions of principal cells (Freund and Buzsáki, 1996). The somas of basket cells are located in
all layers of the dentate gyrus, however, mostly in the border of the granule cell layer and
the hilus, and within or around the pyramidal cell layer of the hippocampus proper (Seress,
1978; Seress and Pokorny, 1981; Scharfman, 1995; Freund and Buzsáki, 1996; Klausberger et
al., 2003; Baude et al., 2007). A small proportion of the basket cells are located relatively far
from the pyramidal cell layer, at the border between stratum radiatum and stratum
laconosum-moleculare (Freund and Buzsáki, 1996; Klausberger et al., 2003). In addition,
another small population of basket cells have their soma located in the stratum oriens of the
CA1 (Cossart et al., 2006).
The apical dendritic tree of these cells runs across the molecular layer of the dentate gyrus
or the stratum radiatum of both CA1 and CA3 and in many cases it penetrates to the stratum
laconosum-moleculare (Seress and Pokorny, 1981; Scharfman, 1995; Freund and Buzsáki,
1996; Baude et al., 2007). The basal dendrites of basket cells always enter to the hilus in the
dentate gyrus and spread throughout the entire stratum oriens in the CA1 and CA3 (Seress
and Pokorny, 1981; Scharfman, 1995; Freund and Buzsáki, 1996; Baude et al., 2007). In the
dentate gyrus, the basket cells are regulated by projections from the entorhinal cortex, the
associational commissural pathway, CA3 pyramidal cells and mossy fiber collaterals (Ribak
and Peterson, 1991; Kneisler and Dingledine, 1995a,b; Freund and Buzsáki, 1996). Basket cells
in the CA3 and CA1 are receiving afferents from mossy fibers, Schaffer collaterals, the
entorhinal cortex, the associational commissural pathway and the local principal cells
(Frotscher and Zimmer, 1983; Frotscher, 1985; Frotscher, 1989; Gulyás et al., 1993a; Buhl et
al., 1994; Freund and Buzsáki, 1996; Miles et al., 1996).
In the dentate gyrus, axons from the basket cells run through the granule cell layer, where
they form dense pericellular nets of synaptic boutons (Ribak and Seress, 1983; Han et al.,
1993; Freund and Buzsáki, 1996). In the hippocampus proper, axon collaterals from basket
cells are present within the pyramidal cell layer and the proximal stratum oriens (Freund and
Buzsáki, 1996; Klausberger et al., 2003; Baule et al., 2007) covering the somas and the proximal
dendrites of the target neurons (Buhl et al., 1994; Sik et al., 1995). In addition to principal cells,
basket cells may form synapses with the small number of interneurons (Sik et al., 1995). The
number of the target neurons of a single basket cell is estimated to be more than 1500
pyramidal cells (Sik et al., 1995).
92.3.3 Dendritic inhibitory cells
Interneurons which do not meet the description of chandelier or basket cells share one
common characteristic as they have been shown to innervate pyramidal and granule cell
dendrites. These dendritic inhibitory cells show greater variability of location of somas and
dendritic and axonal arborisations as compared to interneurons innervating the perisomatic
regions of principal cells (Freund and Buzsáki, 1996).
The most of the dentate hilar interneurons responsible for the dendritic inhibition can be
divided into three subgroups according to the study by Han et al (1993). The investigators
named the neurons in the first subgroup as hilar commissural-accociational pathway related
(HICAP) cells. The cell bodies of these neurons are located either deep in the hilus or close to
the  border  between  hilus  and  granule  cell  layer  (Han  et  al.,  1993;  Buckmaster  and
Schwartzkroin, 1995; Freund and Buzsáki, 1996; Sik et al., 1997). The dendritic trees of the
HICAP cells are known be either smooth or contain spines (Han et al., 1993; Buckmaster and
Schwartzkroin, 1995; Freund and Buzsáki, 1996; Sik et al., 1997). The apical dendrites of
HICAP cells cross the granule cell layer and spread to the molecular layer through its entire
structure (Han et al., 1993; Buckmaster and Schwartzkroin, 1995; Freund and Buzsáki, 1996;
Sik et al., 1997).  The basal dendrite of these neurons branches to the hilus. HICAP cells can
be activated by perforant path stimulation (Sik et al., 1997) indicating that efferents from this
pathway regulate the activation of these types of interneurons. Most of the axons cover the
inner third of the molecular layer, however axonal labelling is often found also in the granule
cell layer and hilus (Han et al., 1993; Buckmaster and Schwartzkroin, 1995; Freund and
Buzsáki, 1996; Sik et al., 1997). The axonal cloud of the HICAP cells overlaps with the
associational and commissural efferents to the granule cells being the densest within the most
proximal part of the dendrites (Han et al., 1993; Buckmaster and Schwartzkroin, 1995; Freund
and Buzsáki, 1996; Sik et al., 1997).
The second subgroup of the dendritic inhibitory neurons located in the dentate gyrus is
called hilar perforant path-associated (HIPP) cells (Han et al., 1993). The cell bodies of these
neurons is located in the hilus, close to the border of the granule cell layer (Han et al., 1993;
Freund and Buzsáki, 1996; Sik et al., 1997). The dendritic tree of HIPP cells is present only in
the hilus and does not penetrate to the molecular layer (Sik et al., 1997). In addition, dendrites
are densely covered with long thin spines (Sik et al., 1997). In contrast to HICAP cells, the
dendritic tree of HIPP neurons coincides with the distribution of mossy fiber collaterals and,
because the axons are not found in the molecular layer, it avoids entorhinal and comissural-
associational pathway afferents (Amaral, 1978; Sik et al., 1995; Freund and Buzsáki, 1996).
The axons of the HIPP cells cross granule cell layer and form long horizontal collaterals by
covering the entire outer two thirds of the molecular layer (Sik et al., 1995; Freund and
Buzsáki, 1996; Goldberg and Coulter, 2013). The axons have been shown to innervate the
perforant path terminal field, distal granule cell dendrites and other interneurons (Han et al.,
1993; Sik et al., 1995).
The third subgroup of interneurons in the dentate gyrus contains cells called molecular
layer perforant pathway associated cells (MOPP cells)(Han et al., 1993). The somas of MOPP
cells are located deep within the molecular layer and smooth dendrites in outer two-thirds
of the molecular layer reach hippocampal fissure in the perforant path terminal zone (Han et
al., 1993; Halasy and Somogyi, 1993; Freund and Buzsáki, 1996).  The MOPP cell has an
extensive cloud of axons which mostly innervates the distal dendrites of the granule cells
(Halasy and Somogyi, 1993; Freund and Buzsáki, 1996).
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Interneurons responsible for dendritic inhibition in the hippocampal proper are very
similar to those described above in dentate gyrus. Interneurons innervating pyramidal cell
dendrites in stratum radiatum and oriens are called the bistratified and trilaminar cells (Buhl
et al., 1994; Sik et al., 1995). The somas of these cells are located within or near to the
pyramidal cell layer or alternatively in the border between stratum oriens and alveus (Buhl
et al., 1994; Sik et al., 1995; Freund and Buzsáki, 1996; Klausberger et al., 2004; Baule et al.,
2007). Bistratified cells have spine free dendritic trees running radially and occasionally
sending out horizontal branches (Buhl et al., 1994; Sik et al., 1995; Freund and Buzsáki, 1996;
Klausberger et al., 2004; Baule et al., 2007). The dendrites do not reach the stratum laconosum-
moleculare (Buhl et al., 1994; Sik et al., 1995; Freund and Buzsáki, 1996; Klausberger et al.,
2004; Baule et al., 2007). The horizontal trilaminar cells have dendrites running horizontally
in the stratum oriens-alveus border (Sik et al., 1995; Freund and Buzsáki, 1996) and radial
trilaminar cells similar to those in bistratified cells except that the dendrites of radial
trilaminar cells often penetrate to the stratum laconosum-moleculare (Freund and Buzsáki,
1996). The distribution of the dendritic tree of bistratified cells indicates that they receive an
input from commissural-associational fibers and from local collaterals (Sik et al., 1995;
Freund and Buzsáki, 1996). The dendrites of the horizontal trilaminar neurons are restricted
to the stratum oriens-alveus border suggesting that they receive an input from the collaterals
of pyramidal cells (Freund and Buzsáki, 1996). The axons of bistratified cells densely cover
both the entire extension of the stratum oriens and proximal (from the pyramidal cell layer)
stratum radiatum (Buhl et al., 1994; Sik et al., 1995; Freund and Buzsáki, 1996; Klausberger et
al., 2004). The axons of horizontal trilaminar cells have collaterals also within the pyramidal
cell layer and the axonal arbor is directed more to the stratum radiatum than to stratum
oriens (Freund and Buzsáki, 1996).
The interneuronal class in the hippocampal proper which is similar to HIPP cells, refers to
neurons terminating in conjunction with entorhinal afferents (O-LM cells)(Freund and
Buzsáki, 1996). The somas of these neurons are located either in the stratum oriens or the
pyramidal cell layer depending of the subfield (Freund and Buzsáki, 1996; Klausberger et al.,
2003). In the CA1, the dendrites of O-LM cells run horizontally within the stratum oriens-
alveus border (Sik et al., 1995; Freund and Buzsáki, 1996; Klausberger et al., 2003). In
comparison, in the CA3, the dendrites are present in all layers except stratum laconosum-
moleculare (Gulyás et al., 1993a,b; Freund and Buzsáki, 1996).  The axons of O-LM neurons
form a dense cloud in stratum laconosum-moleculare targeting distal pyramidal cell
dendrites and dendrite spines and are co-aligned with the entorhinal input (Gulyás et al.,
1993a; Sik et al., 1995; Freund and Buzsáki, 1996). However, a smaller proportion of axons is
found also within stratum oriens (Sik et al., 1995; Freund and Buzsáki, 1996). Furthermore,
O-LM  neurons  can  form  synapses  with  other  GABAergic  cells  in  the  stratum  laconosum-
moleculare (Katona et al., 1999).
The third group of hippocampal interneurons responsible for dendritic inhibition is the
neurons with the axons and dendrites in stratum radiatum (Gulyás et al., 1993a; Freund and
Buzsáki, 1996; Miles et al., 1996). The somas of these neurons are located in the stratum
radiatum or in the pyramidal cell layer and the radially running dendritic tree is mainly
located in the stratum radiatum (Gulyás et al., 1993a; Freund and Buzsáki, 1996; Miles et al.,
1996). Only a small number of the branches can reach the other layers. In the CA1, the major
input to these cells originates from Schaffer and commissural collaterals (Gulyás et al., 1993a).
In the CA3, the input emerges from commissural-associational fibers and recurrent
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collaterals (Gulyás et al., 1993a). The axons target the proximal and the distal dendrites and
dendritic spines of pyramidal cells (Gulyás et al., 1993a). One group of interneurons have cell
bodies in stratum laconosum-moleculare near to the border of stratum radiatum (Franck et
al., 1988; Kunkel et al., 1988; Lacaille and Schwartzkroin, 1988a,b; Freund and Buzsáki, 1996).
Their spinefree dendrites project through stratum laconosum-moleculare and radiatum.
Some branches reach pyramidal cell layer or cross the hippocampal fissure. The input to these
neurons  originates  from  the  ipsi-  and  contralateral  CA3  subfield  and  from  the  entorhinal
cortex (Kunkel et al., 1988; Freund and Buzsáki, 1996). The axons cover widely stratum
laconosum-moleculare and the border between that and stratum radiatum (Franck et al.,
1988; Kunkel et al., 1988; Lacaille and Schwartzkroin, 1988a,b; Freund and Buzsáki, 1996).
Similar to the dendrites, some branches reach the hippocampal fissure and progress to the
dentate gyrus. Axon projections target mainly pyramidal cell dendrites.
The  next  subgroup  of  interneurons  responsible  for  dendritic  inhibition  are  the
interneurons projecting across the subfield boundaries.  Somas of these cells are located in
the  border  of  stratum oriens  of  the  CA1 and alveus  (Sik  et  al.,  1994;  Freund and Buzsáki,
1996). The spiny dendrites cover largely only stratum oriens of the CA1 and imput to them
is comes predominantly from the local collaterals of the CA1 pyramidal cells (Sik et al., 1994;
Freund  and  Buzsáki,  1996).  The  axon  arbour  widely  covers  the  stratum  oriens  but  it  also
branches to pyramidal cell layer and stratum radiatum of the CA1 (Sik et al., 1994; Freund
and Buzsáki, 1996). One main branch runs to stratum oriens and radiatum of the CA3 and
other crosses the hippocampal fissure and passes to the CA3c and hilus of the dentate gyrus
(Sik et al., 1994; Freund and Buzsáki, 1996). The axons have been shown to contact the
dendrites of pyramidal cells, but also cell bodies.
According to the review of Freund and Buzsáki (1996) interneurons specialized in
innervating other interneurons can be divided into three different subgroups. The neurons
in the first subgroup can be visualized by calretinin (CR) and their somas are located not only
in the stratum radiatum and oriens but also in the pyramidal layer of the hippocampus. In
the  dentate  gyrus,  the  somas are  located in  the  hilus  and granule  cell  layer  and dendrites
span all  layers  if  the  subfield.  The main excitatory input  to  these  neurons originates  from
commissural-associational fibers and perhaps from the entorhinal cortex. A specific feature
of this subclass of neurons is that they can form dendro-dendritic junctions with each other,
and thus form a highly coordinated activity (Acsády et al., 1996; Gulyás et al., 1996;
Chamberland and Topolnik, 2012). Axons ramify in stratum radiatum and innervate mostly
other interneurons responsible for the dendritic inhibition of principal cells (Acsády et al.,
1996; Gulyás et al., 1996). The second subgroup contains neurons which can possibly be
visualized by vasoactive intestinal peptide (VIP) and these can be found only in
hippocampus proper (Acsády et al., 1996; Freund and Buzsáki, 1996). Their vertically
oriented somas are located in the stratum radiatum near to the stratum laconosum-
moleculare border. The dendrites are present only in the stratum laconosum-moleculare.
Because of the location of the dendritic tree, the possible input to these neurons mainly comes
from the entorhinal cortex. The axons are located mainly in the stratum radiatum and they
innervate a similar type of interneurons than the first subgroup. It is possible to visualize the
last subgroup of interneurons innervating other interneurons also with VIP. However, these
types  of  neurons  are  located  not  only  in  the  hippocampus  proper  but  also  in  the  dentate
gurus (Acsády et al., 1996; Gulyás et al., 1996). In the dentate gyrus, the vertically oriented
somas are located in the molecular layer and in the hippocampus proper both in the stratum
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radiatum and the pyramidal cell layer (Acsády et al., 1996; Gulyás et al., 1996). The apical
dendrites of these neurons project to the stratum lacososum-moleculare and basal dendrites
to the stratum oriens (Acsády et al., 1996; Gulyás et al., 1996). The main axon passes to the
stratum oriens-alveus border where it branches horizontally formin a dense plexus (Acsády
et al., 1996; Gulyás et al., 1996). The terminal field of these neurons is similar to O-LM in the
hippocampus proper and HIPP cells in the hilus indicating that they innervate other
interneurons responsible for inhibition of the distal dendrites of principal cells. Interactions
within the networks formed by interneurons innervating other interneurons are believed to
generate coherent inhibitory signals which are distributed to many pyramidal cells
(Whittington et al., 1995).
2.3.4 Neurochemical classification of the interneurons
The neurochemical content has been the most widely used characteristic for the functional
classification of interneurons. It has been speculated that around 10% of hippocampal
neurons are GABAergic (Freund and Buzsáki, 1996) and their hippocampal localization was
revealed by in situ hybridization of both GABA synthesizing enzyme glutamic
decarboxylases (GADs)(Houser and Esclapez, 1994). The existence and synthesis of the
GABA in the brain were demostrated by Roberts and Frankel (1959) and Udenfriend (1950).
Since most if not all hippocampal interneurons are GABAergic, there is a need for other
markers to classify in more detail the different types of interneurons. The selective expression
of  various  neuropeptides  such  as  somatostatin  (SOM),  cholecystokinin  (CCK),  VIP,
neuropeptide Y (NPY), enkephalins and substance P is known to occur in some interneurons
(Hökfelt et al., 1980, Somogyi et al., 1984). Also, the expression of calcium-binding proteins
parvalbumin (PARV), calbindin and CR has been shown to be associated with GABAergic
neurons (Celio, 1986, 1990; Acsády et al., 1993; Klausberger and Somogyi, 2008).
The neuropeptide CCK is present in interneurons immunopositive to GAD (Somogyi et al
1984; Kosaka et al., 1985). Kosaka and collegues (1985) found that from all (i.e. 97%) of the
CCK-positive neurons that they observed were also GAD-immunopositive. However, from
all GAD immunopositive neurons, only around 10% are immunoreactive to CCK (Kosaka et
al., 1985). The number of CCK neurons as compared to all GAD immunopositive neurons,
however, depends on the laminar area of the hippocampus. In stratum radiatum and
laconosum-moleculare of CA3 and CA1, 15-20% of all GAD immunopositive neurons are
immunoreactive also for CCK (Kosaka et al., 1985). Further, in pyramidal cell layer of the
hippocampus proper, about 10% of all interneurons are immunoreactive for CCK, but in the
stratum oriens only 6% (Kosaka et al., 1985). In the dentate gyrus, CCK-ir neurons are present
mainly in the hilus, immediately below the granule cell layer (Freund and Buzsáki, 1996).
Only about 9% of all GAD-ir interneurons in the dentate gyrus are CCK-ir (Kosaka et al.,
1985). The morphology of CCK-ir neurons suggests that many of the CCK-ir neurons are
basket cells (Freund and Buzsáki, 1996). Another morphologal cell type expressing CCK is
Schaffer collateral associated cells (Somogyi and Klausberger, 2005).
Neurons immunopositive for the neuropeptide SOM had their characteristic distribution
pattern studied by many laboratories (e.g. Somogyi et al., 1984; Kosaka et al., 1988; Nomura
et al., 1997; Katona et al., 1999). About 90% of SOM-ir neurons are also immunopositive for
GAD indicating that almost all of these neurons are GABAergic (Kosaka et al., 1988). About
14% of all GAD immunopositive neurons are SOM-ir (Kosaka et al., 1988). However, there
are large differences between subfields and layers in the density of SOM-ir neurons when
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compared with the total number of GABAergic neurons. In the hilus of the dentate gyrus and
stratum  oriens  of  the  hippocampus  proper,  about  30%  of  all  GAD-ir  neurons  are  also
immunopositive for SOM (Kosaka et al., 1988). In the pyramidal cell layer and stratum
radiatum of the CA3, only 5-10% of all GABAergic neurons are also SOM-ir (Kosaka et al.,
1988). SOM-ir neurons are rarely found in the granule cell layer and molecular layer of the
dentate gyrus and pyramidal cell layer and stratum radiatum of the CA1 where only about
2% of all GAD-ir neurons containg SOM. In the dentate gyrus, according to the characteristic
soma location and axonal and dendritic distribution, SOM-ir neurons are most likely HIPP
cells (Freund and Buzsáki, 1996; Katona et al., 1999; Goldberg and Coulter, 2013). In the CA1
of the hippocampus proper, SOM-ir neurons show the same morphological features as the
horizontal O-LM cells or bistratified cells whereas in the CA3, their morphology corresponds
to stratum lacososum-moleculare projecting cells (Freund and Buzsáki, 1996; Katona et al.,
1999; Baude et al., 2007; Goldberg and Coulter, 2013). Many of the SOM containing
interneurons in the stratum oriens correspond to septum projecting interneurons (Gulyas et
al., 1993a).
The anatomical localization of NPY-ir neurons has not been as extensively studied than in
the subgroup of GABAergic interneurons containing SOM. However, there is some overlap
of NPY and SOM which is indirect evidence that at least some part of the NPY-ir neurons are
also GABAergic (Köhler et al., 1987; Deller and Leranth, 1990; Freund and Buzsáki, 1996). In
the dentate gyrus, NPY-ir neurons are most prominent in the hilus and in the border between
hilus and granule cell layer as well as in the hippocampus proper in stratum oriens (Köhler
et al., 1986; Milner and Veznedarogly, 1992; Freund and Buzsáki, 1996). The morphological
classification  of  NPY-ir  neurons  has  not  been  fully  clarified.  In  the  dentate  gyrus,  NPY-ir
neurons  which  contain  also  SOM  are  probably  HIPP  cells  according  to  their  morphology
(Freund and Buzsáki, 1996). The pyramidal shaped NPY-ir neurons in the border between
hilus and granule cell layer most likely belong to the group of basket cells even though they
display some special features as compared to the classical basket neuron (Freund and
Buzsáki, 1996). In the hippocampus proper, it is known that 40-60% of NPY-ir neurons are
also  SOM-ir  and  their  morphological  features  correspond  to  O-LM  neurons  (Freund  and
Buzsáki, 1996). In addition, it is known that Ivy and neurogliaform interneurons contain NPY
(Price et al., 2005; Fuentealba et al., 2008; Szabadics and Soltesz, 2009; Szabadics et al., 2010).
The calcium binding protein, PARV, is known to colocalize with GAD in the brain (Celio
1986). In the hippocampus all PARV immunopositive neurons are also known to be GAD
immunopositive (Kosaka et al., 1987). However, only around 20% of GAD immunopositive
neurons are immunoreactive for PARV, indicating that only a subgroup of hippocampal
interneurons contains PARV (Kosaka et al., 1987). PARV-ir neurons are most prominent in
the pyramidal cell layer of the CA3 and CA1 (40-50% of all interneurons), the granule cell
layer of the dentate gyrus (20-30%), stratum oriens of the CA3 and CA1 (20-30%) and hilus
of the dentate gyrus (15-20%)(Kosaka et al., 1987; Freund and Buzsáki, 1996). In addition, a
minority of neurons in the molecular layer of the dentate gyrus and stratum radiatum and
laconosum-moleculare of the hippocampal proper are PARV immunopositive (1-4%)(Kosaka
et al., 1987; Freund and Buzsáki, 1996). Based on the morphology of the PARV-ir neurons
and their laminar distribution, this subgroup of neurons is believed to contain both basket
cells and chandelier (axo-axonic) cells (Kosaka et al., 1987; Freund and Buzsáki, 1996;
Klausberger et al., 2003). In addition, PARV-ir neurons which innervate the dendrites of the
pyramidal cells are known to be bistratified or O-LM cells (Klausberger et al., 2003; Somoqyi
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and Klausberger, 2005). In the study of Klausberger and colleagues (2003), all basket cells
that were immunopositive for PARV, were also immunonegative for CCK indicating that
there is no overlapping between these two neurochemicals. However, a small number of
PARV-ir neurons are known to be also SOM- immunopositive (Dinocourt et al., 2003).
Immunostaining of calcium binding protein CR has identified a large number of
interneurons in all layers of the hippocampal proper and dentate gyrus (Gulyás et al., 1992;
Miettinen et al., 1992; Freund and Buzsáki, 1996; Nomura et al., 1997). These neurons have
been shown to represent a heterogenous group according to their morphology and
neurochemical contents, however, the majority of them contain GABA (83% of all CR-ir
neurons)  (Miettinen,  et  al.,  1992).  CR-ir  neurons  can  be  divided  into  spiny  and  spine-free
neurons  according  to  their  connectivities.  Spiny  CR-ir  neurons  in  the  dentate  gyrus  show
similarities wirh the HIPP cells whereas in the hippocampus proper they resemble the O-LM
cells, although their function is not fully understood (Freund and Buzsáki, 1996). Spine-free
CR-ir neurons belong mostly to the neuronal class which innervates other interneurons, but
a minority of them can be categorized into the group of horizontal neurons with somas near
to the border of the hippocampal fissure (Freund and Buzsáki, 1996).
2.3.5 Interneurons in epilepsy
In many studies, a reduction in the number of hippocampal inhibitory interneurons has been
considered as the major pathology resulting in the development of unprovoked seizures in
both experimental models and human TLE (Obenaus et al., 1993; Mathern et al., 1995a;
Wasterlain et al., 1996; Magloczky and Freund, 2005; Toth et al., 2010). Moreover, the
importance of hippocampal GABAergic interneurons in seizure control has been emphasized
by studies showing increased susceptibility to epileptic seizures in genetically modified mice
which have an abnormal development of the hippocampal GABAergic neurons
(Vreugdenhil et al., 2003; Schwaller et al., 2004). Other studies have demonstrated that
increasing hippocampal GABAergic function, for example, by NPY gene therapy (Noe et al.,
2008), administration of neurosteroids (Biagini et al., 2010), transplantation of GABAergic
cells (Maisano, et al., 2012), or by GABA-enhancing pharmacological treatments (Czuczwar
and Patsalos, 2001; Söderpalm, 2002) results in the suppression of epileptiform activity and
seizures.
It  has  been  proposed  that  degeneration  or  dysfunction  of  the  cells  which  are
immunoreactive for parvalbumin (PARV-ir) or cholecystokinin (CCK-ir) impairs the
inhibition in the perisomatic region or AIS of the principal cells in the dentate gyrus and the
hippocampus proper (Soriano and Frotscher, 1989; Toth et al., 1997; DeFelipe, 1999; Arellano,
et al., 2004; Zhang and Buckmaster, 2009). The importance of the perisomatic inhibition has
been revealed in studies demonstrating that the perisomatic inhibition is crucial in the timing
of the action potential (Miles et al., 1996) and in the generatation of different rhythmic
activities within the network (Cobb et al., 1995; Sik et al., 1995; Whittington et al., 1995;
Penttonen et al., 1998; Ledri et al., 2012). Quantitatively estimated loss of PARV-ir neurons
has been revealed after SE induced by kainate (Buckmaster and Dudek, 1997; Kuruba et al.,
2011), pilocarpine (André et al., 2001; Dinocourt et al., 2003; Ferrari et al., 2008; Long et al.,
2011), electrical stimulation (Gorter et al., 2001; van Vliet at al., 2004; Sun et al., 2007) and after
lateral FPI (Toth et al., 1997; Zhang et al., 2011a,b)(Table 1). Similarly, the loss of CCK-ir
neurons has been shown after SE induced by kainate (Buckmaster and Dudek, 1997),
electrical stimulation (Sun et al., 2007) and after lateral FPI (Toth et al., 1997; Zhang et al.,
15
2011a,b)(Table 2). A reduction in the numbers of interneurons immunoreactive for SOM,
NPY, or CR can compromise the dendritic inhibition of principal cells or other inhibitory
neurons (Mathern et al., 1995; Cossart et al., 2001; Magloczky and Freund, 2005; Toth, et al.,
2010).  The loss of CR-ir neurons has been revealed after SE induced by pilocarpine
(Dinocourt et al., 2003; Long et al., 2011) and electrical stimulation (van Vliet at al.,
2004)(Table 3). The quantitatively estimated loss of SOM-ir neurons has been claimed to
occur after SE induced by kainate (Sperk et al., 1992; Buckmaster and Dudek, 1997;
Buckmaster and Jongen-Rêlo, 1999), pilocarpine (Dinocourt et al., 2003; Long et al., 2011) and
electrical stimulation (Gorter et al., 2001; Sun et al., 2007)(Table 4). In addition, the loss of
NPY-ir neurons has been demonstrated after SE induced by kainate (Sperk et al., 1992;
Kuruba et al., 2011), pilocarpine (André et al., 2001; Ferrari et al., 2008; Long et al., 2011) and
electrical stimulation (Sun et al., 2007)(Table 5).  However, after the loss of neurons, the axons
of the remaining GABAergic neurons can sprout, which can compensate for the early post-
injury impairment of inhibition (Mathern et al., 1997; Bausch 2005; Zhang et al. 2009;
Magloczky, 2010). Moreover, abnormalities in GABAergic innervation can result in abnormal
tuning and sychronization of principal cells, which is believed to compromise cognitive
function in epilepsy (Klausberger and Somogyi, 2008).
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Table 1. Review of the quantitative studies estimating the number of parvalbumin immunoreactive
interneurons in the rat hippocampus after different epileptogenic insults.
Rat
strain
Model Time
point
Hippocampus subfield with
reduced number of neurons
Reference
Wistar lateral FPI 7 d hilus Toth et al., 1997
Wistar lateral FPI 7 d dentate gyrus and CA3 Zhang et al., 2011a
Wistar lateral FPI 7 d dentate gyrus and CA3 Zhang et al., 2011b
Sprague
-Dawley
kainate (i.p.)
up to
335 d
dentate gyrus
Buckmaster and Dudek,
1997
Fisher
344
kainate (i.p.) 12 d dentate gyrus, CA3 and CA1 Kuruba et al., 2011
Sprague
-Dawley
pilocarpine (i.c.)
up to
18 d
hilus, granule cell layer and
stratum oriens of the CA1
André et al., 2001
Wistar pilocarpine (i.p.)
up to
3 months
stratum oriens of the CA1 Dinocourt et al., 2003
Wistar pilocarpine (i.p.)
up to
2 months
hilus and CA3 Ferrari et al., 2008
Sprague
-Dawley
pilocarpine (i.p.)
up to
2 months
hilus Long et al., 2011
Sprague
-Dawley
electrical
stimulation
up to
6 months
hilus Gorter et al., 2001
Sprague
-Dawley
electrical
stimulation
7 d
dentate gyrus and
hippocampus proper
van Vliet et al., 2004
Sprague
-Dawley
electrical
stimulation
up to 7 d
and rats
with
epilepsy
hilus Sun et al., 2007
Abbreviations: FPI, fluid percussion injury; i.c. subcutaneous; i.p. intraperitoneal
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Table 2. Review of the quantitative studies estimating the number of cholecystokinin immunoreactive
interneurons in the rat hippocampus after different epileptogenic insults.
Rat strain Model Time
point
Hippocampus subfield with
reduced number of neurons
Reference
Wistar lateral FPI 7 d hilus Toth et al., 1997
Wistar lateral FPI 7 d dentate gyrus and CA3 Zhang et al., 2011a
Wistar lateral FPI 7 d dentate gyrus and CA3 Zhang et al., 2011b
Sprague-
Dawley
kainate (i.p.) up to
335 d
dentate gyrus Buckmaster and Dudek,
1997
Sprague-
Dawley
electrical
stimulation
up to 7 d
and rats
with
epilepsy
hilus Sun et al., 2007
Abbreviations:  FPI, fluid percussion injury; i.p. intraperitoneal
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Table 3. Review of the quantitative studies estimating the number of calretinin immunoreactive
interneurons in the rat hippocampus after different brain insults.
Rat strain Model Time
point
Hippocampus subfield with
reduced number of neurons
Reference
Sprague-
Dawley
pilocarpine (i.c.) up to
18 d
hilus, granule cell layer and
stratum oriens of the CA1
André et al., 2001
Wistar pilocarpine (i.p.) up to
2 months
hilus and CA3 Ferrari et al., 2008
Sprague-
Dawley
pilocarpine (i.p.) up to
2 months
hilus Long et al., 2011
Sprague-
Dawley
electrical
stimulation
up to 7 d
and rats
with
epilepsy
dentate gyrus and
hippocampus proper
van Vliet at al., 2004
Abbreviations:  FPI, fluid percussion injury; i.c. subcutaneous; i.p. intraperitoneal
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Table 4. Review of quantitative studies estimating the number of somatostatin immunoreactive
interneurons in the rat hippocampus after different epileptogenic insults.
Rat strain Model Time
point
Hippocampus subfield with
reduced number of neurons
Reference
Sprague-
Dawley
kainate (i.p.) up to
90 d
hilus Sperk et al., 1992
Sprague-
Dawley
kainate (i.p.) up to
335 d
dentate gyrus Buckmaster and
Dudek, 1997
Sprague-
Dawley
kainate (i.p.) up to
12
months
hilus Buckmaster and
Jongen-Rêlo, 1999
Wistar pilocarpine
(i.p.)
up to
3
months
stratum oriens of the CA1 Dinocourt et al.,
2003
Sprague-
Dawley
pilocarpine
(i.p.)
up to
2
months
hilus Long et al., 2011
Sprague-
Dawley
electrical
stimulation
up to
6
months
hilus and granule cell layer Gorter et al., 2001
Sprague-
Dawley
electrical
stimulation
up to 7
d and
rats with
epilepsy
hilus Sun et al., 2007
Abbreviations: FPI, fluid percussion injury; i.c. subcutaneous; i.p. intraperitoneal
20
2.4 CORTICO-THALAMIC-CORTICAL NETWORK
The thalamus is the major relay of the information coming from the periphery on its way to
the cortex (Sherman and Guillery, 2006). Before cortical areas receive information from
outside or inside of the body, it first has to go through the corresponding thalamic relay
nucleus.  The reticular nucleus of the thalamus (RT) is a shell-like nucleus coordinating the
activity between cortico-thalamic-cortical pathways (Guillery at al., 1998; Jones 2009). It is
known that the efferents from the RT innervate virtually all different thalamic relay nuclei
(Shosaku et al., 1989; Pinault and Deschênes, 1998). All neurons in the RT are GABAergic
and thus their effect on the relay cells is inhibitory (Houser et al., 1980; Ross et al., 1995). In
addition, all neurons of the RT are immunopositive for the calcium binding protein PARV
(Seto-Ohshima et al., 1989; Arai et al., 1994; Ross et al., 1995).
The RT can be divided into different sections depending of the related functional
thalamocortical pathway (Shosaku et al., 1989; Guillery at al., 1998; Pinault and Deschênes,
1998; Jones 2009). Each sector sends axons to a particular thalamic relay nucleus and receives
afferents from the same nucleus. However, the major afferents to the RT are corticothalamic
projections innervating both distal and proximal dendrites of GABAergic neurons (Jones,
2009). One important aspect is that the part of the RT through which thalamocortical fibers
pass to the particular cortical area, also receives projections from the same cortical region
(Carman et al., 1964; Jones, 2009). Moreover, the synchronous action of the RT is highly
regulated by dendrodendritic connections between neurons in the RT (Jones, 2009).
Table 5. Review  of  the  quantitative  studies  estimating  the  number  of  neuropeptide  Y
immunoreactive interneurons in the rat hippocampus after different epileptogenic insults.
Rat strain Model Time
point
Hippocampus subfield with
reduced number of neurons
Reference
Fisher
344
kainate (i.p.) 12 d dentate gyrus and CA3 Kuruba et al.,
2011
Sprague-
Dawley
pilocarpine (i.p.) up to 2
months
hilus and CA3 Long et al., 2011
Sprague-
Dawley
electrical
stimulation
up to 7 d
and rats
with
epilepsy
 hilus Sun et al., 2007
Abbreviations: FPI, fluid percussion injury; i.p. intraperitoneal
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The rostrodorsal pole of the RT projects to the anterior ventral (AV), anterior dorsal (AD),
and lateral dorsal nuclei (LD) (Shosaku et al., 1989; Pinault and Deschênes, 1998). In
comparison, anterior medial nucleus (AM) projecting RT cells are located in a more ventral
site. The cells projecting into the ventral lateral nucleus (VL) are located in the rostral zone
and in the ventral medial nucleus (VM) are located in the rostroventral zone of the central
part of the RT. The dorsal RT includes the cells projecting to the lateral posterior nucleus (LP).
The neurons innervating the dorsal lateral geniculate (DLG) and medial geniculate (MGD)
nuclei  are  located  in  the  dorsocaudal  part  of  the  RT.   The  ventral  posterior  lateral  (VPL),
ventral posterior medial (VPM) and posterior nuclei (Po) are targets of efferents from the
caudal region of the central pole of the RT. Finally, the rostroventral part of the RT projects
to the medial dorsal (MD), central lateral (CL), central medial (CM) and parafascicular (Pf)
nuclei. The synapses formed between efferents from the RT and relay cells are concentrated
on the proximal and secondary dendrites and on the soma (for review, see Jones, 2009).
Lesions in the RT have been shown to be present after different types of brain insults. Ross
et al. (1993) found a loss between one in four up to three in four of the neurons in the
dorsolateral portion of the RT at the level of MD and VL after a severe head injury in humans.
It is also known that ischemic brain damage after cardiac arrest triggers a loss of one third to
one half of the neurons in the RT at the level of thalamic MD and VL nuclei in humans (Ross
and Graham, 1993). A neuroimaging study has also revealed that thalamic lesions are
associated with epilepsy and continuous spike-wave during slow sleep in children (Guzzetta
et al., 2005). Further, findings from a rat model of cardiac arrest (Table 6) indicated that the
loss of PARV-ir neurons was most prominent in the middle portion of the reticular nucleus
at the level of the VPM and VPL nuclei (Kawai et al., 1995; Ross et al., 1995). Moreover, a
unilateral ibotenic acid lesion of the RT was associated with spike-wave discharges and sleep
spindles in a genetic rat model of absence epilepsy (Meeren et al., 2009). An ibotenic acid
induced lesion of the RT attenuates also high-voltage spindles in Sprague-Dawley and Fisher
344 rat strains (Buzsaki et al., 1988). In addition, previous MRI studies have identified
atrophy of the thalamus in chronic time points after lateral FPI (Kharatishvili et al., 2007;
Niskanen et al., 2013) evidence of thalamic lesions also after experimental TBI.
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Table 6. Review of quantitative studies estimating the number of neurons being lost in the rat
reticular nucleus after different brain insults.
Rat strain Model Time point
(post-
insult)
Finding Reference
Sprague-
Dawley
Global ischemia
due to cardiac
arrest
7 d most severe cell loss in
middle sections; region of
the RT with loss of PARV-ir
neurons occupied 40-50%
of the area per section and
60% of the rostocaudal
length
Kawai et al.
(1995)
Long
Evans
Global ischemia
due to cardiac
arrest
7 d 80% of loss of PARV-ir
neurons in the middle
region
Ross et al.
(1995)
Sprague-
Dawley
Global ischemia
due to cardiac
arrest
6 h, 1 d,
3 d, 7 d
highest number of TUNEL
positive neurons found at
3d post-insult
Böttiger et al.
(1998)
GAERS Genetic - no change between
controls and GAERS
Sabers et al.
(1996)
Abbreviations: GAERS, genetic absence epilepsy rats from Strasbourg; ir, immunoreactive;
TUNEL, terminal deoxynucleotididyltransferase-mediated dUTP-biotin nick endlabeling
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2.5 GABAA RECEPTORS
The GABAA receptors are the main mediator of fast inhibitory neurotransmission in the adult
CNS (Mohler et al., 1998).  The receptor is a 275 kDA heteropentameric glycoprotein formed
by five different subunits (? 1-6, ? 1-3, ? 1-3, ?, ? 1-3, ?, ?, ?). The properties of these receptors
depend on their subunit combination (Mohler et al., 1998; Fritschy and Brünig, 2003;
Campagna-Slater and Weaver, 2007). Electrophysiological studies of the GABAA-receptors
have revealed that these receptors mediate an increase in membrane conductance at a
potential near to the resting level of ?70 mV (Olsen and DeLorey, 1999). This increase of the
conductance is usually accompanied by a membrane hyperpolarization, resulting in an
increase in the firing threshold and a reduction in the probability of action potential initiation.
The  reduction  in  membrane  resistance  is  accomplished  after  the  GABA  binding  and  Cl- -
influx through its receptor-associated channel.
The loss of presynaptic GABAergic terminals has been shown to result in reduced
transmitter release and abnormal expression patterns of GABAA-receptor subunits in post-
synaptic neurons, and this may also contribute to the hyperexcitability of the brain (Zhang et
al., 2007). Analysis of tissue from patients with TLE has revealed changes in the subunit
expression levels as compared to control tissue (Loup et al., 2000; Pirker et al., 2003). Previous
studies  have  also  shown  altered  expression  of  GABAA receptor  subunits  in  rat  models  of
acquired epilepsy induced by SE (Friedman et al., 1994; Schwartzer et al., 1997; Tsunashima
et al., 1997; Brooks-Kayal et al., 1998; Sperk et al., 1998; Fritschy et al., 1999) or TBI (Gibson et
al., 2010; Kharlamov et al., 2011; Raible et al., 2012). Moreover, GABAA receptor subunit gene
polymorphisms have been shown to be associated with seizure susceptibility (Xi et al., 2011;
Balan et al., 2013).
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3 Aims of the study
The main objective of this thesis study was to profile and compare cellular and molecular
alterations in the GABAergic network occurring during acquired epileptogenesis after two
different epileptogenic insult in rat.  In addition, a special emphasis was placed on assessing
thalamic alterations, particularly in the somatosensory part, after TBI.
The specific aims were as follows:
1. To assess the epilepsy phenotype in rats at 6 months after TBI or SE. (II)
2. To estimate the total number the hippocampal interneurons labeled by PARV, CCK,
CR, SOM or NPY at 1 and 6 months after TBI or SE. (I, II)
3. To examine changes in the PARV immunoreactivity in the RT and VPM-VPL of the
thalamus at 6 months after TBI. (III)
4. To measure gene-expression alterations in the GABAA receptor subunits at 6 months
post-TBI. (III, Unpublished work)
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4 Materials and methods
4.1 ANIMALS
A total of 189 adult male Sprague-Dawley rats (initial body weight 275 g; Harlan Netherlands
B.V., Horst, the Netherlands) were used in this study.
All rats were individually housed in a controlled environment (temperature 22 ± 1 °C;
humidity 50-60 %; lights on from 07:00 to 19:00 h). Pellet food and water were provided ad
libitum. All animal procedures were conducted in accordance with the guidelines of the
European Community Council Directives 86/609/EEC and Committee for the Welfare of
Laboratory Animals
4.2 ANAESTHESIA
During all procedures rats were anaesthesized with an intraperitoneal (i.p.) injection of a
solution (6 ml/kg) containing sodium pentobarbital (58 mg/kg), chloral hydrate (60 mg/kg),
magnesium sulphate (127.2 mg/kg), propylene glycol (42.8 %) and absolute ethanol (11.6 %).
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4.3 ANIMAL MODELS
4.3.1 Study design (I, II, III, Unpublished work)
Figure 1. Study design. The present study analyzed and compared two models of acquired focal
epilepsy,  in  which  epileptogenesis  was  triggered  by  traumatic  brain  injury  (TBI)  or  status
epilepticus (SE). (A) TBI was induced by lateral fluid-percussion injury (FPI) (Kharatishvili et al.,
2006). In the 6-month follow-up group, rats were implanted with cortical electrodes and exposed
to a pentylenetetrazol (PTZ) seizure susceptibility test at 5.5 months post-TBI. Thereafter, they
were continuously video-EEG monitored for 2 wk to detect spontaneous seizures. At 6 months
post-TBI, they were perfused for histology. One group of rats with TBI was perfused for histology
at 1 month post-TBI. In addition, two post-TBI rats were perfused for histology at 4 h after insult
to assess the extent of neurodegeneration. In the RT-PCR array experiment, tissue was sampled
at 6 months post-TBI. (B) Status epilepticus (SE) was induced by electrical stimulation of the
amygdala (Nissinen et al., 2000). In order to obtain rats with or without epilepsy, animals received
injections of diazepam at 2 and 6 h after the appearance of SE (Pitkänen et al., 2005). The 6-
months follow-up group underwent 2-wk continuous video-EEG monitoring starting at 5.5 months
post-SE in order to detect spontaneous seizures. At 6 months post-SE, they were perfused for
histology. One group of rats was perfused for histology at 1 month post-SE. Sham-operated
controls were subjected to all procedures except for the induction of TBI or SE.
29
4.3.2 Rat model of traumatic brain injury (I, II, III)
The induction of TBI was done according the lateral fluid percussion (LFP) described by
McIntosh et al. 1989 and Kharatishvili et al. (2006). Animals (n = 74, from which 13 were in
the 1-month group and 61 were in the 6-month group) were placed in a Kopf stereotactic
frame  (David  Kopf  Instruments,  Tujunga,  CA,  USA).  First,  the  skull  was  exposed  with  a
midline skin incision followed by extraction of the periosteum. The left temporal muscle was
detached from the lateral ridge and then a circular craniectomy (Ø 5 mm) was performed
over the left parietal lobe midway between lambda and bregma keeping the dura mater
intact. The edges of craniectomy were sealed with a modified Luer-Lock cap that was filled
with saline while the calvaria was covered with dental acrylate (Selectaplus CN, Dentsply
DeTrey GmbH, Dreieich, Germany). Lateral FPI was induced 90 min after the administration
of  anaesthesia  by  connecting  the  rat  to  a  fluid-percussion  device  (AmScien  Instruments,
Richmond, VA, USA) via a female Luer-Lock fitting. In this study, the mean severity of the
impact was 3.30 ± 0.02 atm. Control animals (n=35, from which 10 were in the 1-month group
and 25 in the 6-month group) received anaesthesia and all surgical procedures but without
lateral FPI.
For the assessment of the animal’s epilepsy phenotype, cortical electrodes were implanted
around 5 months post-TBI (3 wk before sacrifice) according to the methology described
previously (Kharatishvili et al., 2006). After anaesthaesia rats were placed in a stereotactic
frame. Six cortical stainless steel screw electrodes (E363/20 Plastics One Inc., Roanoke, VA,
USA) were placed on the skull so that one was rostral to the craniectomy, one was
contralateral to the centre of the craniectomy, two were bilaterally over the frontal cortex,
and two were bilaterally over the cerebellum (ground and reference electrodes). Electrodes
were attached to a plastic pedestal and fixed on the skull with dental acrylate.
To assess post-TBI increase in seizure susceptibility, rats underwent a pentylenetetrazol
(PTZ, 1, 5-pentamethylenetetrazole) test under video-EEG recording at 1 wk after electrode
implantation. In that test, the animals were placed in transparent plexiglass cages (47 x 29 x
50 cm3) and connected to the video-EEG system via a 6-channel commutator (Plastics One,
Inc., Roanoke, VA, USA) and shielded cables. Video-EEG recording was performed using a
Nervus EEG recording system (sampling rate 200-256 Hz, high pass filter of 0.3 Hz and low
pass filter of 100 Hz; Taugagreining, Iceland) that was connected to a Nervus magnus 32/8
amplifier (Taugagreining, Iceland), an SVT-S3000P Time Lapse 168 VCR (Hitachi, Japan), and
a WV-CL350 Video Camera (Panasonic, Japan). After a 3-4 h baseline video-EEG recording,
animals were injected with PTZ (25 mg/kg, i.p., Sigma-Aldrich YA-Kemia Oy, Finland)
dissolved in 0.9% saline (final concentration 12.5 mg/ml) and continuously video-EEG
monitored for 60 min. After the PTZ-test, video-EEG recording was continued for two weeks
(24/7) to detect spontaneous seizures using the protocol from the study of Nissinen et al.
(2000).
The EEG files  from the  PTZ test  and video-EEG recording were  visually  analyzed.  The
electrographic parameters assessed after PTZ test included (1) latency to the first spike (sec),
(2) latency to the first epileptiform discharge (ED)(sec), (3) total number of spikes, (4) total
number of EDs, (5) duration of EDs (sec), (6) occurrence of electrographic seizures (yes/no),
(7) latency to an electrographic seizure, and (8) duration of an electrographic seizure (sec).
An epileptiform spike was defined as a high-amplitude (twice baseline), short-lasting
(20-70 ms), sharply contoured waveform followed by a low-voltage slow potential. ED was
defined as a high-amplitude (at least twice the baseline) rhythmic discharge comprised of a
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slow wave, spike-wave, and/or polyspike-wave components lasting <5 sec. An electrographic
seizure was defined as a high-amplitude (more than twice the baseline) rhythmic discharge
with temporal evolution in wave morphology and amplitude, having a clear onset and offset,
and lasting >5 sec. In addition, the occurrence of behavioral seizures during the first 60 min
after PTZ administration was monitored.
After first hour, each EEG file was analyzed manually by browsing through the EEG
recording on the computer screen. If an electrographic seizure was observed, behavioral
severity was also analyzed from the corresponding video-recording. A spontaneous
electroencephalographic seizure was defined as high-amplitude rhythmic discharge that
clearly represented a new pattern of tracing (repetitive spikes, spike-and-wave discharges,
and slow waves) and lasted for at least 5 sec. Epileptic events occurring with an interval less
than 5 sec without the EEG returning to baseline were defined as belonging to the same
seizure.
4.3.3 Rat model of status epilepticus (II)
First, for induction of SE rats underwent the implantation of electrodes. After anesthesia rats
(n=56, from which 14 were in the 1-month group and 42 in the 6-months group) were placed
to a stereotactic frame (lambda and bregma at the same horizontal level). To implant the
stimulation electrode to the lateral nucleus of left amygdala, a hole (Ø 3 mm) was drilled into
the exposed skull at 3.6 mm posterior and 5.0 mm lateral to the bregma, according to the rat
brain atlas of Paxinos and Watson (1986). A bipolar stimulation electrode (distance between
the tips 0.5 mm) was lowered down to 6.5 mm ventral to the surface of the brain. Thereafter,
two unipolar screw electrodes were implanted bilaterally over the frontal cortex and two
bilaterally over the cerebellum (ground and reference electrodes). The electrodes were
connected to a plastic pedestal and fixed to the skull with dental acrylate. The animals were
allowed to recover in their cages for 7-14 d before the induction of SE.
The induction of SE was conducted using well characterized protocol previously
described by Nissinen et al. (2000). First, rats were placed individually into transparent
plexiglass cages and video-EEG monitored via amygdaloidal and cortical electrodes for at
least 30 min. Subsequently, SE was induced by stimulating the left amygdala for 20-40 min
with a 100 ms train of 1 ms biphasic square-wave pulses (400 µA from peak to peak) at 60 Hz
with an interval of 0.5 s as described before (Nissinen et al., 2000). The progression of SE was
followed with continuous video-EEG monitoring. To limit the later development of epilepsy
to about 50% of all animals, rats were treated with diazepam (i.p., Stesolid Novum, 5 mg/ml,
Dumex-Alpharma, Denmark) at 2 h (20 mg/kg) and 6 h (10 mg/kg) after the onset of SE
(Pitkänen et al., 2005).  Control animals (n=24, from which 10 were in the 1-month group and
14 in the 6-month group) were subjected to all procedures except for electrical stimulation of
the amygdala.
After the 6-month post-SE survival period, animals underwent 24/7 video-EEG
monitoring for 2 wk to detect the occurrence of spontaneous seizures. Analysis of the video-
EEG recording was done similarly than that described for post-TBI animals.
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4.4 HISTOLOGY
4.4.1 Processing of the tissue (I, II, III)
For histology rats were deeply anaesthetized and transcardially perfused according to the
pH-shift  protocol:  0.9%  sodium  chloride  solution  (4  °C)  for  2  min  at  the  speed  of  30-
35 ml/min, followed by 4% paraformaldehyde (PFA) in 0.1 M sodium acetate buffer, pH 6.5
(4 °C) for 10 min, and 4% PFA in 0.1 M sodium borate, pH 9.5 (4 °C) for 15 min. Brains were
quickly  removed from the skull  and postfixed in  4% PFA in  0.1  M sodium borate,  pH 9.5
(4 °C) for 6 h. Next, the brains were cryoprotected in 20% glycerol in 0.02 M potassium
phosphate buffered saline (KPBS, pH 7.4) for 36 h. The brains were blocked, frozen in dry ice
for 15 min, and stored at -70 °C until further processing.
The brains were sectioned in the coronal plane (1-in-8 series, 25 µm) with a sliding
microtome (Leica SM 2000, Leica Microsystems Nussloch GmbH, Nussloch, Germany). The
first series of sections from all rats was stored in 10% formalin at room temperature and the
rest in cryoprotectant tissue-collecting solution [TCS; 30% ethyleneglycol, 25% glycerol in
0.05 M sodium phosphate buffer (PB), pH 7.4] at -20 °C until being processed.
4.4.2 Thionin staining (I, II, III)
The first series was stained with thionin to define the cytoarchitectonic borders of different
brain areas. First, sections were washed with 0.1 M PB, mounted on gelatin-coated slides and
dried. The slides were then stained using the protocol as follows: 1 h in chloroform-absolute
ethanol 1:1, 2 times two min in absolute ethanol, two min in 96% ethanol, two min in 70%
ethanol, two min in 50% ethanol, two min in dH2O, 10 sec in 0.625% thionin solution, two
min in 50% ethanol, two min in 70% ethanol, from 30 sec to three min in solution containing
glacial acetic acid in 96% ethanol, two min in 96% ethanol, two min in absolute ethanol, five
min in absolute ethanol, and 3 times three min in xylene. Finally, slides were coverslipped
using DePeX® (BDH Chemical, Poole, United Kingdom) as a mounting medium.
4.4.3 Immunohistochemistry (I, II, III)
PARV immunohistochemistry was done using free-floating sections. First, sections were
washed three times in 0.02 M KPBS, pH 7.4. In order to remove endogenous peroxidase
activity, sections were incubated in 1% H2O2 in 0.02 M KPBS at room temperature for 15 min.
After washing six times in 0.02 M KPBS, nonspecific binding was blocked by incubating the
sections in 10% normal horse serum (NHS) and 0.5% Triton X-100 (TX-100) in 0.02 M KPBS
at room temperature for 2 h. Sections were washed three times in 2% NHS in 0.02 M KPBS
and incubated for 3 d (4 °C ) in a primary antibody solution containing mouse-monoclonal
antibody raised against PARV (1:15000, #235, Swant, Bellinzone, Switzerland), 1% NHS, and
0.5% Triton X-100 (TX-100) in 0.02 M KPBS. Sections were washed three times (2% NHS in
0.02 M KPBS) and incubated in biotinylated horse anti-mouse IgG (1:200, Vector # BA-2000,
Vector Laboratories, CA, USA), 1% NHS and 0.3% TX-100 in 0.02 M KPBS for 1 h at room
temperature. Then, sections were washed three times (2% NHS in 0.02 M KPBS) and
incubated in avidin-biotin (1:100, PK-4000, Vector Laboratories) in 0.02 M KPBS for 45 min at
room temperature. After three washes (2% NHS in 0.02 M KPBS), the sections were recycled
back to the secondary antibody solution for 45 min at room temperature, washed, and
incubated in avidin-biotin solution for 30 min at room temperature.  After three washes (2%
NHS in 0.02 M KPBS), the secondary antibody was visualized with 0.1% 3’, 3’-
diaminobenzidine (DAB, Pierce Chemicals, Rockford, IL, USA) and 0.08% H2O2 in 0.02 M
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KPBS. The sections were washed three times in KPBS, once in 0.1 M PB, and mounted on
gelatin-coated microscope slides. The slides were dried overnight at 37 °C. Finally, the
reaction product was intensified with osmium (OsO4) thiocarbohydrate according to the
method of Lewis et al (1986). Shortly, the slides were incubated in chloroform-absolute
ethanol (1:1) solution for 1 h. Next, the sections were placed twice into absolute ethanol for
three min, and then 96% ethanol for two min, 70% ethanol for two min, 50% ethanol for two
min, dH2O for two min, rinsed in ddH2O, and finally placed to 0.005% OsO4 in ddH2O for 5
min.  Subsequently,  the  sections  were  placed  under  the  running  tap  water  for  30  min  and
thereafter rinsed in ddH2O before they were moved to 0.05% thiocarbohydrazine (TCH) for
12 min. Next, the slides were placed again under the running tap water for 30 min and
thereafter rinsed in ddH2O before they were moved back to 0.005% OsO4 in ddH2O for 7 min.
Further, the slides were placed under the running tap water for 30 min and moved to dH2O
for two min.  Thereafter, the slides were placed in 50% ethanol for two min, 70% ethanol for
two min, 96% ethanol for two min, and twice in absolute ethanol for two min. Then the
sections were rinsed in xylene 3 times for three min. Finally, the slides were dried in a hood.
Finally, slides were coverslipped using DePeX® as a mounting medium.
The protocol for CCK immunohistochemistry was similar to that described above for
PARV, but normal goat serum (NGS) was used instead of NHS, and after removing
endogenous peroxidase activity, the sections were incubated for 15 min in 1% NaBH4 to
increase the penetration of the primary antibody. Rabbit-polyclonal antibody raised against
CCK (1:10000, #43842, Abcam, Cambridge, MA, USA) was used as the primary antibody, and
biotinylated anti-rabbit IgG (1:200, Vector # BA-1000, Vector Laboratories) as secondary
antibody. The protocol for CR immunohistochemistry was similar to that used for PARV, but
NGS was used instead of NHS and after removing endogenous peroxidase activity, sections
were incubated for 15 min in 1% NaBH4. The primary antibody was rabbit-polyclonal
antibody raised against CR (1:10000, #7699/4, Swant) and the secondary antibody was
biotinylated anti-rabbit IgG (1:200, Vector # BA-1000, Vector Laboratories). Furthermore,
SOM immunohistochemistry was conducted by using the same protocol, but NGS was used
instead of NHS and the solution used to block non-specific binding included 10% NGS, 0.5%
TX-100, and 0.1% ovalbumin in 0.02 M KPBS. The primary antibody was rabbit-polyclonal
antibody raised against SOM (1:5000, a gift from G. Sperk, Univ. Innsbruck, Austria) and the
primary antibody solution contained 0.1% ovalbumin. The secondary antibody was
biotinylated anti-rabbit IgG (1:200, Vector # BA-1000, Vector Laboratories). The protocol for
NPY immunohistochemistry was similar to that used for PARV, but NGS was used instead
of NHS. The primary antibody was rabbit-polyclonal antibody raised against NPY (1:10000,
T-4070, Peninsula Laboratories, San Carlos, CA, USA) and the secondary antibody was
biotinylated anti-rabbit IgG (1:200, Vector # BA-1000, Vector Laboratories). In addition,
substance P receptor (SPR) immunohistochemistry was performed using the same protocol
described for PARV, but NGS was used instead of NHS, and after removing endogenous
peroxidase activity, sections were incubated for 30 min in 0.05 M citrate buffer (pH 6.0) in 80
°C for better epitope retrieval. The primary antibody used here was rabbit-polyclonal
antibody raised against SPR (1:2000, #AB5060, Chemicon, Temecula, CA, USA) and the
secondary antibody was biotinylated anti-rabbit IgG (1:200, Vector # BA-1000, Vector
Laboratories).
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For  double  labeling  with  the  lectin  from  wisteria  floribunda  (WFA)  and  Fluoro-Jade  B,
WFA was first immunostained using the same protocol with some modifications as described
above. Shortly, free-floating sections were first washed three times in 0.02 M KPBS (pH 7.4).
In order to remove endogenous peroxidase activity, the sections were incubated in 1% H2O2
in 0.02 M KPBS at room temperature for 15 min. After washing six times in 0.02 M KPBS,
sections were incubated for 3 d (4 °C ) in a primary antibody solution containing antibody
raised against WFA (biotin conjugated, 1:4 000, L-1516, Sigma, Saint Louis, MO, USA) and
0.5% TX-100 in 0.02 M KPBS. Sections were washed three times in 0.02 M KPBS and incubated
in avidin-biotin (1:100, PK-4000, Vector Laboratories) in 0.02 M KPBS for 2 h at room
temperature. After three washes in 0.02 M KPBS, the antibody was visualized with 0.1% 3’,3’-
diaminobenzidine (DAB, Pierce Chemicals) and 0.08% H2O2 in 0.02 M KPBS. The sections
were washed twice in KPBS, twice in 0.1 M PB, and mounted on gelatin-coated microscope
slides. The slides were dried overnight at 37 °C. In order to perform Fluoro-Jade staining,
WFA-stained sections were rinsed for 2 min in ddH2O (ddH2O) and incubated for 20 min in
0.06% KMnO4 and then the slides were rinsed again for 2 min in ddH2O and incubated for 30
min in a solution containing 0.001% Fluoro-Jade B, 0.1% acetic acid in ddH20. The slides were
rinsed three times for 1 min in ddH20 and three times for 3 min in xylene. Finally, slides were
coverslipped using DePeX® (BDH Chemical) as a mounting medium.
The specificity of the immunoreactivity in all used immunohistochemical stainings was
tested by omitting either the primary antibody or the secondary antibody from the staining
protocol.
4.5 STEREOLOGICAL ANALYSIS
4.5.1 Hippocampus
4.5.1.1 Quantitative estimation of the hilar neurons (II)
The total number of hilar neurons was estimated in Nissl stained preparations using
unbiased stereology as previously described by West et al. (1991). The analysis was
performed using the Stereoinvestigator® software (MicroBrightField Inc., Williston, VT,
USA) together with an Olympus BX50 microscope equipped with a motorized stage-
controller and a HitachiTM HVC20A camera. Every hippocampal section in a 1-in-8 series,
yielding a total of 12-13 sections per animal, was analysed. A sampling grid of 120 x 120 µm
was laid on the section. For every x-y step, cells were counted using a counting frame of 24 x
24 µm. The counting was performed throughout the section avoiding the neurons that were
in focus at the surface of the section. In order to calculate the total number of hilar cells, the
following equation was used:
Ntot = ?Q · 1/ssf · 1/asf · 1/tsf
where the section sampling fraction (ssf) was 1/8, area sampling fraction (asf, the area of
counting frame divided by area of sampling grid) was 0.04, and tissue sampling fraction
(tsf, the height of the mounted section thickness divided by the dissector height) was 1.
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4.5.1.2 Quantitative estimation of the number of hippocampal interneurons (I, II)
Each immunopositive neuron throughout the entire septo-temporal axis of the hippocampus
and dentate gyrus was plotted in a 1-in-16 series of 25 µm-thick sections (400 µm apart from
each other) using the AccuStage MDPlot 5.3 software and MD3 Microscope Digitizer
(AccuStage, Shoreview, MN, USA) connected to a Leica DMRB microscope (Table 7).
Table 7. The number of immunopositive neurons plotted from one hippocampus of a control rat
Neurochemical Mean(n=9) SEM SD Minimum Maximum CE (%)*
Parvalbumin 1187 35 151 925 1612 1.4
Cholecystokinin 393 12 73 263 525 2.1
Calretinin 1637 35 160 1102 1994 1.1
Somatostatin 1650 48 309 1160 2419 2.1
Neuropeptide Y 1968 35 215 1589 2313 1.2
Abbreviations: CE, coefficient of error; SD, standard deviation; SEM, standard error of mean
* CE (%)= [(sd/mean)/n] · 100
Then, the cytoarchitectonic boundaries of different hippocampal subfields were drawn on
computer-generated plots from the immunostained and/or thionin-stained sections using
camera lucida on a stereomicroscope equipped with a drawing tube. In order to calculate the
total number of immunopositive cells, the following equation was used:
Ntot = ?Q · 1/ssf · 1/asf · t/h
where ?Q was the total number of neurons counted, the section sampling fraction (ssf) was
1/16, area sampling fraction (asf) was 1, and tissue sampling fraction (t/h, the height of the
mounted section thickness divided by the dissector height) was 1 (West et al., 1991). After
the quantitative estimation of the number of immunoreactive neurons, any reduction in
axonal or dendritic immunolabeling was assessed qualitatively in a light microscope.
The visual examination of the SPR immunohistochemistry was done only for post-TBI rats.
First,  the  magnitude of  the  loss  of  SPR immunoreactive  neurons was estimated with light
microscope. After that, the loss of SPR-ir neurons was compared to adjacent PARV-ir cases
in control and experimental rats at either 1 or 6 months after TBI.
4.5.1.3 Analysis of neurodegeration (II)
In the qualitative assessment of neurodegeration after TBI, double labeling of the WFA and
Fluoro-Jade B was visually analysed using fluorescence microscope [Electronic ballast (ebq
100-04-L)] connected to the Leica DMRB microscope]. Since the TBI causes the
neurodegeneration in the perilesional cortex and hippocampus immediately after TBI, the
time point of 4h post-injury was chosen for this study.
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4.5.2 Thalamus
4.5.2.1 Estimation of the total volume of the RT (III)
The RT is visible in PARV-immunostained preparations based on previous studies showing
that neurons of the RT are immunoreactive for PARV (Celio, 1981; Seto-Ohshima et al., 1989;
Arai et al., 1994; Ross et al., 1995).
The total volume of the RT was estimated using the Cavalieri principle. First, the outline
of the RT was drawn in each PARV-immunolabeled section (1-in-8 series, each section 200
?m apart from each other, 7-9 sections per rat) using Stereoinvestigator® software
(MicroBrightField Inc., Williston, VT, USA) and Olympus BX50 microscope equipped with a
motorized stage and a HitachiTM HVC20A camera. Next, the volume of the RT was calculated
using the formula:
V (RT) = t  ·  a(s) ·  ? S (RT)
where t equals the section thickness (8 x 25 µm), a(s) equals the area of the RT (mm2), and ?
S (RT) is the total number of sections per rat (7-9) (Gundersen at al., 1988a,b; Schmitz and
Hof, 2005; Kharatishvili and Pitkänen, 2010).
4.5.2.2 Stereological estimation of the number of neurons in the RT (III)
The total number of PARV-ir neurons in the RT was estimated using unbiased stereology
described by West et al. (1991). In the analysis, the same Stereoinvestigator® software and
microscope setup were used as described above. Every section in a 1-in-8 series containing
the RT, yielding a total of 7-9 sections per animal, was analysed. A sampling grid of 90 x 90
µm was laid on the section. In every x-y step, cells were counted using a counting frame of
20 x 20 µm. In order to calculate the total number of PARV-ir cells, the same equation utilized
for the stereological estimation of the total number of hilar neurons was applied. In the
equation, ?Q  was the number of neurons counted, the section sampling fraction (ssf) was
1/8, area sampling fraction (asf, the area of counting frame divided by area of sampling grid)
was 0.049, and tissue sampling fraction (tsf, the height of the mounted section thickness
divided by the dissector height) was 1.
On average 248 neurons were counted in controls (min-max 201-301, CE 1.5%), 161
neurons in rats with TBI ipsilaterally (min-max 133-210), and 205 neurons in rats with TBI
contralaterally (min-max 126-238).
4.5.2.3 Estimation of the volume of the VPM-VPL (III)
The volume of the VPM-VPL in a standardized 600 ?m-thick coronal slice [3.4 – 4.0 caudal
from the bregma, Paxinos and Watson (1986)] was estimated using Image J software (version
1.46r, http://rsb.info.nih.gov/ij/). In each rat, digital RGB color images were captured from
successive PARV-immunostained sections at three levels [-3.4, -3.6, -3.8 from the bregma,
Paxinos and Watson (1986)] using Leica DMRB microscope equipped with a Nikon
DXM1200F camera operated by a Nikon ACT-1 2.7 software (III, Fig. 5B). A scale bar taken
with the same magnification as the digital images was used to scale the software.
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The volume of the VPM-VPL was calculated using a Cavalieri estimation as described
above. In the equation, t equals the section thickness (8 x 25 µm), a (s) equals the VPM-VPL
area (mm2), and ? S (VPM-VPL) is the total number of sections per rat (3).
4.5.2.4 Assessment of the intensity of the PARV positive axons in the VPM-VPL (III)
PARV-ir  axonal  density  in  the  VPM-VPL  was  estimated  by  measuring  the  intensity  of
immunolabeling from the digital photomicrographs described above [-3.4, -3.6, -3.8 from the
bregma, Paxinos and Watson (1986)]. The analysis was performed using Image J software.
First, the boundary of the VPM-VPL was drawn from PARV-ir preparations, in which it is
readily visible, and confirmed from the adjacent thionin-stained sections. Subsequently, the
area  of  the  VPM-VPL  was  divided  into  four  quadrants  (VPM-lat,  VPM-med,  VPL-lat  and
VPL-med)(III, Fig. 5B). RGB color images were then converted to gray scale and the threshold
for  the  minimum  and  maximum  gray  scale  values  was  adjusted  to  be  comparable  to  the
staining intensity in the original photomicrograph. The mean optical density was measured
in the four quadrants of the VPM-VPL. Background staining was measured from the internal
capsule in the same section (background region, 2.5 x 105 µm2). The density of PARV-ir axonal
immunolabeling was calculated by using the equation: (Mean intensity of background region
– Mean intensity of PARV-ir in measured area)/ Mean intensity of background region.
4.6 ESTIMATION OF THE SEVERITY AND LOCATION OF THE CORTICAL
INJURY AT 6 MONTHS AFTER TRAUMATIC BRAIN INJURY (III)
In the experiment evaluating the association of thalamic damage with the rostrocaudal extent
and severity (depth) of the cortical injury at 6 months post-TBI, each thionin-stained section
throughout the rostrocaudal extent of the cortical lesion was scored as (a) damage not
extending through the depth of the cortex and (b) damage extending through the depth of
the cortex.
4.7 RT-PCR ARRAY
4.7.1 Tissue preparation (III and unpublished work)
Deeply anaesthetized rats (n=34) were transcardially perfused with 0.9% NaCl (30 ml/min, 4
oC, for 4 min) to remove blood from the tissue. The brain was removed from the skull, the
hemispheres were separated, and each hemisphere was placed into its own cryomold (#4557,
Tissue-Tek,  Sakura  Finetek,  USA)  on  ice  (4 oC). Thereafter, ice cold optimum cutting
temperature formulation (O.C.T., #4583, Tissue-Tek, Sakura Finetek) was added to the
cryomolds to cover the entire sample. The cryomolds were snap-frozen in isopentane, chilled
with dry ice, and stored at -70 °C.
4.7.2 Laser capture microdissection (III and unpublished work)
Coronal 8-µm-thick sections were cut with a cryostat (Leica CM3050 S, Leica Microsystems
Nussloch GmbH, Germany) from the level between -2.3 to -3.8 mm from the bregma (rat
brain atlas of Paxinos and Watson, 1986). Twentyfive sections were randomly selected and
transferred to laser capture microdissection (LCM) slides (#11505151, Leica, MicroDissect
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GmbH, Herborn, Germany). The sections were stored at -70°C for a maximum of 48 h before
being further processed.
Before performing LCM, sections were stained with cresyl violet (Merck, Darmstadt,
Germany) to help in recognition of the cytoarchitectonic borders of the different brain areas.
First, sections were placed into 96% ethanol for 30 sec, then 70% ethanol for 30 sec, 50%
ethanol for 30 sec, and finally, to 1% cresyl violet in 100% ethanol for 20 sec. Subsequently,
the sections were moved to 50% ethanol for 30 sec, 70% ethanol for 30 sec, 96% ethanol for 30
sec, and 100% ethanol for 30 sec. The sections were rinsed in xylene twice for 5 min. Finally,
the slides were dried in a hood for 20 min.
LCM was performed immediately after cresyl violet staining. From the hippocampus, the
granule cell layer of the dentate gyrus and the pyramidal cell layer of the CA1 were
microdissected with a Leica LMD Laser Microdissection System (Leica, Wetzlar, Germany)
into  the  extraction  buffer  from  the  Arcturus®  PicoPure  RNA  Isolation  Kit  (Applied
Biosystems,  Foster  City,  CA,  USA).  In  addition,  the  sample  block  containing  both  the
thalamus and the underlying hypothalamus were microdissected. The extraction buffer
containing microdissected cells was vortexed and incubated for 30 min at 42 °C. After
incubation, the cell extract was centrifuged at 800 x g for 2 min and stored at -70 °C.
4.7.3 Quantitative RT-PCR analysis (III and unpublished work)
For quantitative PCR isolation of RNA was performed using Arcturus® PicoPure RNA
Isolation Kit (Applied Biosystems) according to the manufacturer’s protocol (PicoPure RNA
User Guide, Part Number 12682-00ARC Rev A, Carlsbad, CA, USA). Endogenous DNA was
removed using the RNase-Free DNase Set (Qiagen, Hilden, Germany). The RNA
concentration and its quality (A260/A280>1.8) were measured with a NanoDrop 1000
spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). First strand cDNA
synthesis was done with an RT2 First Strand Kit (C-03, SABiosciences, Frederick, MD, USA)
according to the user’s manual (Part #1022A Version 5.01, SABiosciences) using 70-80 ng of
RNA.
Gene expression of GABAA receptor subunits was assessed quantitatively using
RT2ProfilerTM PCR Array: Rat Neurotransmitter Receptors and Regulators (PARN-060C,
SABiosciences) (TBI n=4-5; controls n=3-5) Template cDNA was mixed with RT2SYBR
Green/ROX qPCR Master Mix (SABiosciences) and moved to the RT2ProfilerTM PCR Array
plate (SABiosciences). The following program was used in the PCR (StepOne Software v2.1,
Applied Biosystems, Foster City, CA, USA): 1 cycle (95 °C, 10 min), 40 cycles (95 °C, 15 sec;
60°C, 60 sec) in a StepOnePlus™ Real-Time PCR System (Applied Biosystems).
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4.8 STATISTICAL ANALYSIS
Data were analyzed by using nonparametric tests in IBM SPSS 19.0 for Windows (SPSS Inc.,
Chicago, IL, USA). Differences in neuronal numbers between the groups were analyzed
using the Kruskal-Wallis test. Post hoc analysis was performed using the Mann-Whitney U-
test. Interhemispheric differences were assessed by the Wilcoxon's test. Correlations were
assessed using the Spearman’s rho correlation coefficient. The results from PCR Arrays were
analyzed using t-test in Web-based data analysis provided by SABiosciences
(http://www.sabiosciences.com/pcrarraydataanalysis.php). The data are presented as mean
± SEM. A p-value of less than 0.05 was considered statistically significant.
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5 Results
5.1 MORTALITY
In this study mortality within 24 h post-TBI was 22% (16 of 74 rats) which indicates a
moderate severity of the TBI (McIntosh et al., 1989; Thompson et al., 2005). There was 5%
mortality within 24 h post-SE (3 of 56 rats).
5.2 EPILEPSY PHENOTYPE OF THE ANIMALS
Only the rats with TBI underwent the PTZ seizure susceptibility test. The latency to the first
epileptiform spike in rats with lateral FPI (n=9) was shorter than that in controls (n=6) (256 ±
53 sec vs. 566 ± 150 sec, p<0.05)(II, Table 1). The number of EDs during the 60-min follow-up
after PTZ injection was higher in affected animals as compared to that in controls (330 ± 84
versus 109 ± 32, p<0.05)(II, Table 1). The total number of spikes/60 min, latency to the first
ED, or the mean duration of EDs did not differ between the affected and control rats (II, Table
1). None of the affected or control rats exhibited spontaneous seizures during the 2-wk
continuous video-EEG monitoring performed at 6 months after the lateral FPI or the sham
operation.
There was 28 stimulated rats and 11 (39%) of them developed spontaneous seizures and
furthermore 82% (9/11) of these had a mean daily seizure frequency <1 seizure/d during the
2-wk  recording  period  (II,  Table  2).  The  average  seizure  duration  in  the  “low  seizure
frequency group” was 106.9 ± 12.2 sec (II, Table 2). In the remaining 18% of rats (2/11), the
mean seizure frequency was ?1 seizure/day with a mean seizure duration of 89.8 ± 12.5 sec
(II, Table 2).
5.3 HISTOLOGICAL ANALYSIS OF THE PARVALBUMIN AND
CHOLECYSTOKININ POSITIVE NEURONS IN THE HIPPOCAMPUS
Histologic analysis of the hippocampal interneurons was conducted at either 1 month or 6
months post-insult. The 1-month groups consisted of the following animals: (1) Rats with TBI
(n=9), (2) Controls for TBI (n=8), (3) Rats with SE (n=14), (4) Controls for SE (n=10). From the
6-months groups, animals were selected for which there was successful 2-wk video-EEG
monitoring and high quality immunohistochemistry. Consequently, the analysis was
performed in: (1) Rats with TBI (n=9), (2) Sham-operated controls for TBI (n=9), (3) Rats with
SE and epilepsy (n=7, 2 with “high” seizure frequency (> 1/day) and 5 with “low” (< 1/day)
seizure frequency), (4) Rats with SE and no epilepsy (n=7), (5) Sham-operated controls for SE
(n=7).
Stereological estimates of PARV-positive (II, Supplementary tables 1.1 and 1.2) and CCK-
positive neurons (II, Supplementary tables 2.1 and 2.2) in different subfields of the dentate
gyrus and hippocampus proper are shown separately. Data are also shown separately for the
ipsilateral and contralateral sides. Results are summarized in Table 8.
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5.3.1 Dentate gyrus
5.3.1.1 Traumatic brain injury (I, II)
At 1 month post-TBI, the number of PARV-ir neurons in the ipsilateral dentate gyrus was
62% of that in controls (p<0.001)(I, Fig. 6; II, Fig. 2A). Laminar analysis revealed that this was
related to a reduction in the number of immunopositive cells in the hilus (39% of cells
remaining as compared to controls, p<0.001). At this time point, the number of CCK-ir
neurons did not differ from controls (II, Fig. 2A). Contralaterally, the number of PARV-ir or
CCK-ir neurons did not differ from that found in controls (I, Fig. 6; II, Fig. 2A). In addition,
interhemispheric analysis revealed that the total number of both PARV-ir and CCK-ir cells
was lower ipsilaterally than contralaterally (61%, p<0.01 and 75%, p<0.05 of cells remaining,
respectively)(I, Fig. 6; II, Fig. 2A). Ipsilaterally, the loss of PARV-ir neurons was related to a
reduction in numbers of cells both in the granule cell layer (68% remaining as compared to
the contralateral side, p<0.01) and the hilus (42%, p<0.01). In comparison, the loss of CCK-ir
neurons was related only the reduction of the number of neurons in hilus (69% remaining as
compared to the contralateral side, p<0.01). Ipsilaterally, at 1 month post-TBI, the
immunohistochemical labeling of PARV-ir axons was considerably decreased in the dentate
gyrus, being greatest in the supragranular region and the inner molecular layer of the
infrapyramidal blade (I, Fig. 7). In addition, there was a patchy loss of immunopositive
dendrites in the hilus and molecular layer (I,  Fig. 7).  Overall,  ipsilaterally the reduction in
immunoreactive elements was more pronounced septally than temporally (data not shown).
Contralaterally, the reduction in the axonal immunolabeling was less extensive than on the
ipsilateral  side  (I,  Fig.  7).  The  immunopositive  dendrites  in  the  hilus  and  molecular  layer
were also better preserved than those on the ipsilateral side (I, Fig. 7).
At 6 months post-TBI, the total number of PARV-positive neurons in the ipsilateral dentate
gyrus was 35% (p<0.001) and the total number of CCK-ir neurons 63% (p<0.05) of that in
controls (I, Fig. 6; II, Fig. 2A).  Laminar analysis revealed that the loss of PARV-ir neurons
was related to a reduction in immunopositive cells in granule cell layer (36% of cells
remaining as compared to controls, p<0.001) and hilus (26%, p<0.001), but the loss of CCK-ir
neurons was present only in hilus (56%, p<0.01). Contralaterally, the number of PARV-ir cells
was 56% (p<0.001) and the number of CCK-ir cells 64% (p<0.01) of that in controls (I, Fig. 6;
II,  Fig. 2A). The loss of PARV-ir cells was accompanied by a reduction in immunopositive
neurons in the molecular layer (65%, p<0.05), granule cell layer (51%, p<0.01), and the hilus
(60%, p<0.001). Once again, the loss of CCK-ir neurons was related to hilus (57%, p<0.01) An
interhemispheric comparison revealed that the total number of PARV-ir cells ipsilaterally
was 65% of that on the contralateral side (p<0.01)(I, Fig. 6; II, Fig. 2A).   This was related to a
reduction in cells of the hilus (47% of that on the contralateral side, p<0.01). The number of
CCK-ir neurons did not differ between hemispheres (II, Fig. 2A). In line with the major loss
of immunopositive somata, there was a robust decrease in the immunolabeling of
perisomatic PARV containing axons in the granule cell layer (I, Fig. 7; II, Fig. 3), and this was
more severe ipsilaterally than contralaterally (I, Fig. 7). Overall, the pericellular CCK-ir
immunopositivity around the granule cells (particularly the upper third and supragranular
region) in the dentate gyrus was substantial despite the loss of CCK-positive neurons in the
hilus  (II,  Fig.  4).  As  a  comparison,  the  number  of  CCK-ir  pericellular  plexi  around  the
presumed hilar mossy cells was reduced in those regions in which there was a loss of CCK-
ir immunopositive hilar cells, particularly in the infrapyramidal blade (II, Fig. 4).
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When post-TBI time points were compared, the neuronal numbers in the ipsilateral
dentate  gyrus  were  lower  at  6  months  than  at  1  month  post-TBI  in  both  PARV  and  CCK
immunohistochemical staining (58%, p<0.001, 65%, p<0.05 as compared to the 1-month
group, respectively)( I, Fig. 6; II, Fig. 2A).  A reduction in numbers of PARV-ir neurons was
seen in all layers of the dentate gyrus, including the molecular layer (65% of cells remaining,
p<0.05), granule cell layer (52%, p<0.001), and the hilus (65%, p<0.01). The loss of CCK-ir
neurons occurred only in the hilus (67%, p<0.05). Contralaterally, there was a similar pattern,
with 55% (p<0.001) of PARV-ir neurons and 54% (p<0.05) of CCK-ir neurons remaining at 6
months post-TBI as compared to the 1-month group (I, Fig. 6; II, Fig. 2A). The loss of PARV-
ir neurons related to a reduction in immunopositive cells of the molecular layer (57% of cells
remaining as compared to the 1-month group, p<0.001), granule cell layer (50%, p<0.01), and
the hilus (59%, p<0.001). Similar to the ipsilateral situation, also contralaterally the loss of
CCK-ir neurons was related to the reduction in the numbers of neurons in the hilus (49%,
p<0.01). Ipsilaterally, the reduction in PARV-ir axonal immunolabeling was much more
robust at 6 months than at 1 month post-TBI (I, Fig.  7 and Fig.8). Furthermore, the reduction
in the immunolabeling of PARV containing dendrites in the hilus and the molecular layer
was more severe at 6 months than at 1 month post-TBI (I, Fig. 7 and Fig.8). Contralaterally,
the reduction in PARV-ir axonal immunolabeling was less severe than ipsilaterally but
clearly more pronounced at 6 months than at 1 month post-TBI (I, Fig. 7 and Fig. 8). Finally,
the reduction in PARV-ir immunopositive elements at 1 month post-TBI was more limited to
the septal end whereas at 6 months post-TBI it extended throughout the entire septotemporal
axis (data not shown). Contralaterally, the pattern was similar even though the reduction in
PARV immunoreactivity was milder (I, Fig. 7 and Fig. 8).
5.3.1.2 Status epilepticus (II)
At 1 month post-SE, the number of PARV-ir or CCK-ir neurons in the whole dentate gyrus
did not differ from that in controls either ipsilaterally or contralaterally (II, Fig. 2A).
However,  laminar  analysis  of  PARV-ir  neurons  revealed  a  lower  neuronal  number  in  the
granule cell layer ipsilaterally than contralaterally (81% of cells remaining, p<0.01). There
were  no  interhemispheric  differences  in  the  number  of  CCK-ir  neurons  (II,  Fig.  2A).  The
qualitative analysis did not reveal any change in axonal or dendritic immunolabeling
patterns (data not shown).
At 6 months post-SE, the total number of PARV-ir or CCK-ir neurons assessed in the whole
SE group (including rats with and without epilepsy) did not differ from that in controls either
ipsilaterally or contralaterally (II, Fig. 2A). Ipsilaterally in the whole SE group, however, the
total number of PARV-ir neurons in the dentate gyrus was 91% of that contralaterally
(p<0.01)(II, Fig. 2A). Laminar analysis revealed that this was related to a reduction in the
numbers of immunopositive cells in the hilus (88%, p<0.05). The number of CCK-ir neurons
assessed in the whole SE group did not differ between hemispheres (II, Fig. 2A). When a mild
reduction in PARV-ir neuronal numbers was observed, there was also a slight reduction in
the immunolabeling of PARV containing axons in the supragranular region and inner
molecular layer ipsilaterally (II, Fig. 3). When animals with or without epilepsy were
compared, no differences were found in PARV-ir neuronal numbers (II, Fig. 2A) or axonal
immunolabeling (data not shown). However, in rats with epilepsy, the number of PARV-ir
neurons in the ipsilateral dentate gyrus was 87% of that contralaterally (p<0.05)(II, Fig. 2A).
Laminar analysis revealed that this was related to a reduction in the numbers of
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immunopositive cells of granule cell layer (87% as compared to contralateral side, p<0.05). In
addition, the number of CCK-ir neurons was lower in granule cell layer ipsilaterally than
contralaterally in the subgroup of rats with epilepsy (79%, p<0.05). In rats without epilepsy,
no differences in any of the cell counts were found when compared to either controls or to
the contralateral side (II, Fig. 2A).
When the post-SE time points were compared, the neuronal numbers in the whole group
of animals did not differ ipsilaterally (II, Fig. 2A). Contralaterally, however, the PARV-ir
neuronal numbers in the 6-month group were lower in the whole dentate gyrus (87% of cells
remaining, p<0.05) (II, Fig. 2A) as well as in the molecular layer (75% of cells remaining,
p<0.01) and granule cell layer (86%, p<0.05) as compared to the 1-month group.
Contralaterally, also the number of CCK-ir neurons in the granule cell layer was reduced at
6 months post-SE when this was  compared to the 1 month group (78% of cell remaining,
p<0.05).
5.3.1.3 Comparison of animal models (II)
Ipsilaterally,  the  number  of  PARV-ir  neurons  in  the  dentate  gyrus  in  a  group  of  rats  at  1
month post-TBI was 58% of that in post-SE rats (p<0.001)(II, Fig. 2A). Laminar analysis
revealed that this was related to a reduction in the numbers of immunopositive neurons of
the granule cell layer (71%, p<0.001) and of the hilus (36%, p<0.001). The number of CCK-ir
neurons was lower only in the hilus at 1 month post-TBI as compared to the 1 month post-
SE group (78% of cells remaining, p<0.05). Contralaterally, the number of PARV-ir neurons
in the dentate gyrus in the TBI group was 83% of that in the SE group (p<0.05)(II, Fig. 2A).
This  was  related  to  a  lower  number  of  neurons  in  the  molecular  layer  (81%  of  that  in  SE
group, p<0.05) and in the granule cell layer (84%, p<0.01). No difference was observed
contralaterally in the number of CCK-ir neurons when post-TBI and post-SE animals were
compared (II, Fig. 2A). The reduction in axonal immunolabeling was clearly more
pronounced at 1 month after TBI than at 1 month after SE (data not shown). The reduction in
the immunolabeling of PARV containing dendrites in the hilus and molecular layer was also
more severe at 1 month post-TBI compared to rats at 1 month post-SE (data not shown).
Contralaterally, there was no difference detected in the immunolabeling of PARV containing
elements (data not shown).
When 6-month time points after brain insults were compared, ipsilaterally the number of
PARV-ir neurons in the dentate gyrus of rats with TBI was 37% of that in rats with SE
(compared to the whole SE group, p<0.001)(II, Fig. 2A). Similarly, the number of CCK-ir
neurons in the dentate gyrus of rats with TBI was 51% of that present in the rats with SE
(p<0.001)(II, Fig. 2A). The lower number of PARV-ir neurons was related to a loss of cells in
the granule cell layer (38%, p<0.001) and in the hilus (28%, p<0.001). As a comparison, a
reduction in the number of CCK-ir neurons was seen only in the hilus (45%, p<0.001).
Contralaterally, the numbers of PARV-ir and CCK-ir neurons in the TBI group were 52% and
61% of that observed in the SE group (p<0.001 and p<0.01, respectively)(II, Fig. 2A).  Laminar
analysis  revealed  that  this  was  related  to  a  lower  number  of  PARV-ir  neurons  in  the
molecular layer (61%, p<0.01), granule cell layer (49%, p<0.001), and hilus (53%, p<0.001). The
lower number of CCK-ir neurons was associated with the reduction in the number of neurons
in the hilus (52% of cells remaining, p<0.001). The loss of PARV-ir axonal immunolabeling
was  clearly  more  pronounced  at  6  months  post-TBI  than  at  6  months  post-SE  (II,  Fig.  3).
Furthermore, the loss of PARV-ir dendritic labeling was more severe in the TBI group than
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in the SE group (II, Fig. 3). In the TBI group, there were very few PARV-ir dendritic elements
remaining in the dentate gyrus, whereas in the SE group the loss of dendrites was patchy (II,
Fig.3). In addition, the reduction of PARV immunopositive elements at 6 months post-TBI
extended more widely throughout the entire septotemporal axis as compared to that present
in  the  SE group (II,  Fig.  3).  Contralaterally,  the  pattern of  loss  of  PARV-ir  projections  was
similar even though the difference between the groups was not as evident as that seen
ipsilaterally (data not shown).
5.3.2 CA3 subfield of the hippocampus proper
5.3.2.1 Traumatic brain injury (II)
At 1 months post-TBI, the number of PARV-ir or CCK-ir neurons in the whole CA3 did not
differ from that in controls either ipsilaterally or contralaterally (II, Fig. 2B). Interhemispheric
analysis revealed, however, that ipsilaterally the number of PARV-ir neurons in the whole
CA3 was only 78% of that on the contralateral side (p<0.05) (II, Fig. 2B). There was a decline
in the PARV immunolabeling of the perisomatic terminal plexus in the ipsilateral CA3
pyramidal cell layer, particularly in the CA3a region (data not shown). In addition, the rats
displayed a clear loss of PARV-ir dendrites, which was most pronounced in the CA3a
stratum radiatum (data not shown).
At 6 months post-TBI, ipsilaterally the number of PARV-ir neurons was only 49% of that
in controls (p<0.01)(II, Fig. 2B) and the decrease involved all layers of the CA3. The number
of neurons in the stratum oriens was 41% (p<0.001), in the pyramidal cell layer 49% (p<0.01),
and in the stratum radiatum it was 58% (p<0.05) of that in controls. Contralaterally, there was
a decreased number of cells in the whole CA3 region (57% of cells remaining as compared to
controls, p<0.01)(II, Fig. 2B). Laminar analysis revealed that this related to a reduction in
PARV-ir neurons of stratum oriens (58%, p<0.05) and pyramidal cell layer (55%, p<0.05). The
number  of  CCK-ir  neurons  did  not  differ  from  that  in  controls  either  ipsilaterally  or
contralaterally (II, Fig. 2B). There were no interhemispheric differences in the number of
CCK-ir neurons (II, Fig. 2B).
When the post-TBI time points were compared, ipsilaterally the number of PARV-ir
neurons at 6 months was 50% of that present at 1 month post-TBI (p<0.05)(Fig. 2B). This
reduction was found both in the stratum oriens (32%, p<0.001) and stratum radiatum (54%,
p<0.05). The number of CCK-ir neurons did not differ between time points ipsilaterally (II,
Fig. 2B). Contralaterally, the number of PARV-ir neurons in the whole CA3 at 6 months was
44% (p<0.01) and the number of CCK-ir neurons 64% (p<0.01) of that observed at 1 month
post-TBI (II, Fig. 2B). Similar to the situation on the ipsilateral side, contralaterally there was
a decrease in PARV-ir neurons present in both stratum oriens (29%, p<0.001) and stratum
radiatum (51%, p<0.05). The decrease in the number of CCK-ir cells in the contralateral CA3
was related to a reduction in immunopositive neurons in stratum oriens (50%, p<0.05),
pyramidal cell layer (63%, p<0.05), and stratum radiatum (69%, p<0.01). Ipsilaterally, the
immunolabeling of PARV containing axonal plexus was clearly reduced in the pyramidal
cell layer (data not shown). The PARV-ir dendritic loss was most pronounced in the stratum
radiatum of the CA3a (data not shown). Contralaterally, there was also a reduction in the
PARV immunolabeling of the axonal plexus in the CA3a, even though it was not as severe as
that encountered ipsilaterally (data not shown). In addition, the loss of PARV
immunopositive dendrites was most pronounced in the CA3a stratum radiatum (data not
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shown). There was a extensive inter-animal variability in PARV-ir in the CA3, ranging from
being an almost undetectable unilateral reduction to a major bilateral decrease in
immunoreactivity (data not shown).
5.3.2.2 Status epilepticus (II)
At 1 month post-SE, the number of PARV-ir or CCK-ir neurons in the whole CA3 did not
differ from that in controls either ipsilaterally or contralaterally (II, Fig. 2B). In addition, there
were no interhemispheric differences (II, Fig. 2B). Qualitative analysis did not reveal any
change in axonal or dendritic immunolabeling (data not shown).
At  6  months  post-SE,  the  number  of  PARV-ir  or  CCK-ir  neurons  in  the  whole  CA3  as
assessed in the entire SE group (epileptic and non-epileptic animals) did not differ from that
in  controls  either  ipsilaterally  or  contralaterally  (II,  Fig.  2B).  Ipsilaterally,  however,  the
number of PARV-ir neurons in the whole CA3 was 87% of that found contralaterally
(p<0.05)(II, Fig. 2B). Laminar analysis revealed that this was related to a reduction in the
numbers of PARV-ir neurons of the pyramidal cell layer (87% of that on contralateral side,
p<0.05). The number of CCK-ir neurons did not differ between hemispheres (II, Fig. 2B). The
distribution  of  PARV  immunopositive  axons  displayed  occasional  mild  patchiness  in  the
perisomatic region of the pyramidal cell layer in those cases in which there were reduced
numbers of immunopositive neurons (data not shown). A patchy reduction of PARV
immunopositive dendrites was visible, even though mild, in the stratum oriens and stratum
radiatum in cases with reduced neuronal numbers (data not shown). Ipsilaterally, in the
subgroup of animals with epilepsy, the number of PARV-ir neurons in the whole CA3 was
lower than that in rats without seizures (76%, p<0.05)(II, Fig. 2B). In particular, the number
of  PARV-ir  neurons  was  reduced  in  the  pyramidal  cell  layer  (71%  of  that  in  rats  without
seizures, p<0.01).  Interhemispheric analysis revealed that in epileptic rats, the number of
PARV-ir neurons in the ipsilateral whole CA3 was 77% of that on the contralateral side
(p<0.05)(II,  Fig.  2B).   The  reduction  of  the  number  of  cells  was  most  prominent  in  the
pyramidal cell layer (75% remaining as compared to contralateral side, p<0.05). As in the
dentate gyrus, in non-epileptic rats the neuronal counts did not differ from those in controls
(II, Fig. 2B). In addition, no interhemispheric differences was observed (II, Fig. 2B) nor was
any  difference  detected  in  the  distribution  of  PARV  immunopositive  or  CCK
immunopositive axons between epileptic and non-epileptic animals (data not shown).
When post-SE time points were compared, ipsilaterally the number of PARV-ir neurons
in the whole CA3 at 6 months was 74% of that present at 1 month post-SE (p<0.05)(II,  Fig.
2B). This was due to the reduced neuronal numbers in the stratum oriens (70%, p<0.01) and
pyramidal cell layer (75%, p<0.05). Contralaterally, no differences were detected (II, Fig. 2B).
The number of CCK-ir neurons in the CA3 did not differ between the time points either
ipsilaterally or contralaterally (Fig. 2B). At 6 months post-SE, the distribution of PARV
immunopositive elements showed occasional mild patchiness, this was not seen at 1 month
post-SE (data not shown).
5.3.2.3 Comparison of animal models (II)
Ipsilaterally, the number of immunopositive neurons at 1 month post-TBI was 75% of that in
rats with SE (p<0.05)(II, Fig. 2B). Laminar analysis revealed that this was related to the lower
number of neurons in the pyramidal cell layer (72% of that at 1 month post-SE, p<0.01).
Ipsilaterally, the number of CCK-ir neurons did not differ between groups (II, Fig. 2B).
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Contralaterally, there were no differences in the number of PARV-ir neurons between groups
(II, Fig. 2B). However, contralaterally the number of CCK-ir cells in the whole CA3 at 1 month
post-SE was 78% of that at 1 month post-TBI, (p<0.01) (II, Fig. 2B) and this was related to a
lower number of immunopositive neurons in the stratum oriens (58%, p<0.05). The reduction
in immunolabeling of PARV containing elements was more pronounced ipsilaterally after
TBI than SE (data not shown).
Ipsilaterally, the number of PARV-ir neurons at 6 months post-TBI was 50% of that at 6
months post-SE (p<0.01)(II, Fig. 2B). The difference was detected in all layers of the CA3,
including the stratum oriens (37%, p<0.001), pyramidal cell layer (55%, p<0.01), and stratum
radiatum (53%, p<0.01). Contralaterally, the number of PARV-ir neurons in the whole CA3
at 6 months post-TBI was 49% of that in the SE group (p<0.001)(II, Fig. 2B). Laminar analysis
revealed that this was associated with the reduction in the numbers of PARV-ir neurons in
the stratum oriens (41% of that at 6 months post-SE, p<0.01), pyramidal cell layer (52%,
p<0.001), and stratum radiatum (54%, p<0.01). The number of CCK-ir neurons in the CA3 did
not  differ  between  groups  either  ipsilaterally  or  contralaterally  (II,  Fig.  2B).  Similar  to  the
situation  in  the  dentate  gyrus,  the  loss  of  PARV-ir  axons  and  dendrites  was  clearly  more
severe and widespread after TBI than SE (data not shown). In line with the fact that there was
only a mild loss of CCK-ir cells in the CA3 in different experimental conditions, there was
substantial pericellular axonal immunoreactivity around the CA3 pyramidal cells (data not
shown).
5.3.3 CA1 subfield of the hippocampus proper
5.3.3.1 Traumatic brain injury (II)
At 1 month post-TBI, the number of PARV-ir neurons in the ipsilateral CA1 was 82% of that
in controls (p<0.05)(II, Fig. 2C). In particular, the decrease was seen in the pyramidal cell layer
where 80% of cells were remaining (p<0.01 as compared to controls). Contralaterally, no
differences were found in comparison to controls (II, Fig. 2C). Consequently, at 1 month post-
TBI, the number of PARV-ir neurons in the whole ipsilateral CA1 was 75% of that
contralaterally (p<0.01)(II, Fig. 2C). Laminar analysis revealed that this was related to a
reduction in PARV-ir neurons of the stratum oriens (79% of that of the contralateral side,
p<0.05) and the pyramidal cell layer (74%, p<0.05). The number of CCK-ir neurons in the
whole CA1 did not differ from that in controls either ipsilaterally or contralaterally (II, Fig.
2C). Furthermore, the number of CCK-ir neurons did not differ between hemispheres (II, Fig.
2C). Ipsilaterally, the distribution of PARV-ir perisomatic immunoreactivity was decreased
in the pyramidal cell layer (data not shown). In addition, there was a major loss of PARV
immunopositive dendrites in the proximal stratum oriens and stratum radiatum as
compared to controls (data not shown).
At 6 months post-TBI, the number of PARV-ir neurons in the ipsilateral CA1 was 58% of
that in controls (p<0.01)(II, Fig. 2C). The number of PARV-ir cells in the stratum oriens was
59% (p<0.01), pyramidal cell layer 60% (p<0.01) and stratum radiatum 48% (p<0.01) of that in
controls. Ipsilaterally, the number of CCK-ir neurons did not differ from that in controls in
the whole CA1 (II, Fig. 2C). However, the number CCK-ir neurons in the stratum oriens was
63% (p<0.01) and in pyramidal cell layer it was 61% (p<0.05) of that encountered in the
controls. Contralaterally, the pattern of reduction in PARV-ir was similar but less severe. The
number of PARV-ir neurons in the whole contralateral CA1 was 67% of that in controls
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(p<0.01)(II, Fig. 2C). This was related to a reduction in neuronal numbers within the stratum
oriens (74%, p<0.01), pyramidal cell layer (64%, p<0.01) and stratum radiatum (50%, p<0.001).
Contralaterally,  the number of CCK-ir neurons did not differ from that in controls (II,  Fig.
2C). In addition, the number of CCK-ir neurons did not differ between hemispheres (II, Fig.
2C).  Ipsilaterally, the immunolabeling of PARV containing axons was clearly reduced in the
pyramidal cell layer (II, Fig. 3). The PARV-ir dendritic loss was most pronounced in the
proximal stratum oriens and stratum radiatum (data not shown). Contralaterally, a reduction
was also found in the PARV immunolabeling of the perisomatic axonal plexus, even though
this was less severe than that seen ipsilaterally (data not shown). The loss of PARV-ir
dendrites was visible, but milder than ipsilaterally, and most pronounced in the proximal
CA1 (data not shown). As in the CA3, there was considerable inter-animal variability in
PARV-ir in the CA1 (data not shown).
When post-TBI time points were compared, the  number  of  PARV-ir  neurons  in  the
ipsilateral CA1 at 6 months was 74% (p<0.05) and the number of CCK-ir neurons was 64%
(p<0.01) of that at 1 month post-TBI (II, Fig. 2C). The loss of PARV-ir neurons was associated
with the reduction in immunopositive cells of the stratum oriens (71%, p<0.01) and stratum
radiatum (52%, p<0.01). The reduction of the number of CCK-ir neurons was seen in all
layers, including the stratum oriens (42% of cells remaining, p<0.001), pyramidal cell layer
(59%, p<0.05), and stratum radiatum (74%, p<0.05). Contralaterally, the number of PARV-ir
neurons was 63% (p<0.001) and the number of CCk-ir neurons 69% (p<0.01) of that at 1 month
post-TBI)(II, Fig. 2C). At 6 months post-TBI, the number of PARV-ir cells in the stratum oriens
was 66% (p<0.01), pyramidal cell layer 65% (p<0.01) and stratum radiatum 41% (p<0.001) of
that measured at 1 month after TBI. The decrease in the number of CCK-ir neurons was
related  to  a  reduction  in  immunopositive  cells  within  the  stratum  oriens  (59%  of  cells
remaining as compared to the 1 month group, p<0.01), pyramidal cell layer (67%, p<0.05),
and stratum radiatum (72%, p<0.05). Ipsilaterally, at 1 month post-TBI, the reduction of
PARV immunopositive elements was typically limited to the proximal CA1 whereas at 6
month post-TBI the reduction in the immunolabeling of the axonal plexus was more
widespread (data not shown). Similarly on the contralateral side, the reduction in PARV-ir
axonal labeling was remarkably more robust at 6 months post-TBI as compared to the 1-
month group (data not shown).
5.3.3.2 Status epilepticus (II)
At 1 months post-SE, the number of PARV-ir or CCK-ir neurons in the CA1 did not differ
from that in controls either ipsilaterally or contralaterally (II, Fig. 2C) nor did the number of
PARV-ir or CCK-ir neurons differ between hemispheres (II, Fig. 2C).
In addition, at 6 months post-SE, the number of PARV-ir or CCK-ir neurons in the entire
CA1 as assessed in the whole SE group did not differ from that in controls either ipsilaterally
or contralaterally (II, Fig. 2C). Ipsilaterally, however, laminar analysis revealed a reduction
in PARV-ir neurons in the pyramidal cell layer (81% of cells remaining as compared to
controls, p<0.05). As in the CA3, the distribution of PARV immunopositive axons showed
occasional mild patchiness in the perisomatic region of the pyramidal cell layer in those cases
in which there were reduced numbers of immunopositive neurons (II, Fig. 3). There was also
a patchy reduction in the immunolabeling of PARV containing dendrites in the stratum
oriens and stratum radiatum in cases with a reduced number of immunopositive somata (II,
Fig. 3). Ipsilaterally, in a subgroup of rats with epilepsy, the number of PARV-ir neurons in
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the whole CA1 was 80% of that in controls (p<0.01)(II, Fig. 2C). In particular, a reduction was
noted in the pyramidal cell layer (70%, p<0.01). Ipsilaterally, when animals with or without
epilepsy were compared, the total number of PARV-ir neurons in the CA1 in rats with
epilepsy was 81% of that in rats without epilepsy (p<0.05)(II, Fig. 2C). Epileptic animals
possessed reduced numbers of PARV-ir neurons in the stratum oriens (83%, p<0.05) and
pyramidal cell layer (75%, p<0.05). Contralaterally, the number of PARV-ir neurons in the
pyramidal cell layer in epileptic rats was 63% of that in non-epileptic animals (p<0.05).  There
were no interhemispheric differences in any of the different animal groups (II,  Fig. 2C).  In
addition, no difference was found in the distribution of immunopositive processes between
the epileptic and non-epileptic animals (data not shown).
When post-SE time points were compared, the number of PARV-ir or CCK-ir neurons at
6 months post-SE in the ipsilateral CA1 as assessed in the whole SE group did not differ from
that  estimated  at  1  month  post-SE  (II,  Fig.  2C).  Ipsilaterally,  the  total  number  of  PARV-ir
neurons in the CA1 at 6 months post-SE in the pyramidal cell layer was 84% (p<0.05) and in
the stratum radiatum it was 48% (p<0.001) of that at 1 month post-SE. Contralaterally, the
number of PARV immunopositive cells in the stratum radiatum at 6 months post-SE was 55%
(p<0.001) of that at 1 month post-SE.  Unexpectedly, the 1 month group had a lower number
of PARV-ir neurons in the stratum oriens than the 6-month group (76%, p<0.05).
Contralaterally, at 6 months post-SE the number of CCK-ir neurons in the stratum oriens was
72%, and in the stratum radiatum 78%, of that at 1 month post-SE (p<0.05). The number of
CCK-ir neurons at 1 month post-SE was 70% of that at 6 months post-SE in the pyramidal
layer (p<0.01). As in the CA3, at 6 months post-SE the distribution of PARV immunopositive
processes showed occasional mild patchiness, which was not seen at 1 month post-SE (data
not shown).
5.3.3.3 Comparison of animal models (II)
Ipsilaterally, at 1 month post-insult, in rats with TBI, the number of PARV-ir neurons in the
CA1 was 78% of that in rats with SE (p<0.01)(II, Fig. 2C). Laminar analysis revealed that this
was related to a lower number of neurons in the pyramidal cell layer (75%, p<0.01) and
stratum radiatum (65%, p<0.01). Ipsilaterally, the number of CCK-ir neurons at 1 month post-
SE in the stratum oriens was 72% (p<0.05), and in the pyramidal cell layer 74% (p<0.05), of
that at 1 month post-TBI. Contralaterally, there were no differences in the number of PARV-
ir neurons between groups (II, Fig. 2C). However, contralaterally, the number of the CCK-ir
cells in the whole CA1 was lower at 1 month post-SE than at 1 month post-TBI (86% of cells
remaining, p<0.05)(II, Fig. 2C). The reduction was seen in the pyramidal cell layer (68% of
cells remaining, p<0.05). The reduction in PARV-ir processes was more pronounced after TBI
than after SE (data not shown).
At 6 months post-insult, in rats with TBI, the number of PARV-ir neurons in the ipsilateral
CA1 was 61% of that in the whole group of rats with SE (p<0.001)(II, Fig. 2C). Particularly, a
reduction was seen in the stratum oriens (52%, p<0.001) and in the pyramidal cell layer (71%,
p<0.05). Ipsilaterally, the number of CCK-ir neurons did not differ between groups (II, Fig.
2C).  Contralaterally, the number of PARV-ir neurons in the TBI group was 65% of that in the
SE group (p<0.01)(II, Fig. 2C).  Laminar analysis revealed that this was related to a lower
number of neurons in the stratum oriens (58%, p<0.001). Contralaterally, the number of CCK-
positive neurons at 6 months post-TBI in the pyramidal cell layer was 69% (p<0.05) of that at
6 months post-SE. Both ipsilaterally (II, Fig. 3) and contralaterally (data not shown), the
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reduction of PARV immunopositive processes was remarkably more pronounced after TBI
than after SE. As in the CA3, there was a substantial pericellular axonal CCK-ir around CA1
pyramidal cells (data not shown).
Table 8. Summary of the results from the histological analysis of parvalbumin and cholecystokinin
immunoreactive interneurons.
Parvalbumin Cholecystokinin
TBI SE TBI SE
Hippocampal
subfield
1
month
6
months
1
month
*6
months
1
month
6
months
1
month
*6
months
Dentate gyrus
Ipsilateral ??? ??? NS NS NS ? NS NS
Contralateral NS ??? NS NS NS ?? NS NS
CA3
Ipsilateral NS ?? NS NS NS NS NS NS
Contralateral NS ?? NS NS NS NS NS NS
CA1
Ipsilateral ? ?? NS ?? NS NS NS NS
Contralateral NS ?? NS NS NS NS NS NS
Abbreviations: NS, no significant change as compared to controls, TBI, traumatic brain injury;
SE, status epilepticus
* post-SE animals with epilepsy
Statistical significance: ?p<0.05, ? ??p<0.01, ???p<0.001, as compared to controls,
(Mann-Whitney U test)
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5.4 HISTOLOGICAL ANALYSIS OF THE CALRETININ, SOMATOSTATIN
AND NEUROPEPTIDE Y POSITIVE NEURONS IN THE HIPPOCAMPUS
Histologic analysis was conducted either at 1 month or 6 months post-insult for same groups
described previously for estimation of the hippocampal interneurons responsible for
perisomatic inhibition (PARV-ir and CCK-ir neurons). Stereological estimates of CR-positive
(II, Supplementary tables 3.1 and 3.2), SOM-positive (II, Supplementary tables 4.1 and 4.2)
and NPY-positive neurons (II, Supplementary tables 5.1 and 5.2) in different subfields of the
hippocampus proper and dentate gyrus are shown separately. Data are also shown
separately for the ipsilateral and contralateral sides. Results are summarized in tables 9 and
10.
No stereological counting of NPY-ir cells was done at 1 month post-SE as the intensive
immunoreactivity in the mossy fiber pathway in 29% (4 of 14) of animals with SE biased the
cell counting in the CA3 and the dentate gyrus (II, Fig. 8M, N). In the CA1, there was intensive
NPY-positive immunoreactivity in the pyramidal cell layer (II, Fig. 8O).
5.4.1 Dentate gyrus
5.4.1.1 Traumatic brain injury (II)
At 1 month post-TBI, in the ipsilateral dentate gyrus there was only 77% (p<0.05) of CR-ir,
46% (p<0.001) of SOM-ir and 59% (p<0.001) of NPY-ir neurons remaining as compared to
controls (II, Fig. 5A). Laminar analysis revealed that the loss of the CR-ir neurons was related
to a reduction in immunopositive cells of the granule cell layer (72% of cells remaining as
compared to controls, p<0.01) and in the hilus (75%, p<0.05). The decreased number of SOM-
ir neurons was related to a reduction of cells within the hilus (43% of cells remaining when
compared to controls, p<0.001). The loss of NPY-ir neurons was present in molecular layer
(74% as compared to controls, p<0.01) and hilus (52%, p<0.001). Contralaterally, the number
of  CR-ir  neurons  did  not  differ  from  that  in  controls  (II,  Fig.  5A).  However,  there  was
reduction contralaterally in the number of SOM-ir (86% remaining as compared to controls,
p<0.05) and NPY-ir (91%, p<0.05) neurons in the whole dentate gyrus (II, Fig. 5A). The
interhemispheric analysis revealed that ipsilaterally the total number of CR-ir (77% as
compared to contralateral side, p<0.05), SOM-ir (51%, p<0.01) and NPY-ir (56%, p<0.01) cells
was lower than contralaterally (II, Fig. 5A). The loss of CR-ir and SOM-ir neurons was related
to an ipsilateral reduction in cells both in the granule cell layer (78% remaining as compared
to the contralateral side, p<0.05 and 59%, p<0.01; respectively) and the hilus (71%, p<0.01 and
49%, p<0.01; respectively). Laminar analysis revealed that the ipsilateral reduction of NPY-ir
neurons  was  related  to  a  reduction  in  the  numbers  of  immunopositive  neurons  in  the
molecular layer (63% as compared to contralateral side, p<0.01), granule cell layer (84%,
p<0.01) and in the hilus (51%, p<0.01).
At 6 months post-TBI, in the ipsilateral dentate gyrus there were 74% (p<0.001) of CR-ir,
55% (p<0.001) of SOM-ir and 51% (p<0.001) of NPY-ir neurons remaining as compared to
controls (II, Fig. 5A). Laminar analysis revealed that the loss of CR-ir neurons was related to
a reduction in the immunopositive cells within the hilus (66% of cells remaining as compared
to controls, p<0.001). Laminar analysis also revealed that the decrease in the number of SOM-
ir and NPY-ir neurons was related to a reduction in immunopositive cells in the granule cell
layer (61% of cells remaining as compared to controls, p<0.01 and 66%, p<0.01; respectively)
and within the hilus (55%, p<0.001 and 46%, p<0.001; respectively). Contralaterally, the
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number of CR-ir cells in the dentate gyrus was 77% of that in controls, (p<0.05)(II, Fig. 5A)
which was related to the fact that there were fewer immunopositive neurons in the granule
cell layer (79%, p<0.05). Contralaterally, the number of SOM-ir or NPY-ir neurons did not
differ from that in controls (II, Fig. 5A). Interhemispheric analysis revealed that the number
of neurons in all three interneuron subclass was lower ipsilaterally than contralaterally. The
total number of CR-ir cells was ipsilaterally 86% of that contralaterally (p<0.05)(II, Fig. 5A).
This was related to an ipsilateral reduction in cells within the hilus (76% remaining as
compared to the contralateral side, p<0.05). The total number of SOM-ir cells in the dentate
gyrus on the ipsilateral side was 61% of that contralaterally (p<0.01)(II, Fig. 5A). This was
related to the ipsilateral reduction in cells of the granule cell layer (66% remaining as
compared to the contralateral side, p<0.05) and the hilus (60% remaining as compared to the
contralateral side, p<0.01). Ipsilaterally, the number of NPY-ir cells in the whole dentate
gyrus was 58% of the numbers on the contralateral side (p<0.05)(II, Fig. 5A), and this was
related to  a  reduction in  the  number  of  immunopositive  neurons in  the  granule  cell  layer
(64%, p<0.05) and in the hilus (55%, p<0.05).
When post-TBI time points were compared, the number of CR-ir neurons did not differ
between groups in the ipsilateral dentate gyrus (II, Fig. 5A). Ipsilaterally, the number of SOM-
ir neurons at 6 months post-TBI in the molecular layer was 52% of that at 1 month post-TBI
(p<0.05). In addition, ipsilaterally, the number of NPY-ir neurons in the dentate gyrus at 6
months post-TBI was 83% of that at 1 month post-TBI (p<0.05)(II, Fig. 5A), which was related
to  a  reduction  of  immunopositive  neurons  in  the  granule  cell  layer  (78%,  p<0.05).  On  the
contralateral side, the number of CR-ir neurons at 6 months post-TBI was 86% of that at 1
month post-TBI (p<0.05)(II, Fig. 5A). The number of SOM-ir neurons at 6 months post-TBI in
contralateral molecular layer was 50% (p<0.05), and in contralateral granule cell layer it was
63% (p<0.01), of that at 1 month post-TBI. The number of NPY-ir neurons at 6 months post-
TBI was 81% of that at 1 month post-TBI (p<0.05)(II, Fig. 5A). The decrease was present in the
molecular layer was 50% (p<0.001) and in the hilus, 80% (p<0.01).
5.4.1.2 Status epilepticus (II)
At 1 month post-SE, the number of CR-ir or SOM-ir neurons in the ipsilateral dentate gyrus
did not differ from that in controls (II, Fig. 5A). Similar to ipsilateral side, the number of CR-
ir or SOM-ir neurons in the contralateral dentate gyrus did not differ from that in controls
(II, Fig. 5A). In addition, there we no interhemispheric differences in CR-ir neurons between
post-SE animals and controls (II, Fig. 5A). However, interhemispheric analysis revealed that
the  total  number  of  SOM-ir  cells  in  the  granule  cell  layer  was  lower  ipsilaterally  than
contralaterally (82% of cells remaining, p<0.05).
At 6 months post-SE, the number of CR-ir or SOM-ir neurons assessed in the whole SE
group  (including  rats  with  and  without  epilepsy)  did  not  differ  from  that  in  controls
ipsilaterally (II, Fig. 5A). Ipsilaterally, the total number of NPY-ir neurons in the whole
dentate gyrus was 51% of that in controls (p<0.001)(II, Fig. 5A). Laminar analysis revealed
that this was related to a reduction in the numbers of immunopositive cells of the granule
cell layer (66% of cells remaining as compared to controls, p<0.01) and within the hilus (46%,
p<0.001). Contralaterally, the number of CR-ir, SOM-ir or NPY-ir neurons assessed in the
whole  SE group did not  differ  from that  in  controls  (II,  Fig.  5A).  When hemispheres  were
compared there was no difference in the number of CR-ir or SOM-ir neurons (II,  Fig. 5A).
The number of NPY-ir neurons in the ipsilateral granule cell layer was 90% of that
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contralaterally (p<0.05). On the ipsilateral side, in a subgroup of rats with epilepsy, the
number of CR-ir neurons in the molecular layer was 76% of that in a subgroup of rats without
epilepsy (p<0.05). Contralaterally, the number of CR-ir neurons in the molecular layer was
decreased when rats with epilepsy were compared to rats without epilepsy (76%, p<0.05). In
rats  without  epilepsy,  no  differences  in  any  of  the  CR-ir  cell  counts  were  found  when
compared to controls or the contralateral side (II, Fig. 5A). No difference was found when
the number of SOM-ir neurons in the dentate gyrus was compared between the subgroups
(II, Fig. 5A). On the ipsilateral side, however, in a subgroup of rats with epilepsy, the total
number of NPY-ir neurons in the whole dentate gyrus was only 33% of that in controls
(p<0.01)(II, Fig. 5A). The laminar analysis revealed that this was related to a reduction in the
numbers of immunopositive cells in the molecular layer (57% of cells remaining as compared
to controls, p<0.05), in the granule cell layer (35%, p<0.01) and in the hilus (31%, p<0.01).
Contralaterally, the number of NPY-ir cells in the dentate gyrus was 37% of that in controls
(p<0.01)(II, Fig. 5A), which was related to a reduction in immunopositive neurons within the
granule cell layer (42%, p<0.01) and the hilus (35%, p<0.01). On the ipsilateral side, in a
subgroup of rats with epilepsy, the number of NPY-ir cells in the granule cell layer was 83%
of that on the contralateral side (p<0.05). When rats with and without seizures were
compared, in the subgroup of rats with epilepsy, the total number of NPY-ir neurons in the
whole dentate gyrus was only 36% of that in rats without epilepsy at 6 months post-SE
(p<0.05)(II, Fig. 5A). Laminar analysis revealed that this was related to a reduction in the
numbers of immunopositive cells within the granule cell layer (41% of cells remaining as
compared to rats without epilepsy at 6 months post-SE, p<0.05) and in the hilus (33%, p<0.05).
On the contralateral side, in this same subgroup of rats with epilepsy, the number of NPY-ir
cells in the dentate gyrus was 41% of that in rats without epilepsy at 6 months post-SE
(p<0.05)(II, Fig. 5A), which was related to a reduction in the number of immunopositive
neurons in the granule cell layer (45%, p<0.01).
When post-SE time points were compared, the number of CR-ir neurons did not differ
between groups on the ipsilateral side (II, Fig. 5A). The number of SOM-ir cells at 6 months
post-SE in ipsilateral molecular layer was 32% (p<0.01), and in the ipsilateral granule cell
layer was 73% (p<0.05), of that at 1 month post-SE. Contralaterally, the number of CR-ir cells
in the molecular layer at 6 months post-SE was 76% (p<0.01) of that at 1 month post-SE.
Contralaterally, the number of SOM-ir cells at 6 months post-SE in the molecular layer was
35% (p<0.01), and in the granule cell layer was 62% (p<0.05), of that at 1 month post-SE.
At 1 month post-SE, 29% of animals had intense immunoreactivity in the mossy fiber
pathway bilaterally (data not shown). At 6 months, all except one of the animals that
experienced spontaneous seizures after SE had an immunopositive mossy fiber pathway
bilaterally (data not shown). Only one of those without spontaneous seizures after SE had an
immunopositive mossy fiber pathway (data not shown). In line with these observations,
there was increased immunopositivity in the tip and crest portions of the inner molecular
layer  at  6  months  post-SE  in  animals  with  spontaneous  seizures,  suggesting  NPY-
immunoreactivity  in  sprouted  mossy  fibers  (data  not  shown).  Importantly,  none  of  the
animals with TBI assessed at either 1 or 6 months post-injury had an immunopositive mossy
fiber pathway (data not shown). In addition, despite about a 50% reduction in the number of
hilar immunopositive cells, there was intense axonal labeling in the outer two-thirds of the
molecular layer, suggesting that there had been sprouting of the axons of the remaining NPY-
positive cells (data not shown).
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5.4.1.3 Comparison of animal models
Ipsilaterally, at 1 month post-TBI, the number of CR-ir neurons in the dentate gyrus was 73%
of that at 1 month post-SE (p<0.001)(II, Fig. 5A). Laminar analysis revealed that this was
related to a lower number of CR-ir neurons in the granule cell layer (70%, p<0.001) and in the
hilus (70%, p<0.01). Ipsilaterally, the total number of SOM-ir neurons at 1 month post-TBI in
the dentate gyrus was 58% of that at 1 month post-SE (p<0.001)(II, Fig. 5A). Laminar analysis
revealed that this was related to a reduction in the numbers of immunopositive cells within
the hilus (55%, p<0.001). Contralaterally, at 1 month post-TBI, the number of CR-ir neurons
in the molecular layer was 81% of that at 1 month post-SE (p<0.01). No change was observed
between groups in the number of SOM-ir neurons in the contralateral dentate gyrus (II, Fig.
5A).
Ipsilaterally, at 6 months post-TBI, the number of CR-ir neurons in the dentate gyrus was
70% of those present at 6 months post-SE (p<0.001)(II, Fig. 5A). Laminar analysis revealed
that this was related to a lower number of CR-ir neurons in the hilus (61%, p<0.001).  Also,
ipsilaterally the total number of SOM-ir neurons at 6 month post-TBI in the dentate gyrus
was 65% of that at 6 months post-SE (p<0.001)(II, Fig. 5A). Laminar analysis revealed that this
was related to a reduction in immunopositive cells of the hilus (64%, p<0.001).
Contralaterally, at 6 months post-TBI, the number of CR-ir neurons in the dentate gyrus was
80% of that found at 6 months post-SE (p<0.05)(II, Fig. 5A). Laminar analysis revealed that
this was related to a lower number of CR-ir neurons in the molecular layer (88%, p<0.05). No
change was observed in the number of SOM-ir neurons in the contralateral dentate gyrus
between groups (II, Fig. 5A). Contralaterally, the number of NPY-ir neurons in the granule
cell layer in the SE group was 64% of that in the TBI group (p<0.05).
5.4.2 CA3 subfield of the hippocampus proper
5.4.2.1 Traumatic brain injury (II)
At 1 month post-TBI, the number of CR-ir neurons in the ipsilateral stratum oriens was 85%
of that in controls (p<0.05). The number of SOM-ir neurons in the ipsilateral pyramidal cell
layer was 80% (p<0.05), and in the stratum radiatum it was 73% (p<0.01) of that in controls.
Also, the number of NPY-ir neurons in the ipsilateral pyramidal cell layer was 88% of that in
controls (p<0.05). Contralaterally, the neuronal numbers did not differ between groups (II,
Fig. 5B).  There was not any interhemispheric differences (II, Fig. 5B).
At 6 months post-TBI, the number of CR-ir neurons in the CA3 did not differ from that in
controls ipsilaterally (II, Fig. 5B). However, ipsilaterally, the total number of SOM-ir neurons
in the CA3 was 64% of that in controls (p<0.01)(II, Fig. 5B). Laminar analysis revealed that
this was related to a reduction in the number of immunopositive cells in both the stratum
oriens (57% of cells remaining as compared to controls, p<0.001) and the stratum radiatum
(67% of cells remaining as compared to controls, p<0.05). Ipsilaterally, the total number of
NPY-ir neurons in the whole CA3 was 76% of that in controls (p<0.01)(II, Fig. 5B). Laminar
analysis revealed that this was related to a reduction in immunopositive cells of the
pyramidal cell layer (77% of cells remaining as compared to controls, p<0.05) and of the
stratum radiatum (73%, p<0.01). Contralaterally, the number of CR-ir cells was 81% of that
in controls (p<0.05)(Fig. 5B), and this was correlated with the reduction in immunopositive
neurons within the stratum radiatum (67% as compared to controls, p<0.01). Contralaterally,
also the number of SOM-ir neurons in the stratum oriens was 74% of that in controls (p<0.05).
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Interhemispheric analysis revealed that the number of CR-ir cells was lower on the
contralateral side in the stratum radiatum (72% of cells remaining as compared to the
ipsilateral side, p<0.01). No changes were found between hemispheres in the number of
SOM-ir or NPY-ir neurons (II, Fig. 5B).
When post-TBI time points were compared, the number of CR-ir neurons did not differ
between groups ipsilaterally  (II,  Fig.  5B).  However,  the  number  of  SOM-ir  neurons in  the
whole CA3 was 61% (p<0.001) and the number of NPY-ir neurons was 73% (p<0.001) of that
at  1  month  post-TBI  (II,  Fig.  5B).  Laminar  analysis  of  SOM-ir  neurons  revealed  that  the
lowered number of cells was related to a reduction in the numbers of immunopositive cells
within the stratum oriens (57% of cells remaining as compared to 1 month group, p<0.01), in
the pyramidal cell layer (63%, p<0.01) and in the stratum radiatum (64%, p<0.01). The decline
in of NPY-ir neuron number was related to a loss of in immunopositive cells of the pyramidal
cell layer (77% of cells remaining as compared to controls, p<0.05) and of the stratum
radiatum (73%, p<0.01). Contralaterally in the whole CA3, at 6 months post-TBI the number
of CR-ir neurons was 75% (p<0.01), the number of SOM-ir neurons 58% (p<0.001) and the
number of NPY-ir neurons 76% (p<0.01) of that at 1 month post-TBI (Fig. 5B). The lowered
number of CR-ir neurons was related to a reduction in cells in both the stratum oriens (59%,
p<0.01) and stratum radiatum (66%, p<0.001). The reduction of SOM-ir and NPY-ir neurons
was detected in the stratum oriens (61%, p<0.001 and 76%, p<0.05, respectively), in the
pyramidal cell layer (48%, p<0.001 and 76%, p<0.05, respectively) and in the stratum
radiatum (65%, p<0.01 and 76%, p<0.05, respectively).
5.4.2.2 Status epilepticus (II)
At 1 month post-SE, the number of CR-ir or SOM-ir neurons in the CA3 did not differ from
that in controls either ipsilaterally or contralaterally (II, Fig. 5B). There was not any
interhemispheric differences (II, Fig. 5B).
At 6 months post-SE,  the number of CR-ir or SOM-ir neurons assessed in the whole SE
group  (including  rats  with  and  without  epilepsy)  did  not  differ  from  that  in  controls
ipsilaterally (II, Fig. 5B). Ipsilaterally, however, the number of NPY-ir neurons in the whole
CA3 assessed in the whole SE group was 75% of that in controls (p<0.05)(II, Fig. 5B).
Contralaterally, the number of CR-ir or NPY-ir neurons assessed in the whole SE group did
not differ from that in controls (II, Fig. 5B). Contralaterally, the number of SOM-ir neurons
in the whole CA3 was 78% of the corresponding value in controls (p<0.05)(II, Fig. 5B).
Interhemispheric analysis revealed that the number of CR-ir neurons in the contralateral
pyramidal cell layer was 83% (p<0.05) of that ipsilaterally. Contralaterally, the number of
SOM-ir cells in the pyramidal cell layer (84%, p<0.05) and the stratum radiatum (85%, p<0.05)
was lower than that ipsilaterally. Ipsilaterally, in the subgroup of rats with epilepsy, the total
number of NPY-ir neurons in the whole CA3 was 54% of that in controls (p<0.01)(II, Fig. 5B).
Laminar analysis revealed that this was related to a loss of immunopositive cells within the
stratum oriens (60% of cells remaining as compared to controls, p<0.05), the pyramidal cell
layer (41%, p<0.01) and the stratum radiatum (65%, p<0.05). Contralaterally, the number of
NPY-ir cells in the whole CA3 was 57% of that in controls (p<0.05)(II, Fig. 5B), which was
related to a reduction in the numbers of immunopositive neurons within the pyramidal cell
layer (44%, p<0.01).  Contralaterally, the number of NPY-ir neurons in the pyramidal cell
layer was 90% of that seen ipsilaterally (p<0.05). Contralaterally, in a subgroup of rats
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without  epilepsy,  the  number  of  SOM-ir  neurons  in  the  pyramidal  cell  layer  was  82%
(p<0.05), and in the stratum radiatum 78% (p<0.05), of that ipsilaterally.
The number of CR-ir neurons in the CA3 did not differ between time points either
ipsilaterally or contralaterally (II, Fig. 5B). Ipsilaterally the total number of SOM-ir neurons
at 6 months post-SE in the whole CA3 was 64% of that at 1 month post-SE (p<0.001)(II, Fig.
5B) Laminar analysis revealed that this was related to a reduction in the number of
immunopositive cells in the stratum oriens (62%, p<0.001), in the pyramidal cell layer (64%,
p<0.001) and in the stratum radiatum (68%, p<0.01). Contralaterally, the total number of
SOM-ir neurons at 6 months post-SE in the whole CA3 was 59% of those present at 1 month
post-SE (p<0.001)(II, Fig. 5B).  Laminar analysis revealed that this was related to a reduction
in immunopositive cells in the stratum oriens (60%, p<0.01), the pyramidal cell layer (61%,
p<0.001) and of the stratum radiatum (55%, p<0.001).
5.4.2.3 Comparison of animal models
At 1 month post-insult, the number of CR-ir neurons in the CA3 did not differ between
groups either ipsilaterally or contralaterally (II, Fig. 5B). Contralaterally, the total number of
SOM-ir neurons at 1 month post-SE in the whole CA3 was 86% of that at 1 month post-TBI
(p<0.01)(II, Fig. 5B).
At 6 months post-insult, the number of CR-ir or SOM-ir neurons in the CA3 did not differ
between groups on either the ipsilateral or contralateral sides (II, Fig. 5B). Contralaterally,
however, the number of NPY-ir neurons at 6 months post-SE was 72% of that at 6 months
post-TBI (p<0.05)(II, Fig. 5B), and this was related to a reduction in immunopositive neurons
of the stratum oriens (68%, p<0.05).
5.4.3 CA1 subfield of the hippocampus proper
5.4.3.1 Traumatic brain injury (II)
At 1 month post-TBI, the number of CR-ir, SOM-ir or NPY-ir neurons in the ipsilateral CA1
did not differ from that in controls (II, Fig. 5C). However, the number of CR-ir neurons in the
ipsilateral stratum laconosum-moleculare was 81% of that in controls (p<0.05).  In the control
group, the number of NPY-ir neurons in the stratum oriens was 87% of that in the TBI group
(p<0.05). Contralaterally, there were not any differences (II, Fig. 5C).
At 6 months post-TBI, the number of CR-ir or NPY-ir neurons in the ipsilateral CA1 did
not differ from that in controls (II, Fig. 5C). Ipsilaterally, the total number of SOM-ir neurons
in the CA1 was 75% of that in controls (p<0.01)(II, Fig. 5C). Laminar analysis revealed that
the number of CR-ir neurons in the ipsilateral stratum radiatum was 75% (p<0.001) and the
number of SOM-ir neurons in the stratum oriens was 74% of that in controls (p<0.01). The
number of NPY-ir neurons in the ipsilateral CA1 was 92% of that contralaterally (p<0.05)(II,
Fig. 5C), which was related to the fact that there were fewer cells in the pyramidal cell layer
(88%, p<0.05). Contralaterally, the total number of SOM-ir neurons in the CA1 was 78% of
that in controls (p<0.001)(II, Fig. 5C). Laminar analysis revealed that this was connected with
a reduction in the numbers of immunopositive cells in both the stratum oriens (81% of cells
remaining as compared to controls, p<0.01) and the pyramidal cell layer (64%, p<0.01).
Contralaterally, the number of CR-ir neurons had declined in the stratum radiatum (79% as
compared to controls, p<0.05).
Ipsilaterally, the number of CR-ir or SOM-ir neurons in the whole CA1 did not differ
between time points (II, Fig. 5C). However, ipsilaterally the number of SOM-ir neurons at 6
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months post-TBI in the stratum radiatum was 54% of that at 1 month post-TBI (p<0.01).
Ipsilaterally, the number of NPY-ir neurons in the CA3 at 6 months post-TBI was 76% of that
at 1 month post-TBI (p<0.01)(II, Fig. 5C),  which was related to a reduction in immunopositive
neurons within the stratum oriens (75%, p<0.05), within the pyramidal cell layer (82%, p<0.01)
and within the stratum radiatum (76%, p<0.05). Contralaterally, at 6 months post-TBI, the
number of SOM-ir neurons in the whole CA1 was 74% (p<0.01) and the number of NPY-ir
neurons 87% (p<0.01) of that at 1 month post-TBI (II, Fig. 5C). Laminar analysis revealed that
the loss of SOM-ir and NPY-ir neurons at 6 months post-TBI was related to a reduction in the
number of immunopositive cells in the stratum oriens (80% of cells remaining as compared
to the 1-month group, p<0.05 and 88%, p<0.05, respectively), in the pyramidal cell layer (53%,
p<0.001 and 92%, p<0.01, respectively) and in the stratum radiatum (58%, p<0.05 and 84%,
p<0.05, respectively). Contralaterally, unexpectedly, the 1 month group had a lower number
of CR-ir neurons in the stratum laconosum-moleculare than those found the 6 month group
(72%, p<0.05).
5.4.3.2 Status epilepticus (II)
Ipsilaterally, in controls, the number of CR-ir neurons in the stratum radiatum was 89% of
that at 1 month post-SE (p<0.05). Ipsilaterally, the number of SOM-ir neurons in the whole
CA1 did not differ from those present in controls (II, Fig. 5C). Contralaterally, in the whole
CA1 the number of CR-ir neurons was 89% (p<0.05) and the number of SOM-ir neurons 86%
(p<0.05) of that in controls (II, Fig. 5C). Laminar analysis revealed that the reduction in the
number of CR-ir neurons was related to the loss of cells in the stratum oriens (81% of that in
controls, p<0.01) and the pyramidal cell layer (89%, p<0.01). Laminar analysis of SOM-ir
neurons revealed that the loss was related to a reduction in the numbers of immunopositive
cells in both the stratum oriens (84% of cells remaining as compared to controls, p<0.05) and
stratum radiatum (76%, p<0.05). There were no interhemispheric differences (II, Fig. 5C).
At 6 months post-SE, the number of CR-ir, SOM-ir or NPY-ir neurons assessed in the
whole SE group did not differ from that in controls ipsilaterally (II, Fig. 5C). Ipsilaterally, the
number of NPY-ir neurons assessed in the whole SE group in the stratum radiatum was 81%
of that in controls (p<0.05). The number of CR-ir or NPY-ir neurons did not differ from
controls  contralaterally  (II,  Fig.  5C).  Contralaterally,  the  number  of  SOM-ir  neurons in  the
whole CA1 was 91% of that in ipsilaterally (p<0.05)(Fig. 5C). When the hemispheres were
compared, laminar analysis of CR-ir neurons in the CA1 revealed that in the contralateral
pyramidal cell layer the cell number was 88% (p<0.05) of that ipsilaterally.  Contralaterally,
the number of SOM-ir cells in the pyramidal cell layer was 72% of that ipsilaterally (p<0.05).
Ipsilaterally,  in  the  subgroup  of  rats  with  epilepsy,  the  number  of  NPY-ir  neurons  in  the
stratum radiatum was 77% of that in controls (p<0.05). Ipsilaterally in the subgroup of rats
without epilepsy, the number of CR-ir neurons in the stratum radiatum was 87% of that
counted contralaterally (p<0.05).
Ipsilaterally, the total number of CR-ir neurons did not differ between post-SE time points
(II,  Fig.  5C).  Ipsilaterally,  the  total  number  of  SOM-ir  neurons  at  6  months  post-SE  in  the
whole CA1 was 79% of that at 1 month post-SE (p<0.01)(II, Fig. 5C). However, ipsilaterally,
at 1 month post-SE, the number of CR-ir neurons in the stratum oriens was 76% of that found
at 6 months post-SE (p<0.01). Furthermore, at 6 months post-SE, the number of CR-ir neurons
in the stratum radiatum was 83% of that at 1 month post-SE (p<0.05). Laminar analysis of
SOM-ir neurons revealed that the loss of cells was related to a reduction in the numbers of
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immunopositive cells in the pyramidal cell layer (51%, p<0.001) and within the stratum
radiatum (39%, p<0.001). Contralaterally, the total number of CR-ir neurons did not differ
between groups (II, Fig. 5C). Contralaterally, the total number of SOM-ir neurons at 6 months
post-SE in the whole CA1 was 75% of that at 1 month post-SE (p<0.001)(II, Fig. 5C).  As on
the ipsilateral side, also contralaterally at 1 month post-SE, the number of CR-ir neurons in
the stratum oriens was 74% of that at 6 months post-SE (p<0.01). Laminar analysis of SOM-ir
neurons revealed that the contralateral loss of cells was related to a reduction in the numbers
of immunopositive cells of the pyramidal cell layer (37%, p<0.001) and of the stratum
radiatum (34%, p<0.001).
5.4.3.3 Comparison of animal models
At 1  month post-insult,  the  number  of  CR-ir  or  SOM-ir  neurons in  the  CA1 did not  differ
between animal models ipsilaterally (II, Fig. 5C). Contralaterally, the total number of CR-ir
neurons did not differ between groups (II, Fig. 5C) but the total number of SOM-ir neurons
at 1 month post-SE in the whole CA1 was 77% of that at 1 month post-TBI (p<0.01) (II, Fig.
5C). At 1 month post-TBI, the number of CR-ir neurons in the stratum laconosum-moleculare
was 72% of that at 1 month post-SE (p<0.01). Laminar analysis of SOM-ir neurons revealed
that the loss of cells was related to the reduction in the number of immunopositive cells in
the stratum oriens (74% of cells remaining as compared to the 1 month post-TBI group,
p<0.01).
At 6 months post-insult, the number of CR-ir, SOM-ir or NPY-ir neurons in the whole CA1
did not differ between groups ipsilaterally (II, Fig. 5C). Ipsilaterally, at 6 months post-TBI,
the number of CR-ir neurons in the stratum oriens was 85% of that at 6 months post-SE
(p<0.05). Ipsilaterally, the number of SOM-ir neurons at 6 months post-SE in the pyramidal
cell layer was 66% of that found at 6 months post-TBI (p<0.01). Contralaterally, the number
of CR-ir or NPY-ir neurons in the whole CA1 did not differ between the groups (II, Fig. 5C).
However, the number of SOM-ir neurons at 6 months post-SE in the whole CA1 was 78%
(p<0.001) of that encountered at 6 months post-TBI (II, Fig. 5C). Contralaterally, at 6 months
post-TBI, the number of CR-ir neurons in the stratum radiatum was 91% of that at 6 months
post-SE (p<0.05). Laminar analysis of SOM-ir neurons revealed that the loss of cells was
related to a reduction of immunopositive cells from within the stratum oriens (82%, p<0.01)
and the pyramidal cell layer (58%, p<0.01).
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Table 9. Summary of the results from the histological analysis of the calretinin and somatostatin
immunoreactive interneurons.
Calretinin Somatostatin
TBI SE TBI SE
1
month
6
months
1
month
*6
months
1
month
6
months
1
month
*6
months
Dentate gyrus
Ipsilateral ? ??? NS NS ??? ??? NS NS
Contralateral NS ? NS NS NS NS NS NS
CA3
Ipsilateral NS NS NS NS NS ?? NS NS
Contralateral NS ? NS NS NS NS NS NS
CA1
Ipsilateral NS NS NS NS NS ?? NS NS
Contralateral NS NS NS NS NS ??? NS NS
Abbreviations: NS, no significant change as compared to controls, TBI, traumatic brain injury;
SE, status epilepticus
* post-SE animals with epilepsy
Statistical significance: ?p<0.05, ? ??p<0.01, ???p<0.001, as compared to controls,
(Mann-Whitney U test)
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Table 10. Summary of the results from the histological analysis of the neuropeptide Y
immunoreactive interneurons.
Neuropeptide Y
TBI SE
1 month 6 months 1 month *6 months
Dentate gyrus
Ipsilateral ??? ??? NA ??
Contralateral NS NS NA ??
CA3
Ipsilateral NS ?? NA ??
Contralateral NS NS NA ?
CA1
Ipsilateral NS NS NA NS
Contralateral NS NS NA NS
Abbreviations: NA, not analyzed; NS, no significant change as compared to controls, TBI,
traumatic brain injury; SE, status epilepticus
* post-SE animals with epilepsy
Statistical significance:?p<0.05, ???p<0.01,???p<0.001, as compared to controls, (Mann-
Whitney U test)
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5.5 HISTOLOCAL ANALYSIS OF THE THALAMUS AFTER TRAUMATIC
BRAIN INJURY
5.5.1 Reticular nucleus of the thalamus (III)
The  magnitude  and  topography  of  the  loss  of  PARV-ir  neurons  in  the  RT  in  PARV
immunostained sections was comparable to neuronal loss in thionin-stained preparations
(III, Fig. 2). The total volumes (µm3) of the RT in controls and in injured rats were assessed
using Cavalieri estimations (III, Fig. 4A). Ipsilaterally, the total volume of RT in rats with TBI
was 58% of that in controls (p<0.001) (III, Fig. 4A). Contralaterally, the volume of the RT was
similar to that in controls (III, Fig. 4A). Ipsilaterally, the volume of the RT was 65% of that
contralaterally (p<0.01) (III, Fig. 4A). Ipsilaterally, a decrease in the RT volume was seen
throughout its rostrocaudal extent (p<0.05)(III, Fig. 4B, upper part), being most remarkable
caudally (III, Fig. 3B). Contralaterally, there was a slight reduction in the RT volume at its
mid-rostrocaudal level (p<0.01)(III, Fig. 4B, lower part).
The  total  number  of  PARV-ir  neurons  in  the  RT  was  assessed  by  using  the  optical
fractinator method. The analysis showed that the number of PARV-ir neurons in the
ipsilateral RT was 64% of that in controls (p<0.001)(III, Fig. 4C) and 79% of that contralaterally
(p<0.05)(III, Fig. 4C). Contralaterally, the number of PARV-ir neurons was 84% of that in
controls (p<0.05)(III, Fig. 4C).  Ipsilaterally, the loss of PARV-ir neurons in the RT was more
pronounced caudally than rostrally (III, Fig. 4D, upper part). There was no changes detected
in the terms of rostrocaudal topography in loss of RT neurons on the contralateral side (Fig.
4D, lower part).  Results are summarized in table 11.
There was an association between the volume reduction and loss of PARV-ir neurons in
the  RT  i.e.  the  smaller  the  volume  of  the  RT,  lower  the  number  of  PARV-ir  neurons  both
ipsilaterally (r=0.783, p<0.05)(Fig. 2A-B) and contralaterally (r=0.728, p<0.05) at 6 months
post-TBI (Tables 12 and 13). However, there was no clear association between the extent of
rostrocaudal  cortical  damage  and  the  loss  of  PARV-ir  neurons  in  the  RT  (III,  Fig.  6).  The
severity  of  the  impact  (in  atms)  did  not  correlate  with  the  number  of  remaining  PARV-ir
neurons in the RT (III, Fig. 6).
5.5.2 Ventral posterior medial and lateral nucleus of the thalamus
First, the volume of the VPM-VPL was assessed. In rats with TBI, the volume of the ipsilateral
VPM-VPL was reduced to 51% (p<0.001) and contralaterally to 91% (p<0.05) of that in
controls (III, Fig. 5G). Interhemispheric analysis revealed that after TBI the volume of the
ipsilateral VPM-VPL was 58% of that contralaterally (p<0.01)(Fig. 5G).
Next,  the  measurement  of  the  intensity  of  PARV  positive  axonal  labeling  in  the  entire
VPM-VPL  nuclear  complex  was  conducted  by  assessing  the  mean  grey  value  of
immunostaining (the sum of the gray values of all pixels within the VPM-VPL divided by
the number of pixels). In rats with TBI, the intensity of axonal labeling was comparable to
that in controls both ipsilaterally and contralaterally (III, Fig. 5A). In rats with TBI, however,
the intensity of immunolabeling in the entire VPM-VPL area was higher ipsilaterally than
contralaterally (2.9 units, p<0.01)(III, Fig. 5A). As the qualitative microscopic analysis
revealed differences in the density of immunoreactivity in different parts of the VPM-VPL it
was decided to conduct an assessment of the mean gray value of immunoreactivity in the
four regions of interest, i.e. the lateral (VPM-lat) and medial (VPM-med) halves of the VPM
and the lateral (VPL-lat) and medial (VPL-med) halves of the VPL (III, Fig. 5B). In the
ipsilateral VPM-lat, the density of immunolabeling in rats with TBI was higher than that in
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controls (3.8 units, p<0.001)(III, Fig. 5C) or contralaterally (4.3 units , p<0.01)(III, Fig. 5C).
Contralaterally, there were no differences between the injured and control animals (III, Fig.
5C). In the VPM-med, the density of immunoreactivity did not differ between injured and
control  animals.  In  the  ipsilateral  VPL-lat,  the  density  of  immunolabeling in  rats  with  TBI
was higher than that in controls (3.7 units, p<0.001)(III, Fig. 5D) or contralaterally (4.2 units ,
p<0.01)(III, Fig. 5D).  But on the contralateral side, there was no difference between injured
and control animals (III, Fig. 5D). In the VPL-med, the density of immunoreactivity was
comparable to that in controls (III, Fig. 5E, Fig. 5F, respectively) and there were no
interhemispheric differences (III, Fig. 5E, Fig. 5F).
The increased PARV-labeling after TBI in the ipsilateral VPM-VPL was not relate to its
shrinkage as there was no association between the intensity of PARV-ir in the ipsilateral
VPM-lat or VPL-lat and the volume of the ipsilateral VPM-VPL in rats with TBI (for VPM-lat
r=-0.567, p=0.112; for VPL-lat r=-0.567, p=0.112, n=9)(Table 12). In addition, there was no
association between the numbers of remaining neurons in the RT associated with increased
PARV-ir axonal labeling in the VPM-VPL (Table 12; Fig.2A-B). However, there was a clear
association detected between the volume of the VPM-VPL and the rostrocaudal extent of
cortical damage and the severity of the impact (III, Fig. 6).
Figure 2. 3D figures showing the association between the volume of the RT (µm3), the number of
PARV-ir neurons in the RT, and the mean gray value of the PARV-ir terminal labeling in the VPM-
VPL (panel A) or the total volume of the VPM-VPL (panel B) in rats with traumatic brain injury
(TBI). (A) The smaller the volume of the RT, the lower the number of PARV-ir neurons (r=0.783,
p<0.05). The volume of the RT and the number of neurons in the RT did not correlate with the
mean gray value of the VPM-VPL. (B) In addition, there was no correlation between the volume
of the RT or the number of PARV-ir neurons in the RT and the total volume of the VPM-VPL.
Abbreviations: RT, reticular nucleus of the thalamus; VPM, ventral posterior medial nucleus of the
thalamus; VPL, ventral posterior lateral nucleus of the thalamus.
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Table 11. Summary of the results from the histological analysis of reticular and ventral posterior
medial and lateral nucleus the thalamus.
Brain area Control TBI
RT ipsilateral The number of
PARV-ir neurons
41 000 ± 1800 26 000 ± 1200***
Volume (µm3) 1.08 x 1010 ± 4.75 x 108 6.27 x 109 ± 3.88 x 108***
RT contralateral The number of
PARV-ir neurons
40 000 ± 1800 33 000 ± 2000*
Volume (µm3) 1.07 x 1010 ± 5.19 x 108 9.60 x 109 ± 4.03 x 108
VPM-VPL
ipsilateral
Density of the
PARV-ir axons
109.15 ± 0.43 107.83 ± 0.77
Volume (µm3) 2.88 x 109 ± 9.04 x 107 1.48 x 109 ± 1.16 x 108**
VPM-VPL
contralateral
Density of the
PARV-ir axons
109.31 ± 0.40 110.77 ± 0.86
Volume (µm3) 2.78 x 109 ± 7.09 x 107 2.53 x 109 ± 8.98 x 107*
Statistical significance: *, p<0.05; **, p<0.01; ***, p<0.001 as compared to controls, Mann-
Whitney U-test.
Abbreviations: ir, immunoreactive; PARV, parvalbumin; RT, reticular nucleus of the thalamus;
TBI, traumatic brain injury; VPM, ventral posterior medial nucleus; VPL, ventral posterior
lateral nucleus.
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Table 12. Correlation  of  the  parameters  measured  from  ipsilateral  RT  and  VPM-VPL  of  the
thalamus at 6 months post-TBI (n=9).
Ipsi-
lateral
PARV-ir
neurons
(RT)
Volume
(RT)
PARV-ir
density
(VPM-
VPL)
PARV-ir
density
(VPM-
lat)
PARV-ir
density
(VPL-
lat)
PARV-ir
density
(VPM-
med)
PARV-ir
density
(VPL-
med)
Volume
(VPM-
VPL)
PARV-ir
neurons
(RT)
0.783
*
0.017 0.383 -0.033 -0.467 -0.233 0.133
Volume
(RT)
0.783
*
-0.150 0.183 -0.033 -0.633 -0.300 0.183
PARV-ir
density
(VPM-
VPL)
0.017 -0.150 0.900
**
0.950
***
0.750
*
0.850
**
-0.550
PARV-ir
density
(VPM-
lat)
0.383 0.183 0.900
**
0.867
**
0.483 0.633 -0.567
PARV-ir
density
(VPL-
lat)
-0.033 -0.033 0.950
***
0.867
**
0.617 0.783
*
-0.567
PARV-ir
density
(VPM-
med)
-0.467 -0.633 0.750
*
0.483 0.617 0.833
**
-0.550
PARV-ir
density
(VPL-
med)
-0.233 -0.300 0.850
**
0.633 0.783
*
0.833
**
-0.633
Volume
(VPM-
VPL)
0.133 0.183 -0.550 -0.567 -0.567 -0.550 -0.633
Statistical significance: *, p<0.05; **, p<0.01; ***, p<0.001; Spearman’s Rho.
Abbreviations: ir, immunoreactive; PARV, parvalbumin; RT, reticular nucleus of the thalamus;
TBI, traumatic brain injury; VPM, ventral posterior medial nucleus; VPL, ventral posterior
lateral nucleus.
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Table 13. Correlation of the parameters measured from contralateral RT and VPM-VPL of the
thalamus at 6 months post-TBI (n=9).
Contra-
lateral
PARV-ir
neurons
(RT)
Volume
(RT)
PARV-ir
density
(VPM-
VPL)
PARV-ir
density
(VPM-
lat)
PARV-ir
density
(VPL-
lat)
PARV-ir
density
(VPM-
med)
PARV-ir
density
(VPL-
med)
Volume
(VPM-
VPL)
PARV-ir
neurons
(RT)
0.728
*
-0.393 -0.343 -0.293 -0.469 -0.234 0.527
Volume
(RT)
0.728
*
-0.283 -0.250 -0.333 -0.200 -0.317 0.267
PARV-ir
density
(VPM-
VPL)
-0.393 -0.283 0.967
***
0.917
**
0.967
***
0.967
***
-0.883
**
PARV-ir
density
(VPM-
lat)
-0.343 -0.250 0.967
***
0.917
**
0.900
**
0.950
***
-0.883
**
PARV-ir
density
(VPL-
lat)
-0.293 -0.333 0.917
**
0.917
**
0.833
**
0.917
**
-0.867
**
PARV-ir
density
(VPM-
med)
-0.469 -0.200 0.967
***
0.900
**
0.833
**
0.900
**
-0.883
**
PARV-ir
density
(VPL-
med)
-0.234 -0.317 0.967
***
0.950
***
0.917
**
0.900
**
-0.850
**
Volume
(VPM-
VPL)
0.527 0.267 -0.883
**
-0.883
**
-0.867
**
-0.883
**
-0.850
**
Statistical significance: *, p<0.05; **, p<0.01; ***, p<0.001; Spearman’s Rho.
Abbreviations: ir, immunoreactive; PARV, parvalbumin; RT, reticular nucleus of the thalamus;
TBI, traumatic brain injury; VPM, ventral posterior medial nucleus; VPL, ventral posterior
lateral nucleus.
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5.6 CONTROL EXPERIMENTS
To further address a question of whether the significant loss of immunostained interneurons
after TBI was related to neuronal death rather than simply a change in their chemotype, the
neurodegeneration in the hilus was assessed in more detail. Firstly, unbiased stereological
estimation demonstrated that only 53% of the hilar cells remained ipsilaterally at 1 month
post-TBI (p<0.05 as compared to controls)(II, Fig. 9E). Secondly, WFA-positive perineuronal
nets (indicating PARV-ir neurons) around Fluoro-Jade B positive cells provided evidence of
the death of PARV-ir neurons in both the hilus and in the CA1 stratum oriens at 4 h post-TBI
(II, Fig. 9F-I). Thirdly, qualitative analysis of SPR immunohistochemistry revealed a loss of
immunopositive  neurons  and  this  was  more  pronounced  when  the  reduction  in  PARV-ir
neuronal numbers was greater (II, Supplementary Fig. 1).
5.7 INTERNEURON LOSS AND SEIZURE SUSCEPTIBILITY
5.7.1 Traumatic brain injury
5.7.1.1 Hippocampus (II)
To evaluate the influence of the loss of interneurons on seizure susceptibility, the cell
numbers were correlated with different parameters obtained from the PTZ test. There was
only one parameter in the seizure threshold test which correlated with the total numbers of
all 5 investigated interneuron subclasses at 6 months post-TBI, i.e. the lower the number of
neurons in the contralateral dentate gyrus, the lower the number of epileptiform spikes
(r=0.857, n=7, p<0.05) (II, Supplementary Table 6.1). The sum of the total number of PARV
and CCK positive cells ipsilaterally and/or contralaterally did not correlate with seizure
susceptibility (II, Supplementary Table 6.2). The next question was if a reduction in the
number of perisomatic interneurons in different subfields would be associated with the cell
loss and hyperexcitability. There were a few correlations as the lower the number of PARV-
ir neurons in the ipsilateral stratum radiatum of the CA3, the higher the number of EDs in
the PTZ test (r=-0.719, p<0.05)(II, Supplementary Table 6.3). However, the lower the number
of PARV-ir neurons in the contralateral granule cell layer, the lower the number of
epileptiform spikes in the PTZ test at 6 months post-TBI (r=0.695, p<0.05)(II, Supplementary
Table 6.3). In this study, all of the correlations obtained for CCK-ir neurons were unexpected.
The  lower  the  number  of  CCK-ir  neurons  in  the  contralateral  dentate  gyrus  or  in  the
contralateral hilus only, the lower the number of epileptiform spikes in the PTZ-test (r=0.826,
p<0.05 and r=0.850, p<0.01, respectively)(II, Supplementary Table 6.3). Furthermore, the
lower the number of CCK-ir neurons in these regions, the longer the latency to the first ED
in the PTZ test (contralateral dentate gyrus r=-0.826, p<0.05; hilus r=-0.898, p<0.01)(II,
Supplementary Table 6.3). The lower the number of CCK-ir neurons ipsilaterally in the
stratum oriens, the longer the latency to the first ED in the PTZ test (r=-0.759, n=8, p<0.05)(II,
Supplementary Table 6.3). Finally, the lower the number of CCK-ir neurons ipsilaterally in
the stratum oriens or stratum radiatum, the lower the number of epileptiform spikes in the
PTZ-test (r=0.952, n=8, p<0.001; r=0.719, n=8, p<0.05; respectively)(II, Supplementary Table
6.3).
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The sum of the CR, SOM and NPY positive cells ipsilaterally and/or contralaterally) did
not correlate with any of the indices of seizure susceptibility (II, Supplementary Table 6.2).
When individual neuronal classes were analyzed, only one correlation was revealed as the
lower the total number of CR-ir neurons in the contralateral hippocampus, the longer the
mean duration of the EDs (r=-0.745, n=9, p<0.05)(II, Supplementary Table 6.4). Analysis of
different  hippocampal  subfields  indicated  that  the  lower  the  number  of  CR-ir  neurons
ipsilaterally in the hilus, the longer the mean duration of the ED (r=-0.745, n=9, p<0.05)(II,
Supplementary Table 6.4). In addition, the lower the number of CR-ir neurons contralaterally
in the stratum radiatum of the CA1, the higher the number of EDs (r=-0.828, n=9, p<0.01)(II,
Supplementary Table 6.4). Analysis of SOM-ir neurons indicated that the lower the total
number of SOM-ir neurons in both hemispheres, the longer the latency to the first
epileptiform spike (r=-0.678, n=9, p<0.05)(II, Supplementary Table 6.4). Furthermore, the
lower the total number of SOM-ir neurons in the ipsilateral hippocampus, the longer the
latency to the first epileptiform spike (r=-0.795, n=9, p<0.05) and the first ED (r=-0.700, n=9,
p<0.05)(II, Supplementary Table 6.4). The lower the number of SOM-ir neurons ipsilaterally
in the dentate gyrus or in the hilus only, the higher the number of EDs (r=0.717, n=9, p<0.05;
r=0.733, n=9, p<0.05; respectively)(II, Supplementary Table 6.4). However, the lower the
number of SOM-ir neurons ipsilaterally in the whole CA3 or in the stratum oriens only, the
longer the latency to first epileptiform spike in the PTZ-test (r=-0.720, n=9, p<0.05; r=-0.711,
n=9, p<0.05; respectively)(II, Supplementary Table 6.4). The lower the number of SOM-ir
neurons contralaterally in the pyramidal cell layer of the CA1, the shorter the latency to first
ED (r=0.700, n=9, p<0.05)(II, Supplementary Table 6.4). The lower the number of SOM-ir
neurons contralaterally in the pyramidal cell layer, the higher the number of epileptiform
spikes (r=-0.683, n=9, p<0.05)(II, Supplementary Table 6.4). However, the lower the number
of SOM-ir neurons contralaterally in CA1 or in the stratum oriens only, the shorter the mean
duration of the ED (r=0.686, n=9, p<0.05; r=0.745, n=9, p<0.05; respectively)(II, Supplementary
Table  6.4).   An  analysis  of  NPY-ir  neurons  revealed  that  the  lower  the  number  of  NPY-ir
neurons in the ipsilateral dentate gyrus, the longer the latency to the first spike (-0.810, n=7,
p<0.05)(II, Supplementary Table 6.4). The lower the number of NPY-ir neurons ipsilaterally
in the granule cell layer, the longer the latency to the first ED (r=-0.778, n=8, p<0.05) and the
lower the number of epileptiform spikes (r=0.755, n=8, p<0.05)(II, Supplementary Table 6.4).
The lower the number of NPY-ir neurons in the pyramidal cell layer of the CA3, the longer
the latency to the first spike (-0.857, n=7, p<0.01) and ED (-0.833, n=7, p<0.05)(II,
Supplementary Table 6.4).
5.7.1.2 Thalamus (III)
In this study there were very high correlations between some anatomic parameters and the
effect elicited the PTZ test. However, correlations depended on the treatment, and
consequently, correlations were analyzed separately to controls and rats with TBI. In
controls, smaller the volume of the RT ipsilaterally, shorter the latency to the first spike in
the PTZ seizure susceptibility test (r=0.943, p>0.01) (Table 14). The lower the number of
PARV-ir neurons ipsilaterally (r=-1.000, p<0.001) (Table 14) or contralaterally (r=-0.943,
p<0.01) (Table 14), the greater the number of spikes in the PTZ test.  The lower the density of
PARV-ir axons ipsilaterally in the VPL-med, the greater the number of spikes in the PTZ test
(r=0.829, p<0.05)( Table 14).   The smaller the volume of the VPM-VPL ipsilaterally, the greater
the number of spikes in the PTZ test (r=-0.943, p<0.01)(Table 14). Smaller the volume of the
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RT ipsilaterally, higher the number of EDs in the PTZ test (r=-0.829, p<0.05) (Table 14). The
lower the density of PARV-ir axons ipsilaterally in the VPL-med, the greater the number of
EDs in the PTZ test (r=0.829, p<0.05)(Table 14).   The smaller the volume of the VPM-VPL
contralaterally, the greater the number of EDs in the PTZ test (r=-0.943, p<0.01)(Table 14).
Moreover, the smaller the volume of the RT, the shorter was the mean duration of the EDs
(r=0.943, p<0.01)(Table 14). In addition, the lower the density of the PARV-ir axons in the
VPM-VPL or the smaller the volume of the VPM-VPL, the shorter was the mean duration of
the ED (r=-0.829, p<0.05; r=0.886, p<0.05, respectively)(Table 14). One unexpected finding was
that in rats with TBI there was no correlation between the number of PARV-ir neurons and/or
axonal labeling and seizure susceptibility after TBI (Table 14).
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Table 14. Correlation of PARV-ir and the volumes of thalamic structures with measures of
seizure susceptibility in the pentylenetetrazol test in controls (n=6).
Latency
to the 1st
spike
Latency
to the
1st ED
Number
of spikes
Number
of EDs
Mean
duration
of the ED
PARV-ir neurons in the RT,
ipsilateral
0.600 0.771 -1.0*** -0.657 0.600
PARV-ir neurons in the RT,
contralateral
0.657 0.714 -0.943** -0.771 0.714
Volume of the RT,
ipsilateral
0.943** 0.771 -0.657 -0.829* 0.943**
Volume of the RT,
contralateral
0.657 0.371 -0.086 -0.543 0.714
PARV-ir density in the VPM-
VPL, ipsilateral
-0.314 -0.371 0.714 0.657 -0.543
PARV-ir density in the VPM-
VPL, contralateral
0.086 -0.086 0.086 0.143 -0.086
PARV-ir density in the VPM-
lat, ipsilateral
0.143 -0.143 0.600 0.086 0.029
PARV-ir density in the VPM-
lat, contralateral
0.086 0.086 -0.029 0.371 -0.257
PARV-ir density in the VPL-lat,
ipsilateral
-0.314 -0.371 0.714 0.657 -0.543
PARV-ir density in the VPL-lat,
contralateral
-0.143 -0.029 -0.029 -0.029 -0.200
PARV-ir density in the VPM-
med, ipsilateral
-0.314 -0.371 0.714 0.657 -0.543
PARV-ir density in the VPM-
med, contralateral
-0.029 -0.314 -0.314 0.314 -0.143
PARV-ir density in the VPL-
med, ipsilateral
-0.600 -0.600 0.829* 0.829* -0.771
PARV-ir density in the VPL-
med, contralateral
-0.714 -0.657 -0.657 0.771 -0.829*
Volume of the VPM-VPL,
ipsilateral
0.657 0.714 -0.943** -0.771 0.714
Volume of the VPM-VPL,
contralateral
0.657 0.543 0.543 -0.943** 0.886*
Statistical significance: *, p<0.05; **, p<0.01; ***, p<0.001; Spearman’s Rho.
Abbreviations: ED, epileptiform discharge; ir, immunoreactive; lat, lateral; med, medial; PARV,
parvalbumin; RT, reticular nucleus of the thalamus; TBI, traumatic brain injury; VPM, ventral
posterior medial nucleus; VPL, ventral posterior lateral nucleus.
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Table 15. Correlation of PARV-ir and the volumes of thalamic structures with measures of
seizure susceptibility in the pentylenetetrazol (PTZ) test at 6 months post-TBI (n=9).
Latency
to the 1st
spike
Latency
to the
1st ED
Number of
spikes
Number
of EDs
Mean
duration
of the ED
PARV-ir neurons in the RT,
ipsilateral
0.033 -0.183 0.400 -0.100 -0.059
PARV-ir neurons in the RT,
contralateral
0.189 -0.126 0.385 -0.059 -0.118
Volume of the RT,
ipsilateral
-0.218 -0.233 0.200 0.117 0.059
Volume of the RT,
contralateral
0.117 -0.133 0.267 -0.250 -0.042
PARV-ir density in the VPM-
VPL, ipsilateral
0.050 -0.133 -0.050 0.017 -0.042
PARV-ir density in the VPM-
VPL, contralateral
-0.050 0.083 -0.150 0.333 -0.142
PARV-ir density in the VPM-
lat, ipsilateral
-0.042 -0.233 0.167 -0.067 -0.084
PARV-ir density in the VPM-
lat, contralateral
-0.117 -0.100 0.050 0.400 -0.100
PARV-ir density in the VPL-lat,
ipsilateral
-0.075 -0.217 -0.067 0.067 0.000
PARV-ir density in the VPL-lat,
contralateral
-0.109 0.100 0.017 0.283 -0.293
PARV-ir density in the VPM-
med, ipsilateral
0.117 0.217 -0.317 -0.033 -0.142
PARV-ir density in the VPM-
med, contralateral
-0.042 0.150 -0.250 0.217 -0.109
PARV-ir density in the VPL-
med, ipsilateral
0.092 0.100 -0.450 -0.183 0.117
PARV-ir density in the VPL-
med, contralateral
-0.117 0.000 -0.117 0.283 -0.033
Volume of the VPM-VPL,
ipsilateral
0.234 -0.083 0.267 0.533 0.000
Volume of the VPM-VPL,
contralateral
0.084 -0.150 0.200 -0.050 0.268
Abbreviations: ED, epileptiform discharge; ir, immunoreactive; lat, lateral; med, medial; PARV,
parvalbumin; RT, reticular nucleus of the thalamus; TBI, traumatic brain injury; VPM, ventral
posterior medial nucleus; VPL, ventral posterior lateral nucleus.
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5.7.2 Interneuron loss and seizure susceptibility after status epilepticus (II)
In this study, there was a correlation detected between the number of seizures after SE and
all interneurons as the lower the total number of all interneuron subclasses (both ipsilaterally
and contralaterally), the greater the number of seizures in animals with post-SE epilepsy (r=-
0.829, n=6, p<0.05)(II, Supplementary Table 7.1). Furthermore, the lower the sum of all
interneuron subclasses in the ipsilateral hippocampus proper (CA3 and CA1), the greater the
number of seizures (r=-0.829, n=6, p<0.05)(II, Supplementary Table 7.1). A reduction in the
total number of PARV-ir or CCK-ir neurons did not correlate with the mean duration of
spontaneous seizures or seizure frequency at 6 months post-SE (II, Supplementary Table 7.2).
The lower the total number of all dendritic interneurons (sum of CR-ir, SOM-ir and NPY-ir
neurons both ipsilaterally and contralaterally), the higher the number of spontaneous
seizures at 6 months post-SE (r=-0.829, n=6, p<0.05)(II, Supplementary Table 7.2). When
individual subclasses of dendritic neurons were analyzed, no associations were found
between reductions in the neuronal counts or in the duration or frequency of spontaneous
seizures. The only subfield-specific correlation detected was the lower the number of NPY-ir
neurons in the ipsilateral molecular layer of the dentate gyrus, the higher the number of
spontaneous seizures (r=-0.889, n=6, p<0.05)(II, Supplementary Table 7.3).
5.8 EXPRESSION OF GABAA RECEPTOR SUBUNITS AFTER TBI
5.8.1 Hippocampus (Unpublished work)
The gene-expression change of the 16 different GABAA receptor subunits between controls
and post-TBI animals was calculated using the ??CT-method. Normalization of the target
gene-expression of interest was conducted using the gene-expression value of the ribosomal
protein  large  P1  (Rplp1), hypoxanthine guanine phosphoribosyl transferase (Hprt), lactate
dehydrogenase A (Ldha) and ribosomal protein L13A (Rpl13a). In the granule cell layer of the
dentate gyrus, there was a 1.2-fold upregulation of the expression of Gabrb3 (p<0.05)(Table
16). However, there was no change in the expression of the GABAA receptors subunits in the
pyramidal cell layer of the CA1 at 6 months after TBI (Table 16).
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Table 16. Expression of GABAA receptor subunits at 6 months after traumatic brain injury in
the hippocampus.
Gene code Granule cell layer
of the dentate gyrus
Pyramidal cell layer of the CA1
Fold Change p-value Fold Change p-value
Gabra1 1.12 0.348 0.71 0.201
Gabra2 1.11 0.439 0.91 0.571
Gabra3 1.13 0.417 0.81 0.355
Gabra4 1.00 0.931 0.73 0.239
Gabra5 1.05 0.674 0.73 0.115
Gabra6 0.80 0.690 0.82 0.438
Gabrb2 1.04 0.617 0.74 0.461
Gabrb3 1.17 0.036* 0.72 0.204
Gabrd 1.32 0.058 0.74 0.356
Gabre 2.78 0.105 0.60 0.405
Gabrg1 1.95 0.107 0.92 0.560
Gabrg2 1.13 0.127 0.78 0.234
Gabrp 0.74 0.788 0.36 0.238
Gabrq 3.78 0.327 0.50 0.325
Gabrr1 0.96 0.639 0.63 0.150
Gabrr2 0.91 0.848 0.77 0.814
Statistical significance: *, p<0.05, t-test in Web-based data analysis
(http://www.sabiosciences.com/pcrarraydataanalysis.php)
5.8.2 Thalamus (III)
Normalization of the expression of the GABAA receptor subunits was conducted similarly as
in the hippocampus. Levels of GABAA receptor subunits Gabre (0.152, fold change as
compared to controls, p<0.01) and Gabrq (0.324, p<0.05) were down-regulated in the tissue
block containing both the thalamus and hypothalamus (III, Table 1).
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 6 Discussion
6.1 METHODOLOGICAL CONSIDERATIONS
6.1.1 Animal models
Current epilepsy treatments focus on preventing or suppressing seizures but there are no
therapies available which could prevent epileptogenesis in patients at risk of acquired
epilepsy. In addition, understanding of the changes in the molecular and cellular
mechanisms is needed before it is possible to develop better pharmacological or other
treatment of patients with epilepsy. Thus, there is a clear need to understand and characterize
animal models of epilepsy. In this study, the lateral FPI, the model of TBI, and amygdala
stimulation induced SE-model were chosen as methodology as these are well known and
characterized in our laboratory. In addition, importantly, the hippocampus or thalamus are
not directly damaged in these models as the aim was to study alterations in molecular and
cellular level in these two brain structures.
The rat model of lateral FPI used here mimics human cases of closed brain injury with the
dura mater remaining intact (Kharatishvili et al., 2006; Kharatishvili et al; 2007; Kharatishvili
and Pitkänen, 2010). The incidence of spontaneous recurrent seizures which appears after a
single event of traumatic brain injury and the duration of latent period before seizure onset
is comparable to that in patients. Similar to the human data, the seizure location in this model
is focal, with or without secondary generalization. Further, pathological findings i.e.
neuronal damage, mossy fiber sprouting and ventricular dilatation have shown similarities
to data obtained from hippocampal resectomy of patients with drug-refractory TLE with
hippocampal sclerosis.
The amygdala stimulation induced SE –model mimics the human TLE (Nissinen et al.,
2000). Spontaneous recurrent seizures in patients and in the post-SE animals arise from
temporal structures (Engel, 1996; Nissinen et al., 2000). After an approximately one month
latent period, the animals develop seizures which could be either partial or secondary
generalized (Nissinen et al., 2000). The most common pathological hallmarks associated with
human TLE are well duplicated in this model i.e. hippocampal neurodegeneration and
mossy fiber sprouting (Nissinen et al., 2000).
All  rodent  models  have limitations  when compared to  the  human data.  In  the  simplest
case, when the rodent brain is compared to human brain, one can observe differences in brain
geometry, craniospinal angle, gyral complexity and white to gray matter ratio (Gennarelli,
1994). Moreover, most of the studies intended to investigate post-TBI or post-SE animals have
been conducted in young adult males. It is well-known that there is sexual dimorphism in
the gene expression in the brain, and this could well be a factor influencing epileptogenesis
differently in males and females (Rinn and Snyder, 2005; Sharma et al., 2009). This is an
important factor which should be taken into account when planning future experiments or
when characterizing the animal models since of course patients are not restricted to one
gender.
In order to assess whether rats had developed epilepsy after the 6-month follow-up time,
a 2-wk continous video-EEG monitoring was employed to detect spontaneous seizures.  Due
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to the relatively limited monitoring period, it is possible that some animals with a very low
seizure frequency especially after TBI (0.3 seizures per day, Kharatishvili et al., 2006) were
misdiagnosed as being non-epileptic. However, this would not change the overall conclusion
of the study indicating a lack of correlation between the number of hippocampal
interneurons and seizure susceptibility. In addition, a PTZ test is a common way to assess
seizure susceptibility and the seizure threshold in normal and genetically modified rodents
(Löscher and Nolting, 1991). Studies both in our laboratory (Kharatishvili et al., 2007;
Bolkvadze and Pitkänen, 2012) and elsewhere (Blanco et al., 2009; Rattka et al., 2011) have
revealed a link between the hyperexcitability in the PTZ test and subsequent of spontaneous
seizures.
6.1.2 Histology
As indicated in many studies, reduction in the immunopositive cell counts could result from
a reduced expression of the epitope rather than the death of interneurons (Sloviter 1991;
Wittner et al., 2001; Sun et al., 2007). In order to confirm that the loss of neurons was due to
the cell death, three control experiments were performed in the TBI model in which the loss
of immunoreactivity was more robust than that encountered after SE. Firstly, the total
number of hilar neurons was estimated at 1 month post-TBI to obtain a general
approximation of the severity of neurodegeneration. Similar to previous studies (Buckmaster
and Dudek, 1997; Buckmaster and Jongen-Rêlo, 1999; Thind et al., 2010), the mean number
of hilar neurons in controls was around 47 000. At 1 month post-TBI, only about 53% neurons
were still present ipsilaterally whereas contralaterally the neuronal number did not differ
from that in controls, which is in line with previous observations with the lateral FPI model
(Lowenstein et al., 1992; Toth et al., 1997). The calculation of the sum of hilar PARV, CCK,
SOM, CR, and NPY positive neurons revealed a total of 26 600 interneurons in controls and
14 700 in rats with TBI, evidence that about 45% interneurons had died by 1 month post-TBI,
which could reflect the fact that about every another hilar cell had disappeared. As the sum
of all interneurons was counted, and the analysis did not take into account the partial overlap
of different neurochemicals (Bering et al., 1997; Dinocourt et al., 2003; Sloviter et al., 2003), it
is possible that the total neuronal number calculated was somewhat overestimated. In
addition, mossy cells that form about 40% of the total neuronal population in the hilus are
also damaged by lateral FPI, which could explain at least part of the reduction in the numbers
of hilar neurones (Toth et al., 1997).
The second control experiment performed to prove the cell death was whether the most
clearly  affected  GABAergic  neuronal  population,  PARV-ir  neurons,  co-labelled  with  a
neurodegeneration marker at the early post-TBI phase. As PARV-ir neurons contain WFA
positive perineuronal nets (Härtig et al., 1992), it is possible to perform double-labeling with
the intraneuronally located Fluoro-Jade B, a marker of the neurodegeneration (Schmued and
Hopkins, 2000), and the perineuronally located WFA-ir to demonstrate that there has been
degeneration of PARV-ir neurons (Karetko-Sysa et al., 2011). The results indicated that in
samples collected at 4 h post-TBI, a subpopulation of Fluoro-Jade B positive neurons were
surrounded by WFA-positive perineuronal nets both in the dentate gyrus and the
hippocampus proper.
As  a  third  control  experiment,  the  sections  adjacent  to  those  used  for  PARV
immunohistochemistry  from  controls  and  animals  with  TBI  at  1  or  6  months  earlier  were
stained with an antibody raised against SPR, a marker of hippocampal PARV-ir neurons
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(Sloviter et al., 2001; Sloviter et al., 2003). The results indicated that the more pronounced was
the reduction in PARV-ir neurons, then the greater was the reduction in SPR-ir neurons,
representing another type of proof that the PARV-ir neurons had died after TBI.
6.1.3 Quantitative RT-PCR array
Real time quantitative RT-PCR is a well-established method for measuring gene expression
levels (Heid et al., 1996). The RT-PCR array has been used in many studies assessing of gene-
expression changes in the amounts of various genes at the same time in different conditions
e.g.  cancer,  inflammation  and  cytokine  profiling,  stem  cells,  neuroscience,  signal
transduction pathways, cell adhesion, cell migration and biomarker screening (Gude et al.,
2007; Airoldi et al., 2007; Chen et al., 2007; Dickson et al., 2007; Giuliani et al., 2007; Klopp et
al., 2007; Gridley et al., 2008; Hoffman et al., 2008; Lee et al., 2008; Mueller et al., 2008; Barkic
et al., 2009; Tian et al., 2009; Stirling et al., 2009; Xu et al., 2010; Belser et al., 2011). In all
quantitative PCR experiments, choosing the right reference gene against which to normalize
threshold cycle (Ct) values between different samples during the quantification of the gene
of interest is an important factor if one desires high quality data. The reference gene has to
be chosen to be one which expression does not change due to the treatment being performed.
The PCR array used in this study included five different options for the reference gene: ?-
actin (Actb), Rplp1, Hprt, Ldha and Rpl13a. Since of the expression of ?-actin is known to
change in rat models of the SE and TBI (unpublished observations), it was not used to
normalize expression of GABAA receptor subunits after TBI. Instead, the expression level of
other four genes was used as the reference gene expression level to achieve normalization in
this study as their expression levels were not changed between controls and post-TBI
animals.
6.2 LOSS OF HIPPOCAMPAL INTERNEURONS RESPONSIBLE FOR
PERISOMATIC INHIBITION
Human TLE patients and animals with acquired epilepsy have been shown to display a
reduction in the number of hippocampal interneurons (Mathern et al., 1995; Wasterlain et al.,
1996; Magloczky and Freund, 2005; Toth et al., 2010). However, the link between the severity
of interneuron loss and epilepsy phenotype is still poorly understand.  Even though not all
PARV-ir or CCK-ir neurons are responsible for perisomatic inhibition (Klausberger et al.,
2003; Somogyi and Klausberger, 2005), they are discussed under this one heading as the
analysis performed in this study did not differentiate interneurons according to either their
morphology or connectivity.
According the results of this study, after TBI, there was a clear reduction in the numbers
of PARV-ir neurons in different hippocampal subfields and this was visible already at 1
month post-insult i.e. only 62-82% of PARV-ir neurons were remaining in the ipsilateral
dentate gyrus or CA1. By 6 months post-TBI, the degeneration of PARV-ir neurons had
progressed, being present in different hippocampal subfields bilaterally with only 35-67% of
neurons remaining as compared to that in controls.  Furthermore, by 6 months, the loss of
immunoreactivity extended throughout the septo-temporal axis of the hippocampus, even
though it was still more pronounced septally. Also, in line with reduced number of neurons,
the axonal and dendritic immunolabeling had also declined. When post-SE rats were
compared to post-TBI animals, from all hippocampal areas investigated, there was merely a
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mild reduction in the PARV-ir neurons only in the ipsilateral CA1 at 6 months post-SE. The
reduction was seen particularly in the pyramidal cell layer, in which 70% of PARV-ir neurons
still remained. However, after SE, the number of PARV-ir neurons was reduced only in those
animals that had developed epilepsy by 6 months post-insult not in the non-epilepsy group.
In all post-SE animals, the mild reduction in neuronal somata was associated with a patchy
disappearance of immunopositive axons, particularly septally. Unlike the situation with
PARV-ir neurons, CCK-ir neurons were substantially better preserved both after TBI and SE.
At 1 month post-TBI, CCK-ir neuronal numbers were comparable to those of controls. Also
at 6 months post-TBI, CCK-ir cells were well preserved except in the dentate gyrus where
only about 60% of CCK-ir neurons remained. However, there was still a dense pericellular
axonal plexus around the granule cells. During the 6 months of follow-up after SE, the total
neuronal numbers of CCK-ir cells in different hippocampal subfields remained normal as
compared to controls. These observations are well in line with our laboratory’s previous
magnetic resonance imaging (MRI) studies showing that after TBI in the ipsilateral side,
hippocampal abnormalities progressed for about 3 months. Contralaterally, the MRI signal
abnormalities were milder than those seen ipsilaterally but also progressed for around 3
months (Immonen et al., 2009). Similarly, in the amygdala stimulation model of SE, signal
abnormalities in hippocampus were milder than those seen after TBI but remained for several
weeks (Nairismägi et al., 2004). These data suggest that progressive loss of interneurons and
their processes contribute to the progressive signal abnormality and hippocampal atrophy
after both TBI and SE.
The literature contains three previous studies that have investigated hippocampal PARV-
ir or CCK-ir neurons after experimental TBI. Toth et al. (1997) induced TBI in Wistar rats with
lateral FPI using mild to moderate impact severity (1.4-2.2 atm) and followed the animals for
up to 8 months. Stereological analysis of the histology revealed that 33% of PARV-ir and 44%
of CCK-ir neurons were remaining in the ipsilateral hilus at 7 d post-TBI. Zhang et al. (2011a,
b) also induced mild to moderate (1.8-2.0 atm) lateral FPI in adult Wistar rats. At 7 d post-
TBI, they found that 52-55% of PARV-ir and 52-66% of CCK-ir neurons were remaining in
the ipsilateral dentate gyrus and 54-56% and 54-60% in the CA3, whereas the CA1 was intact.
More numerous studies have revealed the loss of PARV-ir neurons after SE, and two of
those also assessed the number of CCK-ir neurons. Buckmaster and Dudek (1997) induced
SE with intraperitoneal injections of kainate in adult Sprague-Dawley rats and followed-up
the animals for up to 335 days. They counted PARV-ir neurons in the dentate gyrus using an
optical fractionator method and reported that 78% of PARV-ir neurons were remaining as
compared to controls. However, these authors did not find any change in the total number
of CCK-ir. Kuruba et al. (2011) also induced SE with intraperitoneal injections of kainate.
However, they used adult Fisher 344 rats and perfused the animals for cell counting with an
optical fractionator method already at 12 d post-SE. Interestingly, in this rat strain the
reduction of PARV-ir neurons was more robust, resulting in only 46% of neurons remaining
in the dentate gyrus, 37% in the CA3, and 40% in the CA1.
Four studies have quantitatively assessed PARV-ir neurons after pilocarpine-induced SE.
André et al. (2001) triggered SE with subcutaneous injections of pilocarpine in adult Sprague-
Dawley rats and followed the animals for up to 18 d. Counting of cells from 2-3 sections using
a 1 cm2 grid revealed that only 20% of PARV-ir neurons remained in the stratum oriens of
the CA1, 40% in the hilus, and 54% in the granule cell layer of the dentate gyrus. Interestingly,
clear reductions in neuronal numbers were seen already at 24 h after SE in the stratum oriens
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of the CA1, i.e., before epilepsy onset, towards more the chronic time points. In the study of
Dinocourt et al. (2003), the researchers induced SE with pilocarpine (i.p.) in adult Wistar rats
and followed-up the animals for 3 months. Stereological analysis of the CA1 revealed that
43% of PARV-ir neurons were remaining in the stratum oriens, but no change was seen in
the pyramidal cell layer or stratum radiatum. Ferrari et al. (2008) induced SE with
intraperitoneal pilocarpine in Wistar rats and followed-up the animals for 2 months. They
found  fewer  PARV-ir  neurons  in  the  CA3  region  and  in  the  hilus,  but  not  in  the  CA1  as
compared to controls. Long et al. (2011) induced SE with intraperitoneal injections of
pilocarpine in adult Sprague-Dawley rats. They followed the animals for up to 2 months and
quantified the neuronal numbers with MetaMorph imaging software with four sections per
animal. Analysis revealed that at 1 or 7 d post-SE, there was no change in the number of
PARV-ir neurons in hilus, CA3 or CA1. At 15 d post-SE, 88% of PARV-ir neurons were
remaining in the hilus. However, there was a 39% increase in the number of PARV-ir neurons
in the CA1. At 1 and 2 months post-SE, only 63% and 58% of the neurons were still present
in the hilus, respectively. In contrast, the number of PARV-ir neurons in the hippocampus
proper remained increased by 21-46%.
Three  studies  have  quantified  PARV-ir  neurons  after  induction  of  SE  with  electrical
stimulation of the hippocampus or its afferent pathways. Gorter et al. (2001) induced SE in
adult Sprague-Dawley rats, followed-up the animals for up to 3 or 6 months and counted cell
densities (cells/mm2). They found that only 8-16% of the PARV-ir neurons remained in the
hilus and 43-44% in the granule cell layer. With the same model and counting method, van
Vliet et al. (2004) found that after 1 wk <30% of PARV-ir neurons were remaining in the
dentate gyrus and 50-60% in the hippocampus proper. They also reported that in the rats
with progressive epilepsy, the number of PARV-ir neurons was comparable to that at 1 week
post-SE. However, in a subgroup of rats with non-progressive epilepsy, the number of
PARV-ir neurons was comparable to that in controls. Sun et al. (2007) induced SE in adult
Sprague-Dawley rats by hippocampal stimulation. They sacrificed rats at different post-SE
intervals and one group was followed until they developed spontaneous seizures. They
found a reduction in the number of hilar PARV-ir neurons at 1, 3 and 7 d post-SE. However,
rats with spontaneous seizures had PARV-ir neuronal numbers comparable to those in
controls. In addition, that study revealed that there was a loss of CCK-ir neurons in the hilus
at 3 d and 7 d after SE. However, after the rats had become epileptic, the number of hilar
CCK-ir neurons was similar to that in controls. In addition, they did not detect any other
signs of neurodegeneration.
Even though the methods used to estimate the neuronal numbers vary and some of those
methods may cause bias in the way that the cell counts are obtained, the data available reveal
model-dependency particularly in the reduction of hippocampal PARV-ir neurons after SE
and TBI. This maybe related to the severity of SE induced by different methods (chemical vs.
electrical) or the severity of TBI (moderate vs. severe lateral FPI). Furthermore, the genetic
background of the rats and the localization of the primary injury site (hippocampal vs.
extrahippocampal) can influence the severity of damage to PARV-ir neurons. The cross-
sectional data also indicate that there is a progressive decline in neuronal numbers and its
regional extent. Perhaps one of the most important findings of this study was that the loss of
PARV-ir neurons at 6 months after TBI was more robust than that encountered in any of the
SE models. Importantly, the rats with TBI did not show spontaneous seizures in the same
manner as the animals subjected to SE. Whether PARV-ir neurons possess a particular
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sensitivity to the primary mechanical impact associated with TBI remains to be investigated.
In addition, it is still not clear whether any particular type of the PARV-ir neurons, according
to the neurons morphology and connectivity of the neurones, are more vulnerable to TBI
than others; this remains to be clarified.
Taken together, the present study extends the previous observations by showing that
lateral FPI causes clear progressive damage to PARV-ir and CCK-ir neurons in the dentate
gyrus but also in different subfields of the hippocampus proper bilaterally. Interestingly,
perisomatic inhibitory neurons, including both PARV-ir and CCK-ir neurons appear more
vulnerable to TBI than to SE. No association was detected between the number of PARV-ir
or CCK-ir neurons and seizure susceptibility or number of seizures after epileptogenic insult.
6.3 LOSS OF HIPPOCAMPAL INTERNEURONS RESPONSIBLE FOR
DENDRITIC INHIBITION
It has been well established in previous studies that not all CR-ir neurons are responsible for
dendritic  inhibition  of  principal  cells  as  these  nerves  also  innervate  other  interneurons
(Acsády et al., 1996; Gulyás et al., 1996). In addition, a subclass of SOM-ir neurons may project
outside  of  the  hippocampus  and  for  that  reason  they  may  have  different  functions  as
compared to interneurons which are responsible for the inhibition of dendrites of
hippocampal principal cells (Gulyás et al., 1996). However, the results obtained in this study
will be discussed under a single heading because of the importance of the CR-ir, SOM-ir and
NPY-ir neurons for inhibition of the excitatory pyramidal and granule cells.
Overall, in this study, the pattern of the loss of interneurons responsible for dendritic
inhibition was similar to those responsible for perisomatic inhibition. However, some
differences were found. At 1 month post-TBI, 77% of CR-ir and 46% of SOM-ir neurons were
still  present  in  the  ipsilateral  dentate  gyrus.  By  6  months,  the  loss  of  CR-ir  neurons  had
become bilateral with 74% remaining ipsilaterally and 77% contralaterally. Less severe
reductions  in  CR-ir  neuronal  numbers  were  also  found  in  the  CA3.  However,  the  loss  of
SOM-ir neurons had expanded to the ipsilateral CA3, with 64% of neurons remaining, as well
as to the CA1 with 75% of SOM-ir neurons remaining. At 6 months there was also a decrease
in SOM-ir neurons in the contralateral CA1 with 78% of neurons remaining. Unlike the
situation after TBI, it was not possible to detect any major changes in the number of CR-ir or
SOM-ir neurons after SE. The loss of NPY-ir neurons was seen in both animal models. At 1
month post-TBI, 59% of NPY-ir neurons remained in the ipsilateral dentate gyrus. By 6
months post-TBI, there was no significant further reduction in the neuronal numbers in the
dentate gyrus i.e. 51% of NPY-ir neurons were still present. However, at this chronic time
point, the reduction in immunopositive neurons had expanded to the ipsilateral CA3 where
only 76% of NPY-ir neurons could be detected. No changes were observed in the CA1. Unlike
after TBI, stereological counting of NPY-ir neurons at 1 month post-SE could not be
conducted as the intensive terminal immunoreactivity in the hilus and around the CA1
pyramidal cells compromised the reliability of counting in 29% of the rats. Analysis of
sections sampled at 6 months post-SE revealed that there had been a robust bilateral decrease
in  NPY-ir  neurons  in  rats  with  epilepsy,  but  not  in  non-epileptic  rats,  in  comparison  to
controls. In particular, only 33% of neurons could still be observed in the dentate gyrus
ipsilaterally and 37% contralaterally. In the CA3, 54% remained ipsilaterally and 57%
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contralaterally whereas in the CA1, neuronal numbers were normal. These observations are
again well in line with our laboratory’s previous MRI studies which have monitored the
development of the signal abnormalities over several weeks or months after the insult
(Nairismägi et al., 2004; Immonen et al., 2009).
So far, there is no previous quantitative data which would have assessed the number of
CR-ir, SOM-ir or NPY-ir neurons after experimental TBI. However, two previous studies
have investigated CR-ir neurons after triggering epileptogenesis with pilocarpine-induced
SE. Andre et al. (2001) reported a reduction in CR-ir neurons in all hippocampal subfields of
Sprague-Dawley rats, being evident already at 24 h post-SE, and most severe in the stratum
oriens of the CA1 with only 20% of the immunopositive neurons left remaining. Interestingly,
there was no remarkable progression in the degeneration of CR-ir neurons, not even in
animals with spontaneous seizures during the 18-d follow-up. Ferrari et al. (2008) triggered
epileptogenesis with intraperitoneal injections of pilocarpine in adult Wistar rats. Animals
were sacrificed at 2 months and neuronal numbers were counted from three sections and the
authors found that only about 30% of CR-ir neurons were remaining in different
hippocampal subfields. van Vliet et al. (2004) induced epileptogenesis with angular bundle
stimulation and found that at 1 week post-SE only 35-70% of CR-ir neurons remained in the
dentate gyrus, CA3 and CA1 subfields. No further progression in the degeneration of CR-ir
neurons was observed by 3-4.5 months post-SE.
As compared to the <15% reductions in the number of hippocampal SOM-ir neurons found
in this study during the 6 months of follow-up, previous reports have been described much
more severe losses. Sperk et al. (1992) induced SE with intraperitoneal injection of kainite in
Sprague-Dawley rats and followed-up their animals for up to 90 d. They found that already
at 2 d post-SE only 20% of hilar SOM-ir neurons were remaining in the hilus and no further
change was found at later follow-up points. Also, Buckmaster and Dudek (1997) induced SE
with intraperitoneal kainate in Sprague-Dawley rats. After 66-335 d post-SE, 50% of SOM-ir
neurons were remaining in the dentate gyrus as compared to controls. Using the same model,
Buckmaster and Jongen-Rêlo (1999) followed rats for up to 12 months. Unbiased stereological
cell counting revealed that 63% of SOM-ir neurons were remaining in the hilus. Dinocourt et
al. (2003) triggered SE in adult Wistar rats with systemic administration of pilocarpine,
followed the rats for 3 months post-SE, estimated the neuronal numbers with unbiased
stereology in stratum oriens of the CA1, and found that 59% of SOM-ir neurons were still
present. Also, Long et al. (2011) triggered SE with intraperitoneal injections of pilocarpine
but used Sprague-Dawley rats. They followed-up their animals for up to 2 months. Already
at 1 d post-SE, only 54% of SOM-ir neurons were remaining in the hilus, 26% in the CA3, and
47% in the CA1. However, they found that at 2 months post-SE, the number of SOM-ir
neurons was actually abnormally high in the CA1 (145% as compared to controls), but
remained reduced in the hilus and CA3 (65-71% of neurons remaining). Two studies have
investigated SOM-ir neurons after hippocampal electrical-stimulation induced SE. Gorter et
al. (2001) induced SE in adult Sprague-Dawley rats and followed the animals for up to 6
months. The number of hilar SOM-ir neurons in rats with progressive epilepsy was reduced
bilaterally, being only 27-28% of that present in controls. In animals with non-progressive
epilepsy, 29% of SOM-ir neurons were remaining ipsilaterally and 68% contralaterally. Sun
et al. (2007) induced SE with hippocampal stimulation and followed the rats for up to 7 d by
which time some of them had developed recurrent spontaneous seizures. At 1-7 d post-SE,
62-71% of the hilar SOM-ir neurons were remaining. At later time points in those animals
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that had developed epilepsy, 88% of SOM-ir neurons remained. Double-staining of Fluoro-
Jade B and SOM confirmed the neurodegeneration of immunoreactive neurons.
The only interneuron subclass which was actually more severely reduced after amygdala
stimulation induced SE than after TBI or other SE models, has been the NPY-ir neurons. In
contrast to the SE model used here, Sperk et al. (1992) induced SE with intraperitoneal
injection of kainate in Sprague-Dawley rats and followed these animals for up to 90 d. They
found that at 24 h post-SE, there was no change in the number of NPY-ir neurons as
compared to controls. However, at 2 d post-SE only 39%, and at 10-90 d only 59%, of NPY-ir
neurons were remaining as compared to controls. Kuruba et al. (2011) induced SE with an
intraperitoneal injection of kainic acid in Fisher 344 rats and assessed neuronal numbers at
12 d post-SE. They reported that 37% of NPY-ir neurons were remaining in the dentate gyrus
and 64% in the CA3. They did not find any change in the CA1. Long et al. (2011) triggered SE
by administrating intraperitoneal injection of pilocarpine in Sprague-Dawley rats and
followed the animals for up to 2 months. About 47-77% of hilar NPY-ir neurons were
remaining in different time points in the hilus. At 7 d post-SE, but not at later time points,
they noticed a slight decline in NPY-ir neurons in the CA3 as 87% of neurons were remaining
in comparison to controls. Moreover, Sun et al. (2007) induced SE with hippocampal
stimulation and followed rats until they had developed epilepsy. At 3 d post-SE, 67%, and at
7 d only 36% of hilar NPY-ir neurons were remaining. Animals with epilepsy had 53% of
their NPY-ir neurons left and the neurodegeneration of immunopositive cells was confirmed
by double-staining with Fluoro-Jade B and NPY. Thus, unlike the situation with many other
interneuron types, the severity of damage to NPY-ir neurons seemed to be similar rather than
different after systemic kainate admisistration or electrical amygdala stimulation-induced
SE.
The meagre quantitative data available on CR-ir neurons after epileptogenic brain insults
suggest that damage to CR-ir neurons increases in the following order:  (1) SE induced with
electrical amygdala stimulation (2) TBI induced with lateral FPI (3) SE induced with electrical
hippocampal stimulation (4) SE induced with systemic administration of pilocarpine. One
explanation is that the severe CR-ir neuronal death after systemic administration of
pilocarpine or electrical hippocampal stimulation id related to acute SE-induced
hippocampal excitotoxicity. After amygdala stimulation-induced SE and lateral FPI, the CR-
ir neurons remain better preserved as the acute hippocampal involvement in these models is
apparently less severe. As with PARV-ir neurons, SOM-ir neurons are also very vulnerable
to lateral FPI-induced TBI in the different hippocampal subfields, particularly in the dentate
gyrus. The secondary injury which develops over subsequent months induces further
damage and also extends it in a contralateral direction. After SE, however, the vulnerability
of hippocampal SOM-ir neurons appears to be highly model-dependent as previous studies
have  shown  clear  declines  in  numbers  of  SOM-ir  neurons  but  in  the  present  study,  after
amygdala stimulation induced SE, the neuronal numbers were comparable to those found in
controls.  In  this  study,  the  loss  of  NPY-ir  neurons  was  robust  ipsilaterally  after  TBI  and,
interestingly, bilaterally after SE in the subgroup of animals with epilepsy. However, there
were no convincing correlations between the numbers of NPY-ir neurons and either seizure
susceptibility or seizure frequency. It still remains to be investigated whether TBI or SE
induces neurodegeneration in some particular type of the dendritic inhibitory neurons.
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In summary, the present study is the first to show that there is a progressive loss of
interneurons responsible for dendritic inhibition after TBI. The study extends the previous
observations of the loss of these interneurons after SE and, moreover, it was noted that there
was a bilateral loss of NPY-ir neurons at 6 months after amygdala stimulation induced SE.
However, no clear association between the numbers of CR-ir, SOM-ir or NPY-ir neurons and
either the seizure susceptibility or the number of seizures after epileptogenic insult was
found.
6.4 ALTERED PARVALBUMIN IMMUNOREACTIVITY IN THE THALAMUS
AFTER TBI
The results presented here show that lateral FPI-induced TBI results in bilateral reduction of
the total number of PARV-ir neurons in the RT which correlated with the reduction in the
volume of the RT. The decrease was more pronounced in the ipsilateral side where 64 % of
PARV-ir neurons were remaining whereas contralaterally there were 84% left at 6 months
post-insult.  Lateral FPI –induced TBI reproduces the reduction in the number of RT neurons
found in human TBI as reported by Ross et al. (1993) who stated that the majority of patients
who died from severe TBI (6 h to 639 d post-insult) showed a bilateral moderate (?25%) to
severe (25-75%) reduction in the number of RT neurons. The loss was found particularly in
sections sampled at the level of the mediodorsal (MD) and ventrolateral (VL) nuclei.
Qualitative topographic analysis of a neuronal loss revealed that PARV-ir neurons located
dorsorostrally in the RT were preserved in most of animals studied here. At more caudal
levels of the RT, immunopositive cells located in the dorsal or ventral aspects of the nucleus
were preserved better than those in the mid-portion of the nucleus. Thus, the most severe
reduction in PARV-ir neurons after lateral FPI was located in the somatosensory part of the
nucleus projecting to the VPM-VPL (Shosaku et al., 1989; Pinault and Deschênes, 1998). A
major loss of PARV-ir neurons did not correlate with the impact severity (atm) or with the
severity of neuronal loss in the RT. Previously, Ross et al. (1993) has assessed the topography
of the RT damage and its relationship to primary impact after TBI in humans. These
investigators reported that after severe TBI, the neuronal loss was most prominent in the
dorsolateral portion of the RT. However, the appearance of the RT lesion varied greatly
between the patients. In some cases, the cell loss occurred in a small focal region whereas in
others there was almost a complete loss of neurons throughout the whole RT. Interestingly,
in patients with a small frontal contusion, the lesion in the RT was more dorsal than in
patients with severe frontal contusion, in whom the middle and ventral aspects of the RT
appeared to be more damaged. As in the lateral FPI model also in human TBI further studies
will be needed to clarify the mechanism determining the magnitude and the species-specific
topography of the RT damage after TBI.
In addition to the direct mechanical impact to the head, neurons in the RT are known to
be sensitive to the ischemia induced by cardiac arrest. Böttiger et al. (1998) reported a large
number of TUNEL positive cells in the RT already at 6 h after induction of cardiac arrest in
rats. Two other studies have revealed a robust, up to 92 % loss of PARV-ir neurons in the RT
at 1 wk after experimental cardiac arrest in rats lasting for 7-7.5 min (Kawai et al., 1995; Ross
et al., 1995). In the study of Kawai et al. (1995), the loss of PARV-ir neurons was most
apparent in the mid-dorsoventral aspect of the RT located within the 60% of the mid-
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rostocaudal extent of the nucleus. Ross et al. (1995) divided the middle (somatosensory)
region of the RT into three segments (medial, central, lateral) and then assessed the loss of
PARV-ir neurons in different functional segments of the RT. They found that at 1 wk after
cardiac arrest only 8% of the PARV-ir neurons were remaining in the central segment of the
RT, projecting to VPM-VPL. In the medial and lateral segments of the RT which project to
the ventrolateral (VL) and ventromedial (VM) nuclei, 23-33% of the PARV-ir neurons were
still present. These results from animal models are in line with studies in humans, who
experienced ischemic brain damage after a ?5 min cardiac arrest (survival time 2 - 203 d post-
insult),  resulting  in  33-50%  reduction  in  the  number  of  neurons  in  the  dorsal  and  middle
regions of the RT when assessed at the level of the MD and VL (Ross and Graham, 1993). The
level of the RT assessed by Kawai et al. (1995) and Ross et al (1995) corresponds to the
rostrocaudal level of the RT with the most severe loss of PARV-ir neurons after lateral FPI
noted here. In the present study, the post-TBI apnea time varied between 0-25 s, being
significantly shorter than after cardiac arrest. In addition, no correlation was found between
the duration of apnea and the number of PARV-ir neurons remaining in the RT. However,
the contribution of acute post-TBI hypoxia to loss of RT neurons in the present study cannot
be excluded.
The PARV-ir neurons of the RT provide somato-dendritic innervation to the thalamo-
cortical projection neurons in the VPM-VPL (Barbaresi et al., 1986; Harris and Hendrickson,
1987; Pinault et al., 1995; Pinault and Deschênes, 1998). It was decided to study, whether the
loss of RT neurons would affect the GABAergic innervations of thalamo-cortical relay cells
by analysing of PARV-ir terminal labeling in the VPM-VP. The results revealed an increase
in the density of PARV-ir axonal labeling in the lateral aspects of the ipsilateral VPM and
VPL. This associated with the presence of PARV-ir terminals with multiple large
immunopositive varicosities, particularly in the lateral aspects of the VPM-VPL. The pattern
of immunolabeling described here was particularly apparent in the dorsal part of the lateral
half of the VPM. Previous tract-tracing and single-cell labeling studies have demonstrated
that the efferents from the caudal mid-dorsoventral zone of the RT innervate the VPL-VPM
(Shosaku et al., 1989; Pinault and Deschênes, 1998). Interestingly, the caudal portion oh the
RT was the region which was the most severely damaged in the present study. However, the
correlation analysis did not reveal any association between the number of remaining PARV-
ir  cells  in  the  RT and the  density  of  immunolabeling in  the  whole  VPM-VPL or  any of  its
quatrants. It is possible that stereological estimation of the total number of RT cells diluted
the possible effect of a robust focal loss of PARV-ir neurons in the caudal aspects of the RT
on  the  density  of  terminal  inputs  in  the  select  regions  of  the  VPM-VPL.  It  remains  to  be
elucidated whether the increased density of localized patches of large terminals in the
dorsolateral aspects of the VPM-VPL is evidence of plasticity that had occured during the 6
month follow-up in the axons of the surviving RT neurons in the ventrocaudal part of the RT
projecting to the remaining VPM-VPL neurons remains to be studied. Another possibility for
increased immunolabeling in the VPM-VPL is the shrinkage of the nucleus. Visual analysis
of thionin-stained preparations revealed a variable degree of neuronal loss associated with
gliosis and calcifications in the VPM-VPL in all rats with TBI as described previously (Lehto
et al., 2012). The damage to VPM-VPL was confirmed by quantitative volumetry which
revealed a 30-69% reduction in the nuclear volume after TBI ipsilaterally as compared to
controls. The focally increased PARV-ir immunolabeling was more likely to be related to the
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sprouting of the remaining axons than shrinkage of the tissue as the correlation between the
volume and PARV-ir labeling intensity was not found.
Data clearly showed that in control animals, the higher the density of PARV-ir neurons in
the  RT  or  density  of  PARV-ir  terminals  in  the  VPM-VPL,  the  lower  was  the  seizure
susceptibility in PTZ-test. All these correlations were lacking in the post-TBI animals.
However, in most of the rats with TBI, the number of PARV-ir neurons was lower than that
found in any of the control animals. Furthermore a reduction in the number of PARV-positive
neurons in  the  RT after  TBI  did not  seem to  render  the  injured animals  any more seizure
susceptible than the most seizure-susceptible control animals. It remains to be explored
whether the plasticity in GABAergic inhibitory inputs to thalamocortical relay neurons,
which project to the perilesional cortex (S1 and S2) are involved in modulating the occurrence
of induced or spontaneous seizures or other electrographic patterns described during the
progression of the secondary damage after FPI (Lee at al. 1994a, b; Guillery at al., 1998;
Pinault and Deschênes, 1998; Burton and Kopf, 1984; Pierret et al., 2000; Henry and Catania,
2006; Liao and Yen, 2008; D’Ambrosio et al., 2005).
6.5 CHANGES IN THE GABAA RECEPTOR SUBUNITS AFTER TBI
Analysis  of  the  tissue  resections  from  patients  with  TLE  have  revealed  altered  GABAA
receptor subunit expression patterns i.e. there is greater labeling of the ?2, ?2, ?2 and ?3
subunits (Loup et al., 2000; Pirket et al., 2003). Many laboratories have demonstrated the
altered expression of GABAA receptor subunits in rat models of acquired epilepsy induced
by SE (Friedman et al., 1994; Schwartzer et al., 1997; Tsunashima et al., 1997; Brooks-Kayal et
al., 1998; Sperk et al., 1998; Fritschy et al., 1999). However, the gene expression patterns have
been found to depend on the SE model used and the time point post-SE when sampling was
done. Different methods have been used to assess altered gene-expression levels. In general,
some studies have been revealed gene expression changes shortly after SE but also at chronic
time points indicative of long-lasting alterations. One can highlight a few studies. Brooks-
Kayal et al. (1998) induced the SE with pilocarpine (i.p.) and used slot-blot hybridization for
single cells; they found up-regulation of the ?4 (175% of that in controls), ?3 (267%), ? (225%)
and ? (233%) subunits and down-regulation of the ?1 (54% of that in controls) and ?1 (59%)
subunits at 1-4 months post-SE in the dentate granule cells as compared to controls.
Moreover, a recent study by Kobow et al. (2013) utilized next generation sequencing to
analyze the whole rat transcriptome in an epilepsy model where SE had been induced by
pilocarpine (i.p.); they detected down-regulation of Gabrd (log2ratio ?0.9) at 3 months after
SE. The studies of Friedman et al. (1994) and Tsunashima et al. (1997) used in situ
hybridization to assess altered GABAA receptor subunit mRNA levels after kainic acid (i.p.)
induced SE. Friedman et al. (1994) reported the decreased expression of ?1 subunit in the
CA3 and hilus (45% and 56% reduction, respectively), but no change in the granule cell layer
at 24h after SE. Furthermore, Tsunashima et al. (1997) assessed the mRNA levels of different
GABAA receptors subunits at 6h, 12h, 24h, 7d and 30d post-SE. At 6 or 12 h post-SE there
were decreased levels irom granule cell layer of the ?2 (40-60% decrease as compared to
controls) and ?5 (50%). At 12 h post-SE, the mRNA levels of ?1 and ?4 were increased (60%
and 40% as compared to controls, respectively) and remained at the same level on 7d after
SE. At the later time points (7d and 30d), the mRNA levels of all ? subunits were reduced in
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the CA1 (40-80% reduction as compared to controls). In the CA3, the mRNA level of ?2, and
?5 subunits was decreased (20-30% reduction as compared to controls) after one to 30d post-
SE. The level of ?4 subunit was down-regulated only at 30 d post-SE. Interestingly, the
mRNA level of ?1 was first (at 6h-12h post-SE) decreased (50%) but later (7d-30d post-SE)
was restored to the same level or slightly above the control values. In the granule cell layer,
the decrease of the mRNA level of ?1 and ?3 (both 50% of decrease as compared to controls)
was observed at 6 h post-SE. Later, increased levels were found of ?1 (25% after 12h-30d) and
?2 (25% and 50% after 7d and 30d, respectively). In the CA1, levels of all three ? subunits
were decreased (50-70% decrease as compared to controls) after 7-30d post-SE. In the CA3,
the decrease in the mRNA level of all ? subunits was found in the early time points post-SE,
but the levels of the ?2 and ?3 had recovered to close to control values when measured at
more chronic time points. In the granule cell layer, the gene-expression of ?2 had been
reduced (55% of reduction as compared to controls) at 6 h post-SE. In the CA1, the mRNA
level  of  ?2 was reduced in  all  time points  measured as  compared to  controls.  The mRNA
level of ? subunit was decreased in the granule cell layer at all time points after SE.
Three studies have investigated acquired GABAA receptor channelopathy after TBI.
Gibson et al. (2010) induced TBI by using central FPI in adult Sprague-Dawley rats. These
investigators measured the levels of the hippocampal GABAA receptors using western blot
at 3h, 6h, 24h or 7d post-TBI. The level of ?1 was increased by about 25% at 3h and 6 h post-
TBI of that in controls, but later it declined (50%). The protein level of the ?3 was reduced by
about 25% only at 24h post-TBI. The ?3 level was first (3h post-TBI) decreased by about 50%
of that in controls but later (6-24h) it became increased (30%). Finally, at 7d post-TBI the level
of the ?3 became comparable to that in controls. In addition, the protein level of the ?2 was
considerably increased (200% of that in controls) at 3h post-TBI, being later resembling more
the to control values except at 24h post-TBI when it was only about 30% of that on controls.
Raible et al. (2012) induced TBI using lateral FPI in adult Sprague-Dawley rats. They found
reduced levels of the ?1-subunit mRNA in whole hippocampal homogenates at 6 h post-TBI
and reduced levels of ?1-subunit protein at 24 h, 28 h and 1 wk post-TBI. Interestingly, the
level of the ?4-subunit mRNA were increased at 6 h post-TBI but an increase in the protein
level was found only at 24 h post-TBI, as the levels were below those of controls at 1 wk post-
TBI. The study of Kharlamov et al (2011) compared the hippocampal protein values of the
?1, ?4, ?2 and ? subunits between controls, post-CCI Sprague-Dawley rats with or without
spontaneous seizures at 7-11 months post-TBI. These investigators found a decreased protein
expression level of ?2 in the rat group with PTE but an increased level of ? in the subgroup
of rat without seizures.
In this thesis study, in situ hybridization analysis in the lateral FPI model revealed that the
increase in the expression of the ?4-subunit in granule cells was long-lasting, still being
detectable even 4 months post-TBI and it was associated with an increase in expression level
of the ?1 subunit. The present study also assessed mRNA in the laser-dissected granule cell
layer, CA1 pyramidal cell layer and thalamus at 6 months post-TBI but did not reveal any
changes in ?1, ?4, or ?1 mRNA. However, there was an increased expression of the ?3-
subunit in the granule cell  layer and a decreased expression of the ?-  and ?-subunit in the
sample containing the thalamus and the underlying hypothalamus. In rats the ?- and ?-
subunits are mainly localized in the hypothalamus (Sinkkonen et al., 2000; Moragues et al.,
2002), suggesting that the change in the subunit expression perhaps reflected TBI-induced
GABAA receptor channelopathy in the hypothalamus. Interestingly, the ? and ? subunits are
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clustered on the X chromosome (rat reference genome RN4) along with the ?3 (Bailey et al.,
1999). Previous studies have shown overlapping expression patterns of all or part (?3/?, ?3/?,
???) of those three in the developing and adult rat brain (Sinkkonen et al., 2000; Moragues et
al., 2002; Pape et al., 2009). The co-expression of ?, ?- and ?- subunits suggests that they share
regulatory elements. In addition to ?3/??? cluster, there are also clusters for ?1/?2/?2 and
?2/?4/?1/?1 (McLean et al., 1995) indicating that the expression of GABAA receptors subunits
is under coordinated control. In the thalamus, the lack of changes in other GABAA receptors
in spite of the extensive thalamic cell death and reorganization of GABAergic circuitries,
particularly, in the VPM-VPL could be due to the dilution of changes when the entire
thalamus was sampled. Further studies are needed to assess whether there would be nucleus-
specific changes in GABAA receptor subunits after TBI.
Taken together, data from this study reveals that the targets for treatments aiming to
modulate GABAA receptor subunit activity are substantially well preserved in the post-TBI
hippocampus and thalamus. In addition, there seem to be more alterations occurring in the
GABAA receptor subunits after SE than TBI.
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7 Summary and conclusions
The aim of this thesis study was to profile and compare alterations in the GABAergic network
after two different epileptogenic insults. A special emphasis was placed to assessing
neurodegeration of the inhibitory neurons in the hippocampus and in the RT of the thalamus.
In addition, TBI induced plasticity was studied in the thalamus. Finally, the RT-PCR array
was used to investigate if the loss of presynaptic inputs changed the gene-expression of the
GABAA receptor subunits. The main findings can be summarized as follows:
1. In rats with TBI with no spontaneous seizures during two weeks of video-EEG monitoring
at  6  months  post-injury,  the  loss  of  GABAergic  interneurons  in  the  dentate  gyrus  and
hippocampus proper was clearly greater and more widespread than in rats that developed
epilepsy after SE.
2. There was a remarkable decrease in the number of PARV-ir neurons in the RT on the
ipsilateral side, which was associated also with the loss of neurons contralaterally at 6 months
after TBI. In addition, there was a robust increase in the intensity of PARV-ir axonal labeling
in  the  lateral  aspects  of  the  ipsilateral  VPM-VPL,  including  a  high  number  of  large
immunopositive varicosities around the unstained somata of the relay cells.
3. Injured animals with altered PARV-immunolabeling showed increased seizure
susceptibility in the PTZ test, but unlike the situation in controls, there were no correlations
between the seizure susceptibility and density of PARV-immunoreactivity in the RT or VPM-
VPL at 6 months post-TBI.
4. From all GABAA receptor subunits, only upregulation of ?3 in the granule cell layer and
downregulation of ? and ? in the sample block containing both thalamus and hypothalamus
were found at 6 months post-TBI in contrast to previous studies with post-SE models where
more numerous alterations have been detected in the subunit gene expression.
In conclusion, this thesis studied on well-phenotyped animals and conducted an unbiased
quantification of different interneuron classes in the same rat strain. The results challenge the
previous claim that the loss of hippocampal interneurons is a critical pathological change
predisposing to epilepsy. Further, it provided new information on the role of post-traumatic
molecular and cellular alterations in the GABAergic network in the hippocampus and
thalamus.
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Brain insults can trigger 
epileptogenic cascade which 
predisposes the brain to be 
capable of generating spontaneous 
seizures. The aim of this thesis 
study was to profile and compare 
alterations in the GABAergic 
network after traumatic brain 
injury and status epilepticus. 
A special emphasis was placed 
on assessing a reduction in 
the number of the inhibitory 
interneurons in the hippocampus 
and in the reticular nucleus of the 
thalamus in rats whose epilepsy 
phenotype was studied. 
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